var title_f33_35_34352="Tobramycin: Drug information";
var content_f33_35_34352=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tobramycin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/20/41283?source=see_link\">",
"       Tobramycin (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/27/13753?source=see_link\">",
"       Tobramycin (systemic therapy and oral inhalation): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10000 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34352=[""].join("\n");
var outline_f33_35_34352=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/20/41283?source=related_link\">",
"      Tobramycin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/27/13753?source=related_link\">",
"      Tobramycin (systemic therapy and oral inhalation): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_35_34353="Polyostotic fibrous dysplas";
var content_f33_35_34353=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Polyostotic fibrous dysplasia (tibia and fibula)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 516px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Observe the significant expansion of the middiaphysis of the tibia and fibula, with the characteristic ground-glass appearance to the matrix of the fibrous dysplastic lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum TR, Rowe LJ. Yochum and Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34353=[""].join("\n");
var outline_f33_35_34353=null;
var title_f33_35_34354="Echo PI";
var content_f33_35_34354=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Transthoracic echocardiogram (echo)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 486px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHmAfwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACio55o7eJ5Z3WOJBlnY4AHua4TVviroFhctDCl5eFTgvDGNv5sRmk2luNJs7+ivL7r4x6XHEskGl6jIuMsW2Jj9TmprD4zeF7gqtyb20c9fMh3BfxUmlzx7hys9KoqjpGrWGsWi3Ol3cN1A38cTAgex9D9avVQgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKyvEetQaLZebIPMmfiKEHBc/0A7n/AOtWlNIkMTySsqRoCzMxwAB1NeR69qB1W/nvgSYyCIAe0Y6fn1/GplKyGlcq6nqGp68ZJb6ctbo37uFPlj3euO+PfPesV9Ej3jcvU811MkSWthCmMYwKx7u7HnDB71hKVtzRGJqVhCsTDaNoHSuFnsAzPtXksa9EvMyHH97I/SuZ8gpdSIRzyRWdyzmtPvL/AEa68/TLue1k7mKQrn2OOteteD/i9fxSQweIIUurcgDz4l2yr7kdG/DFeY3sIEu1Rk5qe2tGHljbyOKqMmhNJn1hpWo2mq2Ud3p86T28gyrof0PofY1br57+DviJtF8TnTblmNnqDeUOeElz8h/Hkfl6V9CV0xlzIxasFFFFUIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDh/ilqLxWFrpsLbWvHPmEf3Fxx+JI/WuTmCrG6jgKmKk8eXpu/HZg3ZS0WOMD0Jwx/8AQh+VUNRm2K49ciueUtTRLQn8R3WyCIA9xXNCYvk55yata5dedp8EgPQjNZMMn7x1zweRWL1NEa5JeMMOuM1RvbbzLqGWMZz+oq/bc2aN6ZqtdOsdmHYkEHaMHGecY/KkBlw6YBiRslmAOf6CpJY0tYjJ1lPCIB0q6l1BDBE9z5oDghGIABA/HNZ93fLeS+RpsbSzvwCB0/wqtg1KGixO/ifR7S3+a5kvYmOP4fmH8hk/hX1ZmvC/hxoaeH9fs9R1ZkM0z+Qm7+Fn+UY9TkgfQmvc66KOxnUTT1DNGaKM1qZhmijNJmgBaKM0maAForD8V6jcafa27WrKryS7SSueNpP88Vw114+W3kZJ/EFjC6nDK0kIIPoQaAPVaM143L8TrCP/AFniqy/CSI/yFU5PitpPIPiPf/1zVj/6CtAHuGaCTjjrXhLfE3TZPuapqUv+5DP/AIVG3j63k+4mtzfSJ/6kUAe95prSIv3nUfU18/S+NYyDjSdXk/3lQfzeqU3jkJkroN4f9941/qaAPol721T71zAv1kAqBtW09fvX1sP+2or5um+Is0f3NA/76ugP5Kazbn4qX8YOzRbdf966J/ktAH0+2u6YvW9hP0Of5VE3iPSx/wAvWfpGx/pXyfd/GHWEz5emaev+8zt/UVL4R+KWu654s07TZrbT44LiXa5jjfdjBPBLe1AH1bY+INOvr0WlvcZuGUsqMpUsB1xnrWrXlfhVPN+INr/0ytWf/wBCH9a9UoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiijNAHz5qF553jHVJSSd17IFPsDgfoBTPEFwUyQeA2TVGzl36vcS9SZmb8c1J4hyzMvZkyPwrjbN7FNLkS2UsBPzD5lqrDJ/q3/AOAms+GYoVbup5+lWidjOnZvmU0hnWWfOmKfx/WsjWn/ANERQeAxP48/5/GtTTG3aJG3fYDWBqZJtX9pMf8AjtICXW8eQXHPlCOJD7BR/ial+FkJufEd3IwykaBefVjn/wBlrP12by9OsyrgpPCkpHcEKF/mDXWfB6yMdi904+a4lZs+w4H65pR2NpO8tOh3dujXPiW1hgt45FiHmOzHGMdPoM4+vFd9muKfUo9KvIrlziLcI5MD+FiB+hIP4V2SOHVWRgVIyCDwRXTS2OeqncfmjNNzSZrUxHZopuaM0AOozTc0ZoGcv46f/jxT1Lt+W0f1r421adJNV1GTapZ7qVs4/wBs19geO5MXFp6JFIx/Er/hXyBpdg97M0uD87s35mmIhs7J7lwdvFdroehAbSyCr2iaGEVSVrr7W0WFBx0oArWNgkSj5QKvRRtNPHBApaWRgqqByTTZXOdsYJOCcAdq69fAjyW4ubO9L3MahxG6YVmwD1zkfiKANjSvh5ZNY51OSSW4fkGMlQntjvXivjSybRNXns2nilCMcMjZ49D6GvVp9E8U6jpz2N5fW9hZs3SNlZ2984B/WvOvH3gXVbCES2tw2psq7mjhjJZVxkseTgcd8fjQB5zfXY55rnb+7znmnalPJGcSKyEjIyMZFYNzcFs80ANupsk810/waj874j6Z3CCR/wAkNcXIxY16H8BYN/j1ZCP9XbSN/If1oA+nPAab/HN4/wDzzs9v5sn+Nem15x8Nl3+Jdbl/upGn5/8A7NejZoAWiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACikooAKKDSUAfMFvJ5eo3H+zcuv4bjWvrQBt4HPVe/t3rn5m26hqHtdP/AOhVv6uc6dz2xXGzc5GZQly6HocirYBk0+GUfeQEH8KqagcXv5GrmlndYzJ/dkJ/OkM6XRH36Kir/crJu4/MSeP+9hh9as+HJwkTQMcFCR+BqLVla3uCw6HpQBzsNlc6hcrZQAtJu29OFX1PoK9q8P2iaZpsMMfCxoEHvgda8u0/UxpGrxXpybO4AWXAzj0P4V6cl4k9srxMGVgCCOhFSzWGo+7t7jV547S2ZN7OGO9sDA5/pn8K77SLQ6fptvamQyGJcFsYz349uw9q4Pw0WfxRZgB2CrI5K9vlxk+3OPxFeiZraitLmVZ68o/NGajzRure5jYk3Ubqi3UbqVwsSZozUe6jdRcLHD/EWby3nbP+rsi//of+FeI+EtHVdOtmZeSgNeu/FGXFprDA/csiv/jrH+tcbpka2+nW69MRqP0q0SyWCBIU6CormfHyryx4AHep7aOXUb6G0tyqvM2xWc4XOM9an1Dwhf28t2bq4tltoVJ89ZRt3ccEdQeRwaAOs0XQYLTTBLJbT3d06kPJZTFJUU/7LMv6Zq5pFwlu6ta32sPEjFZILqFkXI4wCUJ9OhAryK8ude0/y47fUEZSRt8u8jfBwT2bI4FW0+I/inw1bmLU4Rc28hBEjPvKg++TQB2/xF1fUNWjksPDDTw3cOHaWCXgjuCApP0wa8007wF4q8Q68kWuLqNlaSRs017K+4vxwME9z2IyB2re1n4jyaPbJcy+FYop3AkLwnDMp/iLLnGc9T3rX0r4z+Fr/TPI1OSWyuJRiGHDyluMAlgCASeOTnvQB5x4i+ES2jW8T+J4Z7ood6pCZDuHRVUHd/P6CvIvEWjX2h6rNY6jbywyoeBIoBZeoPBI6EdCcV6f8RtHgV4vE3hjXizmV3MUt1GkkT5/5ZoSH4+meRiqFr4Q8a+NtJhuNQuJriKBmaOS8fCopALMzn6DjnHtQB5hHESa9X+ANrjxLfSkfctSPzZf8K4GGyKyFTgkHGQcg/Q1638D7XyrvU5Mf8s0X9T/AIUAe5fCxc3WvS+sypn6F/8AGvQK4X4VJ/xLtVlP8d8/6Af413GaAHUUmaWgBaKSigBaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopDQAtJRRQAUmaKaaAFJpO9ITWfr2pRaTpF3ezMFWGNmAJ+82OAPcnilcD5ox9o1e4VOQ9yzk+241r61cBbUR55YisvTitnC0kzAzPycVk6vqLSSNz0rkOgivLgSXZIPFaOgzLIlzF33Z+v8AnFc3H5jt8oLMx6+la8VrJaGKSzkNw2394qqQffAPUUNCUk3a+pf89rO7Enbow9RWy88V7bBWYE4yrDvWN5kdwmJVYeoZcH9am0vTZ7q8WDSYpZ7hukarkfU84A98ihDaIZUkhYwyLvibPI5/StnQdTfT0WFW3wdkY4I+ldNZ/DbVri1R7+eyhmPJjBY7fxHGfpWna/Dy+sik1vq0DTqcgNAQB7Zyc/iKbg2JStqbHw9ka5nuLsQusZjCB2GOc9B/n0rtt1Zeiw3trZCLULmKeUHgxRCNQPTA/ngVeLVrFcqsTN8zuSlqTdUW73pC1O5JNupN1Q7qN1FwJt9G+od1G6i4Hm3xQkzp+u/9cwn5qo/rXHG43iGFWRS2FBY4A+p7V0nxQlxouruf4pUT/wAiKtcFaajHDeRtPFFNF91kl4BH1HStEQz0fw5qtlpWzS9WtYkDtiS44kjZmGVLenYfqMUkFxLb6s+nlnaF9yGVo3KSIcdGHUE9wSfUnFT+GdNiuNPSS0ilsI5upt7oTRg/3irbsH8D74roNP8AD+o6bqCNbPby6dKTJcFD5bM/Y7DlfTJBX6UwMi2+H/h/VbndJGqzRnI8iXBOPb/61dBYeAtHt5Lny4S6zY8xLlBKpAHQBsjHeqeraza6FdW8ztaOs0jIwIJkPGeCG4Ax2B+gqXWPF4i0t7iBlRCNsUgjldA2cYOFVvxoAtaz4N0W4sxG9jB5A4eGONYlZSMEfKBx0/KuI1r4EeHNSgRLEvYEP5iTxKr5HZSGzkVraPpmt6tqUd7qviRHsmyUgtbIQbOQcFmO4jHHQ9+legRLb2sA23A2quEAYBcfQcfjQB4zH8HLvR78ajbL4e1WVMbYbm0kgyAO+HdTn/c/+vb1e18QPpiyeIvDBvIhtAg0+6hkihjDZ2pDKsQJHHLhsc44zXoNtJ9qjuC960A6bguD+ZFcH4ztrZLyGS41KR4GBCRyM/lk/wB5sYUkc8Eke1AHm/xIgGoXdtdad4O1HSrdUwGjs3kEo7cxBowAB2Iqf4T6vpFsdQim1KzhuGZAIpZlRzjOflJzXrOm69baP4YuLi/utilSsR8uRY3bb8oUN16c7MiuH8JeXrFhq17qNtbyGe4aRkMYKD5c4APagD1f4W4PhfzVIImuJHBHfoP6V1+a8x8CeAvDc/haxuDpUdtcyb2aayke1kOXPO6Iqc4A5roB4PmtznS/FHiOzx0VrpLtfx+0JIT+efekB2GaWuRj0/xjayAw+INLvocjKXmmMkhHf95HKAD/AMANZvjtZD8Qfh8iXl/DFPe3CTRQXksUcypbSSqHRGCsA6KeQcgYOQSCAegClryHSPGHjTVbjQ/Kl8OwQ6xdX1tFusp3a3Fu7gM374b9wjYbRtwcHPasrWPi3rsHhmPVNPtbSe5stPW91S2Wz3RJ+9dMiZ7iPYG8tsKEkYehpge50ory3VvG+vRaxPJaPo8Wl2/iG00JraaCR7iXzXiDyBxIqqcSkquxuFyT2rK034leK76CXUo9F09NMnju/souri3t9ssQbYpkNyWcllCsDFHtzycDNAHs9FcZ8OPEeo65HqcOtNAL6ylRXiSxktHjDIGAdHeQe4ZXII9DxXG6p498Qz6KbqOXSY7bVX1KytbeGKQ3Vm1vHMwkdvMw/wDqfmAVNpdeT3APZaK8rstIXRv2edVhWLTkabQp53NjafZ1ctbfecFmLSYA3OTliM4FZk3j3xD4U0mSz1C302/nTTdOuLRrWJoVj+0TGDbJ5kuG24B3boweh29QAez0V5G3jnxbFANOu7K2t/ET3bpBAlnFO08KxK7M0a3wSAruHLzHIwQOeL3hLxp4h8UzaDFax6VZG80hdRuXliebawmKMqAOowccZPGc/N0IB6dRXCfBSfWLv4c6Pd67qMd/LNArJJ5TrIBzkSO0j72z3+X6V3dABRRRQAUUUUAFFFFABRRRQAUUUUAFFFIaAA0UUGgANNopCaAAmkJpM00mkMUmub8Y+F4PE8VvHc3dzbrCSQIiMNn1B7+/ua6EmuU8f63JpunJbWj7bq6JUMDyidyPft+PtSeugpSUFzM8q8U+HrC01Q2WkSz3CQjbLI7jBfuBgDp+POayE8MjdlsZ9hXW2NoBGOMVeFsAcUKKR5VSpOo7nIR6KsQ6cfSnNpisoEXEidD3rp7qEKtZcmY5A69utNoxTafmc9e3TQMY7hCrjoR0b6V6j8JorI6DJdwOkl1LIVlI6oB0X+v41w+r2cd5Buxz1B9Kh8C6q/hjXma43GwuB5c2Oi88Pj27+xNZKkou6PUhj5ztCex7sWppaoVlWRFeNgyMMqQcgj1oLUXOskLUhaoi1IWpXHYlLU3dUe6k3UXCxLupN1RbqN1ILEu6jdUW6jdTuB5J8WJtnh+6z/y0vlH/AJFz/SvJb69AB5r0b413Hl+HbU5/1l+p/wDHXNeIX19nPNboyOt8M+Nl8P3pa6sxf2hIJjMzRspHdSP5EYNe06X8dfBl9AI7m4vdFlYAfvIDIgPTqmT/ACr5Nurkknms+WUk0AfVV94z8Lyte/a/s2rWsjZV31O2YHrghGfd37rkVp+FvHPgSyS38y1vtOmKeRFBLbSvFIpb+ExoUbnv1r47LZq1ZaheWbZs7u4tz6xSsn8jQB+g+sa9pOmWiS3HmBMBUEFvJLg9gQisQO3SuMsvHtnNrBGtXWnWUI4SO5WSB+vX96ijGM//AFq+P/7e1e5iMNzquoTRNwySXLsp+oJxU9kQMUAfYHiX4ieGLd1W31i3YhQVFqpmPtjAKA+xrzPxL8Qf7TmQ2lu83lHMUt/tk2H1WMAIOnfNeT2sgAFX1nAFAGzqeqXWo3DXF/cy3Ex/ikbP4D0HtXoHgJtvg27k9XkP/joFeQzXWB1r1nwKcfDjzP8AnoZD/wCPkf0oA9u8GJ5XhXS19YFb8+f61tg1leHRs0DTF9LWIf8AjgrSBqCiUGs/UNC0jU760vdR0qwu7yzYPbTz26SSQEEEFGIypyAeO4q6DTgaYitBpWnW/wBm8iwtI/szO8GyFV8pnzvK4HyltxyR1yc1n3ng7wxfeT9t8OaLc+Shji86xify0JJKrleASzEgep9a474neHLrVtaW5k8Of8JLYnTJbWC286JPslyzZE2JWUDIwN65ddvA5rEvvh1qlxa6xdX1jDqHiBLfS1stQZ08wzQqnnSIxIKElSSTgkcc0xHdar8PdI1bxhb+Ir53kuoJYpo4hbWygNHjZmURecQCA20yEZ7YwK2D4T8ONfXV62gaQb26VluLg2UfmTBvvB225YHvnrWJ8StIutWh0UxacdY0+1vfOv8ASt6L9ri8qRQMSFUba7I+1iAdv0rz7WfBGo3MV6tp4L8t7nT47fRm+2wn+wJRJIS2S+U5ZJMw7vu7OgFMD2fRdF0vQ7VrbRNNstOt2beYrSBIULeuFAGeOtQp4b0NNQu79NF0xb67Qx3FyLWMSTKeCHbGWB7g15dffDNr/UNQvr/Rbe6vZ/EsNwblym97Dy41k5zwh/eAp1PoeKx9T8MJpfivQ9MvvCY1fTTd6zNZaTEbcxiFvs5QhZHWNVBLEKSCOoHAoA94eytXsGsXtoGsmi8g25jBjMeMbNvTbjjHTFZcCaBql/qlilpZz3NpHHY3iPbDiMr5iRElcMmHzgZAye+a8pufCXirStCltYdIl1a4vfCv9jfubuIC2l3SkK7SupKhZQoKhs7OcZzTNU+H+rY8Uppvh9ItT1KCze31SI2ylVjjhW4tyzEuDJ5bj7jId/zHrQB6sPBfhYaelgPDWifYUl85Lf7BF5ayYxvC7cBvfrWlY6RptgYjYafZ2pii8iMwwqmyPOdgwOFzzjpmvHtD+Hc63WkRnRNRh0hdY+1XVrqEliiiP7FNExENoFjCszIpUbi2SWGM17TbW8NpbRW9rFHDbwoI44o1CqigYCgDgAAYwKAKulaNpekG4Ok6bZWJuZDLN9mgWLzX/vNtA3H3NX6KKACiiigAooooAKKKKACiiigAoooNACUUUGgANNNFIaAAmmk0E00mkMCaYTQTTCaVxik14/4ivjqvie6kDZiibyY/ovH6nJ/GvVdQuPs1jcTk48qNn/IZrxHSGy2WOWwWNCOPGSslE10m/fpEvTIrUXk1gWTbr9fYk/p/9etwNgUziiyvqDcYrKnXqDz61pT/ADzD0UZ/GqN2MAtT6GUn7xVhOY2UnOP8/wA81jaxugjLx44OSPUVeE+ydhnhgCKZqCCWA9wRUlPc634a66HiGmSsSm0vbknoO6fh1H4+ld4Wr5/0K7lsL1ShIlgcOnvj/EV7ta3C3NrDPH9yVFkX6EZFZz0Z6uEq88eV7os7qaWphNJmoudY/dRuqPNGaVwH7qN1R5ozQBJmkLcUzNGaBnI6j4eGpwRw6lpiXKIdwWQoQGxjI59zWd/wgOkk8+HLQ/VI/wDGu/zRmr9oyORHn3/CvtGPXw1Y/wDfuP8Axpf+FeaN/wBCzYf9+o/8a9AzSg0e0YciPPx8PNF/6FnT/wDv1H/jUdz4F0S0t5JpPDVgI0GTiGIn+deig1U1g502cH0H8xTVRtg4nmo0Tw4vTw5bD/t2j/xp66VoI+74fgH0t4/8a6baPQUbR6CtjM5Gf/hHreYxPocYcDOBbp/jXSWvhG0ubeKeLRLPy5UDrlIwcEZFc/rCA64/A+6v8q9U0Y40ix/64R/+gipk7FRVzkR4Jtj/AMwSx/74jqeXwpdPp32G0t4LWEkYwQFUZyeBXahqkDVPOx8o+zjFvawwg5EaBAfXAxVkNVYNTw1K4FgGng1AGp4NUImBp4NQg08GncCQU4GowacDTEPzS00GlFAh1FJS0wClpKKAFooooAKKKKACiiigAooooAKKKKACkpTSUAFNNLTTQAE00mlJphNIYE0wmgmmMaQwY1GzUM1RsakZk+LpCnhnUyP+eDj8xivIdMPMh9E/rXqXj2cQeE9RcnA2Kv5sB/WvJ9NY7ZyP7q/1qonnY1+8jT0s7r9vZTW2x59hXP6U2L+T/drcJDBU67zj8O9UcaYgU7C5HLHdWbqz7LdselbcoyKwNbOIWHtT2J3Zk3PyzAdwoqSCVXUxv0NQ37gXEcg+66AiqsjGNhIP9Wx59jUjKuoRm11FX7NXpvw81tL/AE57CQgXNkduP70Z+6fw6fgPWvO9WxNYrJ/Eh61mabq1xpGuw3tofnVRuU9HHQqfriplHmRvh6vspXex9B5ozVLStQh1PT4Ly2bMUq5x3B7g+4NWs1ge0nfVDs0ZpuaM0hi5ozTc0ZouA7NGabmjNAEGoTmC0dlOGOAp9ycVzlxeSxuFWWZmxk5mYAVra0/+oj7Fi35DGP1/Sufm/wCPiQvwc8Z9MV0UYp7mU2+hN9tuCeWk/wDAh6sQySPGrGSYZ5x5rH+tUAvmuqDo3X6d/wDCtEcDArWUUtiE2wy3eSX/AL+H/GkZdy4ZmYHsWJpaKmwyL7PF/d/Wj7PF/dFS0UAUbq1tEIke2R3JwCRyfxpyXTIoVFkVQMACUgAUl026YL2Ufqf8/rURIHUj860jBNXZLeuhfguZXJAlnQrg8TN/j7V0/h66e60xJJWLNvdNx6kK5A/lXGtJ9ksri5cEYUsAepwOB+f867LRLc2elWlufvJGob/exk/rmsKllsaQNUNT1aq6tT1as7l2LKtUitVZWqQNVJklkGng1XVqkU0xE4NOBqJTTgaoCUGlFMBpwpiHilpopRQIdRSUtMApaSloAKKKKACiiigAooooAKDRSUAFIaWkNACGmmlNNNIBCaYTSk0xjSYxGNRsaVjUTGpKEY1GxoY1ExqWxnJ/E58+HFh7TTqhHsAW/mBXm2hZYXKN95QAf1rv/iY5+x6evrOT/wCOn/GuK02IJfT4/jQGrhseXjP4lvIfbny7wE9CMf5/KtyzbfKW7KNo/mf6VzN3IUj8wdY2wa2tFm3xqe5J/nVo49jbYfJWBrgwhroGOV9hXP62cxsabGloYt6A+m20o/gzGfw4/pUNo42lW5U8EVdsY/tOlXUA+8CSv5A/zzWNHJsx6UhMffxmGJ0XJiYfL7e1c+2HuF/3B/M10zOs1uyN6Vy0Z/0xlP8AAdv5UkPoeifCzVTDez6XK3yTAyRAn+MdQPqOf+A16dXz/Bcyafe295B/rIXDj3wen0r3iyuo72zguYTmKZFkX6EZrGorO56uCqc0OV9CxRmm5orM7hc0ZpKTNIB2aM03NNd1RSzsFUdSTTAh1C1W8g2NwQdyn0NZEtjdw5wC6j/gY/x/nWg+pID8kUjj14Gajk1MiNtkD78fLkjGfzrSPOtkQ+VmZbBNpdUCEkg4HocVctI7V7fzZnVicsfmxgdhj6VTV5AoHkucd8jn9aQ8nJtic/7v+NbmRoRwWqwGSX3YjeeB6daRba0jh3TfeA3N8547461nFUPW0/8AHV/xpCkXez/8cX/GgDQFvaJaGRy2cFj85yO+OtVoQwiXf1xzmoVWMEFbUgj0RaZfPM9pIkMUnmONucdAep/KgCjcajp6yOQ8k7k8hM4/PgU22ub69O3TLIKvTcFz+Z6CsqHSLgNmWCTb/d7Cu80e8htdMt4JBIrIuCNh45qZSaWg0k9zLsPDV5cXMcurz5jRg3lbs5x244FdoGrNXU7b+8//AH7b/CnDU7b++/8A37b/AArF8z3NFZGmGqRWqjbXUVxnynzjqMEEfnVlWpDLCtUqmq6tUimqQrFhTUqtVdWqRTVJklhTUgNQK1SKaYiYGnA1EDTwaoCUUoNMFOpiHClFNFOpiFooooAUUUgpaACiiigAooooADSUGigBDSGg0hpAIaYTTjUbdaBiE0xjSsajY1IxrmomNKxqJjUsY1jUTGnMaiY1JSOL+JTfudM/67N/KuTgYJqaA/xKV/r/AErqviT/AKjTT/02P/oNcfcnZdwSDsw/wrSGx5OL/ijb6PFzcRN91xkf1p3hycqhVjzGdn1Of8/nU+vRkKk6DJXn61k6XOf7SEeflZvMB9Rjj/PtVrc5Wdz5n7n3NYerNmJq0mbEGfWsbUX3Aih7jT0KuhSbbmVT/EAfyP8A9eqet2ht7pig+RzuX69xS2LiG+UscA5Uk9h/kCqWr6lNfzbLU4gTo2PvH1+lRKSjua0aE6ztEgMhUH0NYrDbqDEfxYP9P6VtnEsecYbuPQ1jXalLhG/CqTvqjOUHBuMty9Ou6GvUPhdfG68N+QzZe2kZMein5h/M/lXmX3rf8K6f4R3mzV760J4lj3Ae6n/BjUVFeJ0YOXLVS7nq2aKbmms20ZPA9a5z2STNISAMkgAetZ0+ohdohXeWOAxOF/8Ar1WkLzHMzlv9noB+FXGm2S5JFy61FUBFuhmf2OAPx7/hWVJdNNIDMHdh0GVwPoM0+4kaJQViaTPp2qtb20LjcYXTaeFYnFbxgomTk2SyTEDgMv8AvIT/ACqvOvnptlDMpxwEkX+VErQXMqq6SBwcDp/KpJFgt4TBvdd+Tx1qxEcJdciZi2WJBAdcD0qcSxqCQ+T6McVHYwpnzI5ncDIx0FS3VwluvPLnoP6n0FICuJZmlctJCsfGwJIM++cihdwdm82TLYyPMQj8Bis97iR23tJ37MV3fT0FJ57gN++Uep844HsPegDXEyodokMr/wB3jj6kU8KX/wBZIMf3VOB+fU1jidy2N2SRwvmZ/E0qytgHJKg8nCnJ9BQBszv5cLMAzHoAgyapq8yWbSPLNuYgL+6AK/hmqwaTJGw7uw2pwPc09XcDOPkHVto5+mKAJpJZEtov38odiTkxDOPTFSSPKLmOMTsOFz+6ByagEso7EMei4PT1ODVu13yZZmIjHU5ZefxNAE0kssV3D5LlMq2cd+Vq217cRjLXLKPcL/UVSRPn807tig7cnJPv+lYWZtUuC7cqPurnhB70rJjudjbapMkkfmuskTMFzjB5OB04710CmvN4rhXvbC1tjmCOWPLf3iGH6V6GrVlNJPQuLuWVNSqarKalU0kNosqalU1WU1KpqkSWFNPBqFTUimqESg04Go1NPFMQ8U4UwU4UxDhS00UopgLS0lKKACiiigAoooNACUhpaSgBDTaU000gGtTCacTTGpMpDGNROaexqFjUsY1jULGnuahY1LGhrGomNOY1ExqGUcd8SD/omnf9fH/sprjtSOIgw6gV2HxIH+haeewucf8AjjVyGo/8e4ranseRjP4prXCiexHfiuQ+a21SMHoM7fbkZFdZphMmmRk/3a57XoNsiSr1Vh+VUcrOods2KEelZFydwNW7OcS6aoJ5ArI1K8SABFIaZ+FX+p9qcnbUdOLm+WO5RuUa5m+zxd/vn+la8GkCGDpzitPwro/mBZHGWPJJ7mumvdPVYSAK4aknLU+kw1GNCCijy68tminJj4btXPXF3HeW+9PllRhvQ9Qen5V32rWm2fOK8zvrUw63dRjIKyk/gef5GtcO76HDmcEuWdvI3bM7rfB9KueArg2vjK07B5DGf+BAj+ZFU7AYi/CoNPmNrr8EwOPLmR/yIrd6pnmUnyzTPoPNZl1L58zxkjZGcFfU+prSz6Vz+o2O68lkZWG45DAH+YrClbm1PdnsRar9qAU25Hl4O8bA1ZQurxTwYz7cj+RFaQtmX7szj/tof8aVo5ennE/U5/nXSYlBb69H/LNfwJ/qTThqV4OsX6j/AAqybeUn7yn/AIAv+FAilU/cib/eSgCzYTTXMG91VOcDIzn361YZHIwRGw9xVUXNyo5jjI9gR/WlF7KOsC/99/8A1qALAEoGAkePZv8A61VXsyxYssnzHJw4OfzFPF8f4oG/Ag04X6d4pR+A/wAaAIDZ5JP+kAnjIKcCgWYBUjzgF6AqpA/KrIvoe4kH1Un+VPF7bn+NvxRv8KAKLWyKuHkYAnJ3R9frzSeRCWJ8xScYH7o4FP1OG0v0TM6LImdpY4Bz1FZ40hT917dv92QUAXfsUJAUMmOpzEcml+xpuyPK4+6NhAFVV0duyqfowqRdFlJwEx7lh/SgC1DZqD82TnqUDZPt04qzcusNu0kq7YYxwnr6CpdPshZxFQxYscn0/Cn3kcLwlbnb5fXk4oAwoJ7u6uldpCiA7tqnCqvv6/jTNQvTdEw2/EGeWH8f/wBb+dJdziTMFsvl2+efV/r7VJY2oZssPkHX39qALvhrTkkm8+TO2IgqPU+v0FdgprH0kjdMAMAbQB+FayGueb1NYrQsKamU1XU1KppJjLCmpUNV1NSoapElhTUoNV1NTKatCJQaeDUamng00IkFOpgpwqhDxS00UooEOopBS0wFooFFABSUtJQAGmmnGmmgBppppxprUhjDUbGnmo2qRkbmoWNSuahepYyJzUTmnuaiY1LKQxjUTGnsajaoYzkviL/yCrM+l0v/AKA9cffDNv8AhXY/EX/kDWx9Lpf/AEFq5Gcbrf8ACtqex5ON/ifIuaA2/TlHoMflxVLWod9vKB1wcVN4abEUkZ7Mf8as30e4MKtnKcRPq80QW1tDhyMs3p7CpNNtCb5HlJYtySTnJptxo8sF40yHzFPbuKtW8pSSPPBVu/Womro6MJP2dVPoeueG4kW2THpWlfR5Q1ieFp98cY9q6W5Tclc9ro+gvqcFrNv85OK868T2Yi1szAf66NT+XH9K9d1W2znivPfGNodsM4H+rJVvoen8v1pUXaZz4+HPQdumphWwwuKzbpcXx9xWlbHNVL9MXKN6iuw+eue8aZL9o061m/56RI/5gGrNYvg+4+0+GdOf0iEf/fPy/wBK2a43ufRQd4phmpdPiV5rjcoPyp1Gf71RVa0n/XXH0T/2arpv3gnsLLY27dYIj/wAVWfTrb/niB9CRWswBqJlFb8xlYx302DsHH0Y1C+nR9nkH5f4VtMlVbmSG3TdPLHEvq7AU+YLGUdOGeJT+KimHT27Oh/4D/8AXp0+u6dGSFlaU/8ATNCf16VUbxFGf9VaTN/vED/GlzpFKlJ9Cc6e/wD0zP4kf0ppsH/uL+Df/WqufED9fsJ/7+f/AFqWLxHAWxcW80Q9RhhR7RD9jPsSGxb/AJ5n8CKb/ZzH/lm35j/Gtm1eG7hEttIsiHuDUvlGquZ2OdbT8f8ALNv++CaQWbL0Ei/8BIrpPLNKENFwsc4YpAP9c4/4GRVK5gDEEyhz2+bca7RFNcsqExp9BRcLFCK3+bLDA9PWr8I6DsKUR1PFHzRcLF7SxhpvqP5VqIaz7BcPL+FX1rnl8RqtiZTUqmoVNSKaSAnU1MhqupqVTVITLCmpVNQKalU1aETqakBqFTUgNUSSinCmCnCmIf3pwptLTEOFLSUtMBRRQKKACkpTSUAIaQ0ppKTAaaY1PNRtSGMao2qRqiakxkTGoXNStUL1DKRE1QvUrVE1SxkbVG1PNRmpKOX+IX/ICj9rhD+hrketuPpXXfEL/kAr/wBd0/rXIwfNAPpWtPY8nG/xPkR6M/l3jr681r3S55rAjPlXyt68V0BO+IH2rQ5EY90uDVK6jR4fmUH8K1LtMjiqUkZMJ4oEdV4Nn3RRHPbB+o613PnoVwTXmngaZRNJbucOG3KD3HH9f516MsKyIMda5mrOx9HRn7SCkV72FZUJXmuP1izUq6SIGRuCD3rsyrRnB6Vm6paiRCwFYyXU6IvoeS3+nGym3xZMDHjPVfY1SuovMAOOa7XUrUoWDLlDwQa5s25guvLYkxt9wn+VbQraWZ51bLFKd4OyO0+Gs/8AxJJoHPMMxIHorAH+e6trVtZhsHSJR51w4ysanAA9Sew+gJPYGuSsNKEqgr0PpWxb+H04JUVDkm7nbTwzpwUW9ieC7vrxyrXQsZcbtrhMY9VXBJH1YH1AqzDql1pkztPfWE8DBQW2FWBGfvAMcDnqAfpjmopdARof3SgTJ8yHHf8AwPSr9pp8UsEcgTAdQ2D1GR0qkxuku5Iviy0b5fJuDN12KvB9wTjI/X2FQTeIb2TItbJE/wBqRi36DH86jbSo4ZFtydkUhzbuOsUgBO0e2Mn8x6Vo2MYliPmRhJkOyRR0B9vYjBH1p3YKEFuYkk+s3WRJdNGp/hjULj8Rz+tRRaNvffMzO3qxJNdQYVA6VC4C0jRNLZGZHpUSj7oqUafGOiirRnUULOCaLC5mQHT02/dqld6chB+UVuo4YUydAwosCkzi1kuNHu/PtSQM/MnZx6Gu90u8g1OyS5tmyrdQeqnuDXMapbbgwxWL4d1JtE8RLHMxFpdfI/ordm/p9DRGVtBVYKautz0zyxSeWKfuoLCteY5LCBBXMRxfuk/3RXT7qxoY8wR8fwj+VCkFimIvapoouelWBH7VKic0+YLDLcYllH0q0tV0GJ5fotTisnuWtiRalWolqRaAJlqVKhWpVqkImU1MtQLUy1SJJlNSLUS1IKoRKKeKjFPWqQh4pwpopRTEOFKKQUopiHCigUUABpKU0lACGm04000ANNManmmNUjGNUTVKahekMieoHqZ6heoZRC9RNUrVE1SyiM1G1SGo2OOtSM5rx+ufDshH8MiH/wAex/WuNsjmMCu78WKlxoF5EGUthWAzzwwP9K4mwtLhwAkMmPXGK0g7I83GU5TqLlV9Cpcwky5Fatsx8sKavQaLPLgyDaPQVowaDEMeZk/U03UQ6eW1JK8mkc/Ku44AyfQc1JDpk04wEKg9zXWw2FvCOEFWF8tOgFQ6j6HXTy6nH49TmbPw2sLiVHdZ1OVf0P0rUj1W606dY9RjAjfhJlOVJ9PY1pmZB3FVbyWGWFo5QrxsMFT0NZt9TtjTjFWirI2ILiO5iBUg5oeEFSOxrhkvpNHucK7PZk8EnJT2Pt7/AOT2Om6jFeRAqwJNLcLNGJq9gCDxXH6lY5DIwIHUEdj616jdQrIhGK5jVbHk8Vm1ZmidzltC1M29x9muOGU/mPWu5tbuN0BBFefazYsw3x/LOnKH+hqPQ/EBB8qclXXgg9jVrXVBfoz04XSiqum3YWCRSfuzS/kXJH6GueGqoVBDiq1lqQETndy0rn/x44/TFVcOTU6+8njuLd4mYrnlWHVWByCPcEA/hWfBquLpJXwplBhlUdBIucEexGf0rDfUv9qsm/v8O/7wASYZST0den54H5UJg4HeS6moHWqE2qA9DXFSa/CUVvMySM4HJp1u17ft8iNBEf4mHzH6D/GgdkdPJqSA/O4BPQZq5bzlsEZ5rJ0/TUi5CkuerNyTWxBbnjimSzQt5jxVxTuFU4IiOtXYhgUElW7hDKeK4nxVaZRXA6GvQJhlTXL+IkX7O2fWpNIm94W1M6losEznMyjy5P8AeHf8eD+Na5bivNvCmonS9UMMzYtbnAJPRX7H+leiZqkzmqQ5ZEu6qduM28X+4P5VYzUNqf8ARYf9xf5U7kDttOAqhq+oixhOxfMmI+VR/M15/qPirVbaeRvOAlGPLiGCPowFK+ti1TbXMd3rOr2Oi759RuUiVwNq9WbHoOprkbz4jjcRp+mSSJ/flfb+gBrl7bTdS16+a6vd8sjfekl4A9h/gBXU2HhaKNQshaQA8DoMVdorclRk9ixo3ju5ubpY7zSmSI4zJE+dvuQa7Gz1iwuXCRXKbz0VsqT+dYcWkJHFtVAo9AKz9Q00KCQKhy7GqpJrc9AWpVrifC+uyRXKaffsWRvlikPUH+6fb0/zjtlqlqZSi4uzJlqVahXpUy1aM2SrUq1CtSrVITJBTxTFp61SEx4pwpop1MQ4UopBSimIcKKBRQAGkpaSgBDSHrSmkNADDTDUhpjUhkZqJqlaomqRoheoXqZqheoZRC1QtUzVh63qf2dTHBhpWOwDPVvQf1Pb+UsqKvoizd3CxKw3KCOST0X6/wCFQx2cc8XmyxHB6GT7x96zpbm002NbjUp1kkHIQ8Kp9cevuea5vVPH4ldlsoml9COFqDZLlOy+z2yHiNR+FSKIx90AV5tbeKb2W4zcoI4/bmu90BZL+3+0NlIT9xj/ABe9Jal3VrlqWRUFYuo+IbS0k8tpMyeg5x9aXxTeLp1tKzuMBflx/EfQV5cLC6u90txK29yWIzxz7UPQHJI7S58VRkkK4Aqo/iqIdZl/Fq5JtBz1JpjaCB3NK6F7XyOml8Ww/wDPdP8AvoVTl8WQH/luKwm0RR61Wm0kKDxRdB7V9jck8S279ZlweuadpfiiCwulMdyvlE/d/u//AFq5OWx2npWfdWpHIzTSTJdVvofR+ia5DfxL843EVfu4BKpI5r518NeIbnSZlR2ZoQfxWvafDXiWG/t03OCSODnrSa7lRd9itrFicMQK888T6bKM3Vqv75PvqP4h6/UV7PdwJPESuDmuP1mw2MWArO7iy90eVwaleeXxjAq9Zzag6qqsB+FW9T037PdCSNcQu2WH90/4Gt/RoI22nAra91dCTs9TIi0/UJ/vyyAH0wKvQeGjKpEu5mPQsc4ru7GyiZAQBWglmi9BSLucNo2jxR3IWSNQxJC8fdcD5l/9mHqDXW22mY/hqe8sEXNxyI8ATbeoAPDj3X+WfQVoRSPagC9XdFji4jXKn/eA+79en0p2uZuVtCCGxC9qtJbBR0q3E8Uqb4XSRD0ZTkUjnjijYncqsoUUxW5oupFRSzsFUckk4rOk1C2SNnaYPg4VI25bv+VOMJTdkOU4wV2ab8qa5zxChYRIP4m5rS0vUor9G8rfgZ4fqCDgg1BqKb7uAduf6UpRcXZlQkmro5u6sQ8WGHaui8LasJ4hY3L4uohhc/8ALRR3+o7/AJ+tNvYFCZrmNRj8uVJ4JDHNGdysOoNTsaSj7RWPSs1iavqMmn2lvFAFa4IAKZBZRjriuSPirV7iVbeKWJHx8zrGMgevORW1pNtI5aeZmd25Z35LGncyjRafvDFiubwOLhjFv6lWy/51d03SLCzB8iCNXHVmGW/M81Z2rkqRkHgisXWrj7BDDdpOsESlwySMduQcAD3IPTv+tJI1mdHDFFLkQujMvUA8j6jtV6CFO4GRXAJrTvFFc2jqzbTNC3X6r9D0x/hXd28vmW9vcYwsqK+PTIzVGbRbaNSvGKyNRQbTV6Sby3PPBrL1GbINAknc5bVIuWI4I5BrvPCWp/2npEcjtmeP93J7kd/xGK4i/O5HNaHwznYahfW/8LIH/EHH/s1KL1KrRvC56KtSrUS1KtbI4iVKkWo1qUVSEPWnimLT1qkIeKdTRTqYhwpRSClFMQ4UUCigApKWmO20ZoAU1DLcwR/6yaJP95gKy9SlZlILHHpmuU1AA5qJSsUlc7+OWOVd0Tq6+qnIqGa6t4iRJPEh/wBpwK8nugyk7HZc9cHFYN6g3YUbpGrN1fIpQPbZdSsURne9tlRRkkyrgD86r6fq9hqdtJPY3Uc0MbFGcZAB/H614HcW5Mvlx/NL/E3ZadFYOkZjEjlGOSu44J9cVLqlch7XqHibRbHIuNSttw6qjeY35Lk1zd98Q9PTIsbW5uW7FsRqfx5P6V5/Hp4HarMdljtUuo2NRRtXnjXVrs7LaO3tA52hvvMM+54/Sq1zqP2GPc8/23UCuBgghfy4AqulnnjbU8ViF6KBU8zLi+XYwJra71GTzNRlZ+chBwoqzDYRxjAQDFbq2oA6UjQgCpEL4b0yG6vS1xHviiwSn95j0H04J/Cuo13X7fTLVdqmSY/LHbrwfx9B71zNpNNZs5gYDeMMCMjjofqKrGLdK0shLyMclm6mqTsir2RSn+1anc/adSfe4+4g4VB6Af161OIgBwKs7RTSKkkrlKYyCp2qNqAKzRioJYFYHirbUzGaQGLdWikHArJurQYPFdTOg5rLuwsaszHAAzTQHJTW21icdDiuz8OWcptYfJcxyBRyOh+tYKRfaJ4oQPmduR9etepaHpojgTC44q7mtKO7F0jWp7WVbbUVKnsT0PuD3rdu4o7uHcmDn0pz6fDcW5injDIfzB9QexrMCTaTOYgzTwbd+QMlFzj5v8fY1DRZh6vYBdwZcqeorHtre8tMyiCY2g5Euw7QPc16FBBFfvHKEWRd21FPR368+wHJ/KtDW7Ey2bQAliV2sx78VUdFcynOzsczot8GAGa6WJg4FcALSfSkEjnCqdrL6dsg+ldJpeorIg+bmm+5UZXOlLpDbvI/KqpJFZuh6ipla2wFgPMB3Zx/sZ/Mj2yO1XI2S4geN+Uddp/Gqdho8dvHNHJJvjcYGBgrzkHPqDimmDRfuLC0lcu9vHvPVgMN+Y5qs+m2neMt/vOx/maltLlstb3LD7RGM5HHmL2Yf1HY/hSzSjnmhsEjMuNNsSpU2kOD/sDP51z3imzstJ8O6jqEVs4a2jMwaOQgrjr1yOme35da6eRgTWb4rtPt3hDXLUAnz7GeLA77o2H9aqE5RejCdOMlqh/h/Sf7Nikyztu6F+pyckmrd1GWliI7HH6f/WqXR7n7do1jd5B+0QRy59dyg/1qYgEj2OaUm5O7HFKKsihfRM8eBXJ6vb+RDJIx6DvXdyhStcj4rUG3C4yCwzWbRtBlLwppysDcXH8XJz+grsFkhVcIVx7GszR9NdrRDJxxnHYVPbwx3M00LZjliPY5DDsaohu5LLInUGsPxBYjUrKW3lCywPyVLbWVh0ZT61Le6bM+qwwea/lSnAYSY24GT+tSanHbaOgM8xkbGBk5JpFqz0Zy2kaO1vfQR20L2thE3HmvuJHOee+SSfSvTPMUWyRoPkVQoHtXmV/qt3eTskaGGJF3lm6gduK0tK129VTscThP9ZG67WAA5P8AnNMUorodO93ndEx+Zeme4qlczFlGTzjmq97cK5WdD8rDI+lZd7qUcaHLDNDEoj7+cKhFbPwyhLX97PjhYwn5nP8A7LXnt7rCsx54r1T4XaZqFvoUtxfDyWuZBJFGV5CYABPfmqhBt3M61SKjZHarUi1FGxJKsMOOozn8amFapHGSLUi1GtSr0piHinrTBTxVAPFKKQU4UxCilFIKUUxDhRQKKAA1BOcLU5qpdtgGhgYuovwa5q+frW3qL/ernL1sk1hJmkUZN2xLYUZY1QkjCBu7nqa0ZiFzjqapMu41izRGfDahWY9WJyTVuO1z2qzFDz0q2ihRSGVI7X2qwtqB1qYtjpTC59aAFEaLTWI7U0t71E70AOZqjY0xnqNn96QD2amFqiaTFQvMB3oAsF6jeSqUt1jvVZrkseDQBomSms9UlkOOTxUM12FbavJ9KAL5OajlmWIcnJ9KozXwjTAOXNQxsTmWY0AWZJflLucAVzupXRuJdq8IDnHt71Zv7syA44QdBVSGLbaNM/3n6U0BseCLFrzU2lYZVOPxr16zgCIoFcf8ObFU01ZduC5JzXeIuBVG60VhsjJDE8kh2ogLE+gFQ6fEwR55xiaYhmB/hHZfwH6k02Um6vPIB/cQ4aX/AGm6qv4cE/8AAfer2M0xbmPZX0NrqNuAoSMruGBgB3O45/QV1aiO5i9zXHajorvlraQMD/DIcY4xwR9O/wCdSafqs1myQ3odJF4ywxu/ofwpXsc8otas2tT0W2uI9ksKSE9d4yPy71yN7oMqTGTSlY84KqoCH6D+tdul0LuIKjDDEBjnnHfH8vxq9CkaL8oA4wAO1O19iU2jibK01uFR5ttFj/roc/yq4J71Ttks5c+qkEV1Dy4OOKhmkI9KVi1VkcxeW2oXKo0dtsmQ5jYuMg+/se/P64q2LCVLUy6jdRW7f3UG44+p/wAKspCdWs5rmK9WOFZGiBQEtleDzuAHOexrzvxFHfyapNZ/bJpYYwCrSYzj3x7g/hT5Rqcnsav9oqdQkit5XmiXADNjOe/QfSuitVE0BWQZVhgg9xXJaHHBEMTskci4BUsMH6HuK620uIhhVZcj3osaxempkfDss3gHQEdizw2ccDE9SyLsOfxU1qzEoc1lfD3augXFuuP9G1G+hAHZRcyFf/HStbV7CWQ7etD3GtjOe7wxBNc54juQBCSePNUn6ZFN1q4lt5WBJBrmNSv/AD42SRh+dSaxR6zpc0c1gMHGR2rk79p7HWj5bFj95D/eB6of5isDQ/EU0AEUj/MB3/iHrWm2otdzh5Bhe9O4RVizfTtLH5qyOr/eRuhQ/wCeKXT9PmuWFxfuZCB8oJ/WoTOtzcKP4AcnPetQ3iBcKeKVykuxTnsVRLvycLJJH8jEZww5HFcNpF7dxBBqCqs8LFd27krg9foQcexxXcXF8seTurkNcuLeWfKxh5T/AAjv9fajfQcope8yW41YppsahjwvU/yFc69zdXU2Y8sQeCOgrQeynnjDyp8vQ5/hHsK2tHsYmKxqvPoBV/D01MHaps9DE02zuob6C8kWOR4nEgSRdykj1HcV7J4b8cQ37rBqkaWlweFYH92x/Hp+P51zK6VtXhao3lhtB+WhVJJg6MJKx7HIu8B4yN69Pf2pUkDKCO/6H0rzLwp4nn0y4jsr9y9mx2qzdYvTn0/lXbeILS8ntRcaTcPHOvJjU8SD/Gt01NXRxzg6bszdjOTU4FeYpfeJl5Rro/8AbIH+lSrrHiuPql0w97UH+S07Enpq08V5mPFPiKH/AFlsD/v2zD/CnDx1q0f+stbT8Y3H/s1AHpopR0rz7TvH8j3MSX1pEsTMA0kbEbffBzmvQVwQCDkHnNMQtOFJS0xCiigUUAIaoXp4NXm6Gs2/bg0mNHOai3JrnrpuTW1qT8tXO3j8mueRoipM2TTYwCaid/mpUlxWTNDQQALTHbBquJ+Kjef3oAsNJUTSe9VXnAqB7n3pAXGkqJ5R61nyXQ9aryXgHegDReYetQSXA55rJmvgO9ULjUsZwaANqa7AB5qjNfDPBrCkvXkbAqWCN5OTTsFzQM5c1NCe9QRRBRlqZc3scCkAgmkBYvbtYYjzzWZbyySuSM7m/SqwMt5MM9M8CugsbNYIwzdaYFeK12HzJj+dRTym4cIn3B+tOu52uJdifcB/Orlja7QCwpAZl3BtjAI5bijUkIEFvHyxwo+tXb7DX0Ce+fyqJB53iC3XsGzTQ0tT1fw1bC20yCNRwqgVtMyxxs7HCqMk+1UNLGLdB7VLq3OnyoOsu2L/AL6YL/WqNmP0xNtnGxBDS5lYHqC3JH4Zx+FWqAABgUUyQNVry3S4iKOoYHsanJppNA7HOtFdaZOJrctJGoI2E9AfQ/h3roNJ1qG+iwGw44IPGDTZFVxhgDXOatYyW0purI4cdV7NSM50+qO1Rt0o5qHXRKdPnW2IWcowQns2OP1rkLPxDIYEcAtJGwJXoTg8iujbxRo13GqvOYZD/DKpXH49KN0YHL+DdUGheCtbXVN0f9mM9zKD1CbMk+/3TUOlxXt5faLFqu1NQvbZHudi7RG4XcwH05A+gNHxAsYtSGlabYXJSTV7pYpXiOQ0EYMr7vYhAv1cVvWWm22mzf2hdyma6iUhJGJ+UHqeSapvuO5C1vpuleISSP3MMRkCyMWG/IG7nvisPUdenv8AUzPDGXhA2ptOD7nBrG8Q6i2t6v8A6IG8oDZu/v8AP8q6Lw/opVFaUc0kurNIR6lDwNq0Fre+Ire7kaJl1IuqujDIeGJ/T1Y//qrrG1zTzx5rMO+EPH51h6XYW7+L/E1jcQpJHJBaXO11yBuWSPIz3/c9fanal4Us2jBtDcWEo6vb5cOPTbzW0FTb964puol7pvrbWeowCWFo5Y2/iXnn0+vtWLqnheGRGKopB7Yqr8MY5P7DjuyXCzhtwY/fYOQW/T9a66VsqRWUkk7I1hJtXPJdW8LlGzEpRgcgr2/Cs0Je2pIaEOB3U4/SvV72NMEtiuT1RlebyLaLzZj2Hb3NSaps5b+0JowS0Eigf7Q/xqWLUb2cDyLZyPUkAV09j4UMjLNfNubqEHQVsjSoo1woAHtSsXznm15Z6rc/ek8oeijP60WOn3Fq4AjEjn8zXpa6Uj9atQ6VFHyAM1UZNbGdRRn8Rx1tb3zx7TBGqkYIY5rT0PSJLUlpHyxOcAV0wtEWniNVptuW5EVGGwxYgVqje2oZTxWpuVe9Qyyp7UrDucTqdk43YQn6Cu88Baz9v05YJci4gARw3XjofxrHu3jcHGKp+G5Tb+KItn3ZEIYeuCMf596qm7SsTWXNG/Y9DvbZj++gH7wfeUfxD/Go7S5DAc1ojpWbqNsULXEA5HLqO/v9a6TiNBWBpWUMMMAR6EVmWl1uAzWijhhmgCldaLptyczWUBPqF2n8xWvpjeWBbZO1EHl55O0cY/Dj86gpVOyaJ842tz9Dx/XP4UAaopaBRQAoooFFADX6Vj6m4CnNbD9KxdVXKmkxo5DU5hluRXM3t0FbDHA9a29Zhzurj9QjlUnax/GueRqiWS4GetM+0jPWsCd7iInb09KqnUZFzvRhj8ayaLOqN0Mdaie6HrXLvqygc7h+FVpNYUngmiwHTy3gHeqU19jvXOvqhb7oY/hUTXUr9ENFgNmW/J6Gq0l2x71m5uG6IB9aetvcv1OPoKdgJnlZu9REAn5mFOOnzN3Y+1OSxO4K6EH0PNAgikgjPLAkVbF8Av7qMn3IxSJpq9htPqOKcLWSJuRuX9aV0MgmmupujbR6KKhitmaXD5LHpmty0jRhxipbizDYePhxyKLgLpdgIl3N1qxqDlIGC9cUQXaiIiTCsvUf/Wqtczo+M/dbp70gH6fagjcRVyRxGMCq6XaRwgD0qHz1OXkYAe9AFOWTdqiE9h/jUujkP4ijPpms64l8y+O0NtZcZxj1qXw43l6ymenPPTuKaKjuj2zTz+6X6U7U3VRahyApnXJPtlv6VQ0ycGMc9qTxDGbq2tkB489cj1yCP61SNmjdilSVA0bKynuDmlJrI0K0On20iORhpCwUdFB7VotIPWgVh7Go2fFRPMPWqss/vRcaRZebHeoJJQ6kHkVUebJ60nmYGevYD1pIbRkajps0V19psgpJ+8h6MPesbULW/um4tIYh/wACaurutVtrHi6uoUbONpVjj6kVdhu7WTT5buUpHFCC0jE5CgDJP0xzWji46tGHuTeh5RokOrL4wu7iymKjTYhagY3KJJNskgwf9kRfnXbX7atrMSQTqkUf8flg/P8A4VZ8BWh/4RuC9ukxc6i738oI5XzWLKp/3UKr/wABronlgtUDykKucDjrSbQ1TRlaL4dhtVVmUbq6NUWNcKMVWt72Cb/UyBiO3Q/kac8w9aVy1Ewdwh+JLcf8fWkj/wAhTH/49XRlwK5LWZxF448Oz5xvt7y1/wC+vKk/9o1szXirnmhsaiZXw/lC+DtP5/56f+jGrVub1UB5FcX4MviPCliiAlv3nA/66NV6a31K8OIbdgD3biizb0BWildi6zq5WJ9pyegHqai0q5hs4dzkNM3LuepNQTeFNXlIchTjkCs+bw3rcb5aHcPY0+SXYPaw2udL/bTTNth596vw3HALtk1x0dnq0A5s5OPTFPWfUAcG1nB/3DSs+xScHsztlu1HcUpvwB1rjw+olSxtLjaOp2Gq39qEHDNgjsaWq3Gop7Hatfj+9UT34/vVxzaqP71JLeyeXvKuE/vFTii4+VHTXGqKgPzVlXGqyOSFbArAe935IJP0pkcss7hII3dj0AFGrE+WO5uJeED5nzWz4Mha91Y3ODsT5QfX1/pWfonhS9vWV7wGKL+6Dya9L0bS4tOt1jiUKAMVtTptO7OWtWTXLE016UtFFbHMYN7AbS5yv+qflfY+n+f6VZtbjoCavXIjmjeKQOQe4Q8fjisOaKa1Yl0Yxj/loF4/H0oA345AwpzgOpU9xWJb3gAHNaUNwHHWgDctZPNt43PUjn696mrP0yXKSJ/dbI+h5/nmr4NADhRQKKAGydKxtSPymtiXpWBqsmAamQ0ctqmCWrmbyMEmtvVJxk81z9xMOea55GqMy4tlJPFUZbFGzwK0pJlL4zyaa1ZlmJJpaHtUX9kKe1bpxScUgMRdIT0qVNLQHoK1sDGaaWAouBSWwjXtUq2iDsKsbx7U4MpHWgCuIFHah4UYYYAipHbHeoHnA70AM8gLwDkds9qNgxzTGuB61E1wPWgBJIgDuU4b1FCXDIcPyPWqV9fGMqkah5n4Vc4HuSewqhNqEnkP8gWdX8sgHIBI4PuDkfnRYLm+5inXDgMKha2g7ktjsxziuWudfkWaO3t1VZJAmx35GWIwMfTd+VXf7YjdBIWwuEJXbyN3A5z65p2YXNdoYs85P40oSFOVRc+uK4yfU5452EksjCGbJGemScA+owpx/vClm164WKY7VMkc4Tao5K55/HANPlYrnQXzBZkkXtwfxqLTbjy9RRs/xVmG+WdwqyKxYZABzkVLFuSUN0PanYadnc9b0m/Gxee1al3cGWzcR8uuHX/eByP1Fec6ZqR2Da2WHVc8itaLWyowxpbHXo0dzFqCyRK6n5WAYfQ0jXvvXDwa0InMZb5GOUPp6j/D/wCtUz60uODQJI6mW+96py3/ADjNctcauxB21ntqku7JOB70hncR3O49asrKGXGce/pXDQatIMYq3Hq0vrQtAauTa9bO2tWcHnN5N2/7wBeOvNaPi1o4vDkGhWzHdqs6WTEnkxtzMf8Av0sn6VkS6sWmtwXGUJfr04I/9mrFn1Y3ni5GMimLTrYkcjHmynH5hEP/AH3W8qjmlfoc6pRg3bqepS3/AJWPLxtAxj0qtd39veweVK5Rs5B9DXEPrRPHmr/30KhfUwx+8D+NZam2h2Nugt5I2S6UqpznnNXrnW4kBwwrz035/vt+GTUTX/PCysf9w0cr7D549WbXijVi2peHrheBFf4PuHglTH5sv5V1Gna7E222ukhbsrOufwNeS+Jr6U2EEiwyjyru3fJX/pqoP6E1oy3VyVJMUg/CrSktUjOTpyumz1b4W2scvgyweJLfJ8zPyc/6xveuvDS2/wB6zVkHeM8/ka8T+DfizytHsrKVism0uoP8QJJwPcZ/GvbrLUI7iNSGHIroRwvcfHe2rnazeW392Qbf/rVZ8qNxnAIPekZIplw6qw96r/2dCpzAXhP+wxA/KmIla0iP8IqFtOhP8I/KkaO/iOY5klHpIo/pij7dNGcXFq/1jOf54oAadPUD5RisbU/CdnfTCZ4wsuckqPvfWuhivbeXgSBW9HG0/rVkYI46UAnY5CPwjZRtuW3UMOh61fTTHUbWYsp4wea6DAowPSgbbZxt14WKsZbFvLPUw/wn6elT6bosEp/fQIsi8MMYYGurwKY0amQOOHAxkelAinBZPaj/AEeTcv8Ack/xq1FNubY6lH9COv0NS0UAFFISAMk4FRmbccRLvPc5wo/H/CgCRmCqSTgCq00rEfxKOw6Mf8P51XvtRW0VlDCac/wrwF+vpXHa1q8zzCBZiZXGXK8BVPYUAaF9eRSTmK2iiVFbJdFGSfr/AFrT09m2jNc9pcOQDiums48AUAa2msRckdmT+R/+vWyhrDtRtuIT23YP4gj+eK3FFAEgooFFADJVLLxWFqthczA+Wo/Fq6CmOMik1cDyzWdD1P5isSn6OK5K+07VIid9qx+jA/1r3K5gV85FZc+nRvnKiodNMtTZ4Rcrdr/rLeZSO+08UkGpFTsnGD0zXtFxoUEnVB+VY974RtpgQYwfwqXRXRj9oedGUMMqc1FJcFOgzXVXngvyQTbMye3UflXPX2hajExURBx6g4/nWTpSRammUTqapwwIqN9Qhfo4qOfQ9Tc4WD9aYnhXVJTzGo/Wkqcn0DmQ2W/VejVWfUiPutWongi/f7zkfQZqUeALsjidh9VqvZSFzoxV1cjh6ZLqCv0Nb4+HV43/AC8H/vj/AOvUsfw0uz/y8N+VP2TDnRyxum9aYbo+uK7iD4ZT97l/yFX4fhkP+Wk8p/Sj2LD2iPLZ7kw3izSK7RmPblVLYOc9B/nis67uPtV5IiSmBXjyvzAFmU8Z9PvD347V7fF8MLLgyAuf9o5q9B8ONOjIPkrkdDirVLzJdQ8BFgkmz5juXO3blyPnDLz7HP51YHh64upJDGlwUk6qOBtznH5k19E2vgmwiI/dL+Va8Hh2ziAAjX8qpU0JzPm2PwRfTZZ45HZsbi7HnHTOPSr9n4C1ISbo7SLf/fLZP59a+jk0q2TpGPyqdLOFeiD8qbghczPB7D4cX/Vike7khAP51sxfC6SUfvbiTHoDivZViReiinBQKagl0E5M8ih+E9vGdwkfd6g81K3wyIPy3U4/4HXrNGKdkCbWx5I3wzkK4+1y/pUEnw+vLdiZZppIcZ3xqGI+qgZP4Zr2LAoxS5V2Hzy7njsXgu3mO0aqhbum9VYfUdRTpvh5paENe3kef+msw/qa9dlijlXbLGjj0YZpsNvDCSYYY4z/ALCgU0kgcm92eWW3gTSzxb29xKfURMFP0ZgAfzqYeAQxxHYBPeaQfyXNepYoxTJuecwfD21ijJlCs55ZsYH4egrE8BeCLbUNDOsSRYOqTPdoCP8AliTiH/yGqH8TXdfEeeVPClzZ2rMt5qbppsDJ95WmYIXH+6pZ/wDgNdDZ20NnaQ21sgjghRY40HRVAwB+QoA46LwNZr/yzX8qsr4Msh/yzX8q66igDlB4Psx/APyp3/CI2g/gFdTRQB5n8RvDEFv4E164jQFrazkuQAOSYxv/APZa1p/C0DplFUgjII710/iG0/tDQNTs8Z+0WssWOudyEf1qp4NuRqPg/QrzOftFhBNnOc7o1P8AWgDxvwz4TE3hDRbqIFZDbI4ZeCDiuq0+7urRFS4JSReN38Le/tXSfDe1SX4e6Bkf8ucf8q07vRYpQflFAGVa668YHmZx61p2+uwvjLVjXHhp1JMDsmewPH5VRl0bUIuQwf8A3l/wxQB28WpwP/GPzqwtzE3RhXnDxX0R5hz9GIoW9u4f+WM/4EGgD0d1glGGVTUH2JUObaV4j6A8fl0rhY9dnjPzQ3P5D/GrK+KWTrDcfin/ANegDsfMvIfvIk6+3ymlXUB/y1gnj+qgj9DXIDxgo6xzD/tmaevjOD+LzB9Ym/woA64ahAe8n/ftv8Kct7E3CiQ/9s2H9K5NfGVof+WgH1Rh/SpF8YWh/wCW8Q+uRQB1TSyniOE/ViB/jULvJk+bNt9ViTOP51z6+LLU9Lm3/wC+xUcviiFuBND/AN9igDfkliQgiJpW7FznH59PyqjfX0u0iSTy1/up/jXOXniaJVO2VSfRPm/lWLNrF1eOVtYHyf45O30FAGhrWrpAPKj5kb7kY6n3PtVPSbOWVzLLy7HJNWdI0Bi/nXBLysclm6mutstPCYwKAIdPtSqjitq3iwKdDbhR0qyqYoAa3yJv/uEP+Rz/AErcArGdAyMp6EYrWtHMttDIerICfyoAlFFFFABVS9YhSKt1RvuhoA5HWrp4921nH0bFcjeavcox2z3A+kh/xrp9dGd1cXfJ8xoGOOv3YP8Ax93Y/wC2h/xp6+IbvvfXQ+rE1kvHzTTHQM3B4juv+f6T/gS5/mKP7fnJybpG/wB6Nf8ACsLy6aY6AOlj8QyDqbNv95f8CKtx+JSOtvZt/ukj+prj/LpDHQFjuU8UIOtjCfpL/wDWqZfFUf8A0D1P0m/+xrz/AMv2pPL9qAsejL4riH/MO/8AI3/2NSL4tg72Lj6OD/SvNgh7ZoG8dGb8zQFj00eLrX/nzn/Ar/jS/wDCYWo/5c7j/wAd/wAa8zEkw6SP/wB9GnCecf8ALVqAseknxla/8+dz/wCO/wCNIfGlt/z5XP5r/jXnQurgfx5/AU4Xk3qp/CgLHft44gHSwuD/AMCWmHx1F206f/vsVwgvZe6ofwpftzd41oCx3B8dp202X/v6P8KafHfppb/9/v8A7GuK+3HvEPzpfto7xfrQFjsW8euOmlH/AL//AP2NRt8QJR00j/yY/wDsa5P7bH3jb9KX7XCeqsPwFAWOp/4WFL/0CP8AyY/+xo/4WFL/ANAn/wAj/wD2Nct9pt++R+FHn2x/i/8AHTSCx1Y+ILnrpX/kx/8AY1Ivj8fxaY34T/8A2NciJLc/xr+IxS/uD0kj/wC+hQFjsk8e25+/YzD6OD/hViPx1prffgu1/wCAqf8A2auHEcJ6Oh/EUot0PQg0BY9Aj8ZaO/3pZY/96I/0zVqPxPo8nS+Qf7yMP5ivNvso9KX7OB2oFY6e/wBX07VviDpEAvoPsuk20l+5MgCmaTMMQ57hPtB/EV2SX1pJ9y6t2/3ZAf614P4ThW7XUdVOSL66fy8/88o/3aY9jtLf8DreNuPSmFj19ZY2+66n6HNPrx1Ydp4qaOe5i/1VxMn+65FAWPXKK8tj1nVIvuX0/wDwJt386tReKNXj6zJJ/vxj+mKAsekVy/ww+TwJpMGMfZUa0x6eU7R4/wDHKyY/GV+v+st7d/oCP61i+BvGD2djqVq1krCPVLx+JMY8yZpsdP8AppQFjsfhh/yT3w//ANecf8q6evK/h34xW28D6JC1kzeXaou4SdePpXSr44g72Uv4OKBWOu2j0pCinqorlB43te9pOPoRTv8AhN7LvbXX5L/jQFjpHtYm6oKgfToW/gFYX/Ccaf3gux/wFf8AGnDxvph6x3Q/4AP8aAsajaRCf4BUTaJAf4BVNfGmlHr9oX6x/wD16mXxfox63Lr9Ym/oKAsObQIT/AKhfw7Cf4BVuLxPo8hwt8g/3lZf5ircWr6bL/q7+1b281c/zoAxD4aiP8ApjeF4j/APyrqo5EkGY3Vx/snNOoA5A+Fof7g/Kj/hFof7g/KuvoIoA5JfDEA/gFXLbRIIeiCt/bRtoAoxWir0Aq0kYHapcUoFACAUuKKKACr2mnNsF7qzDHpzx+mKo1c0/wC5J/vf0FAFyiiigAqje9DV6qF90agDjNc/irjrz7xrsdbP3q469+8aCkUG60mKc3WkpAJijFLRQA3bRtp1FADNtG0U+igCPZRsFSUUARbKNlSYoxQBFspNlTYoxQBDspNlT4oxQBBspNlWMUmKAINlIUqxto20AVtlGyrG2jbQBW20basbaNlAFfbRt9qn2Umyi4EHI6VmeJb64stEupLaR1uXAhgwx/1rkIn/AI8wra2Vg6qn2zxHpVkOY4A99KP90bIwf+BMW/4BTA0NNiOn6fbWdvI4ht41iQZ7KMD+VWhdXA6St+OKUx0nl0AKL24HWTP1Ap4v5x12H6iovLo2UATi/k7on6077e3/ADzX86rbPajZQBZ+3DvF+TVi6DeJFrHiGJo2wbtJlGegaCMf+hK1aJSsSzQx+LtUT+GS0t5R9d0qn9AtAFrwXdQr4T0pWD5Fuvb2rcF1bnuw/CuZ8HJnwtpf/XBf5VsbKANET25/5afmDSiSA9JV/Os3ZRsoA1B5J6SJ+YpwjQ9GU/jWTtpdvtSA1/s47Uht/asnFODOOjMPxNMDS8j2pPI9qzxLKOkj/wDfRpftE4/5aNSsBeEO05HB9atRXd7D/qru4T/dlYf1rI+1XH/PQ/kP8KUXc4/jB+qigDoYtd1eL7l9Kf8AfAb+YNWk8Vauo5kif/ejH9MVyovZ/wDYP4U4X0vdI/yP+NMDq/8AhMdVH/LO1P1Rv/iqP+Ez1T/njZ/98N/8VXK/bm7xpQL71hH/AH1/9agLHUnxnqv/ADxtB/wBv/iqibxhrB6fZl+kZ/xrnRfL3i/8e/8ArUovYu8b/pQFjbbxXrh6XEY9hEv+FN/4SnXP+ftf+/S/4Vj/AGuE/wALj8B/jSi5t+7Ef8BNILHfeDtYvNSt7r7ZL5k8JDABVAZSOnA9Qa7TTSCkjKcgt/QV5V4L1KC31varZEsTg8EdBu/9lP516vp0BgsIEb74QFvr3piZcFFItLQIKayg9QDTqDQBUlt4W+9FGfqoqjLpVjJnfZWx+sa/4VrMM1GVoAxH0HTG66fbf9+xUTeHNKbrYQfguK3itN2UAc83hjSD/wAuKD6Mw/rUTeFNIJ/49MfSRv8AGul2UFKAOWbwhpJ6QOPpI3+NRt4M0s9FnH0krrNlGygDj28E6ceklyP+BD/Co28D2X8Nxcj8V/wrs9lGygLnEN4Ft/4bycfVQaibwKmflvnH1iH+Nd5s9qNlAXPP28Cvztvx+MX/ANeom8DXH8N7EfqhFeieXR5dA7nm7eCL4fdubc/99D+lRN4L1IdJLY/8DP8AhXpmz2o8ugLnl7eD9VUcLA30k/8ArVE3hPVx0t0P0kX/ABr1Xy6QpQFzyk+FtYH/AC55+kqf41E/hvV162T/AIOp/ka9aMdNMdAXPIX0XU062Fz+EZP8qgfT71Pv2d0v1hYf0r2Mx0wx0Bc8YdHT76sv1GKYCD0Ir2cx1XltIpM+ZFG3+8oNKwXPIaK9Uk0ewf71lbH/ALZL/hVaTw9prdbOMf7uV/kaLBc8zxRivRH8L6Yeluy/SRv8agfwnYHp5y/R/wDEUBc4LFYXh0fa9R1jUzgrJP8AZYT1/dw5U/8AkQy133izRbXRfDmo6jE9w80ELNFGWX95J0ROn8TFR+NGh+AotM0Wysvtbl4YlV22g7mx8x/E5P40Bc57FJtrrW8JAdLs/jH/APXqF/Cko+7dKfqmP60Ducxto210D+GLodJoT+Y/pUL+Hb5enkn/AIEf8KAuYu2k21rNod+v/LJT9HFRNpN8vW3Y/Qg/1oAzttYcy+X40tf+m+nzD/viSP8A+OGuobT7xettL/3zmsDWraeHxHoEjwyrvee35Q85iL4/8hZ/CgCv4MX/AIpTSv8Ar3X+VbOysvwUjf8ACH6M5RgHtIpBx2ZQR/Otg+9AEZSk2VLxRigCLbRtqXFGKAIdtG2pcUYoAh2UbKmxRtoAg20bKmxRtoAg2Uban20baAINtJtqxto2igCvso2VPtpdtAFfZTWWrW2mOvFFwL3g6Mv4msx/v/8AoDV71XiXgKLd4ntj/d5P44H9a9tpiYUUUUCCiiigBMU0in0YoAjxRtqTFJigBm2k21JijFAEe2jbUmKMUAR7aTbUuKMUARbaNtS4oxQBFto2VLijFAEWyk2VLijFAERSk2VNijFAEOymlKsYpMUAVylMKVa20hWgCoY6YYvaruymlKAKRi9qaYvar3l0mygCgYvammKtAx0hj9qAOD8XwjUfEHhvRNu6OS4bUbgZ/wCWVvgrn/ts8P5GupMPtWH4aj/tPxn4k1cqfKtmj0i3J6ERjfKw+skpQ/8AXKusMVAGYYfao2h9q1TFTDFQBktD7VG0Fa7Q+1MaD2oAxmg9qjaD2rZaCo2g9qAMcw1zHjSHy5fD1zyPI1WHn08xXi/9qYrvDB7VyvxIh8vwq9wf+XW7tLrPoI7mJz+imgDM+HEWfh34WOOulWv/AKJWugaAHqo/KqHwzhz8NvCZx10m0/8ARKV0Zg9qAMdrOI/ehjP1UVE2m2x620X/AHwK2zBTTB7UAYbaTZnrbR/gMVGdGsj1gH/fRH9a3zB7U0w+1AGAdEsf+eJH/A2/xqNtCtD0WQfRq6ExUwxe1AXOcbQLbs8w/Ef4VGdAh7TSj64P9K6Qxe1RtHQO5zTaCO1wfxT/AOvUbaEw6XCn/gH/ANeulZKiZDQBzh0WYdJYz9QRTDo1x2eE/wDAj/hXRlaaVoA5w6PddvLP0amnSbwdIgf+BD/GulxThmgZy/8AZd7/AM8D/wB9L/jSf2Xe/wDPu35j/GuqFSrQBzFv4f1W5UtBYyuoOCQR1/OpD4U1xuBp0v4so/rXp3hP/j0n/wCun9BW5QK5534G8Lahp+pPdahEsI2BVXcGOdwbt/u/rXolFFAgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKADFGKKKADFGKKKADFGKKKAExRilooASjFLRQA3FGKdijFAGH4o8Sab4Ys/tesfbUtQjyPLb2E9ysSoMszmJG2ADnLYHB9DU+g6xaa5Zm5sEvVhDbf8AS7Ka1Y8A5CyopIwRyBj3qp8QtOutX8A+JdN0+Lzr280y5t4I9wXfI8TKoySAMkjkkCuR1DwffXOva3qTaRY3k66DaQ6YL7ZJD9tiNweUycFS6fNjoxwetAHpe2k218+6d8O9f/srxHZx6HcWlpqMGmf6NJ9gt1eaO63zlY7UhFAToWJYgAbicAafiT4d3cV9qlrpfhx30H+0Uu7O0sxZvbr/AKIkbk2s7LGwL7+6kMAwz3APW/EmrWvhzQrzVbuKVra2XzJFhUFzkgcAkDPPrWmVrwPWvAmvXOjXFvfeDrbUtTm02ygsJ4biFotLMagSxqZpN68gkFN27dgtxmuj1Lw/4iXXLuyg0SaezuPFVrrX9oLcQiJYF8ncCpcSbwY2424I6E9CAesFaQpXiNz4G1uTw5qVja+G2t/EzpILjxCLyAHUVNwjlAcszeZGrLiVAqdOQTU2ifDq4W60iM6JqMOkLrH2q6tdQksUUR/Y5omIhtAsYVmZFKjcWySwxmgD2Yx00x1LbW0NpbRW9rFHDbwoI44o1CqigYCgDgAAYwKk2+1AFQxU0xe1XNopCtAFExe1c18SLJ7n4feJYoc+cdNuDHxn5xGxX68gV1ZuLb7b9k8+L7X5fm+RvG/ZnG7b1xnjNNv7NbyxuLZ8bJo2jORngjH9aAOO+FsOfhj4QPro9n/6JSumMFVfA+kT6J4K8P6Ve7DdWOn29rKYzld6RqrYPcZBrZMdAGcYKaYParl7NbWNtJc3s8VvbxjLyyuERR6kngVKY/agDMMFNMHtWmYvakMXtQBlGCo2g9q1jF7UxofagDIaComg9q2Gh9qjaH2oAxXhqFoa2ng9qgeD2oGYzRVGY61ngqB4fagDP2Um2rjRe1RmPFAFcLzUiCn7Kcq80AdL4U4tJv8Arp/QVt1i+Fxi0l/66f0FbVAgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKADFeU/HSOxkvfBSarcaJbWR1ObzJdbt1ns1/wBEnx5iM6A84A+YYYqeeh9WooA8Ek1A6BJf3/g6Tw/qElt4dd4H0O1EVmP9Lw7LGjycqCzHBbJU8dqk07xrrRgRLzxhpb6PJqEUNxrVncRXbWEbQyvh5fs0UA3OkaglDt3ndyRXu9FAHz5cay2n+IfEWr2/jiWa5k8MrPp0zRWsa6k0RvPuqY/n2EK3yYzuz90gDodd13U9Kl0iPW/Gs2j2V7p0t/8Ab3tbYK1wBHtt03RkbQCzbTmRugbjFexUUAfOXjbxZqWq+Fr+DxRrB0C9bS7GWHRljiU3zyqGlP7xWkIDZXCFdu35jW03jXxJ/wAJtqEVxrekafFa6lPbf2VcTbpXtkDbJVt1tjKdwCvvE2zqMDoPc6MUAeVfBrxNqGvXWp2+paydXlgt4JGlha3ltldi4bZJCiFclc+VIu9RtJJyQPUNtS4pMUARFKaUqfFJigCsU9qY0dWiKaVoApNHULxVoFKjZKAMx4qrvF7VrPHVd4qAMp4qgaPmtV4vaoXioAzSlIE5q8YfagQ80DNXw2uLWX/f/oK16ztEXZBIP9v+grRoEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRiiigBMUmKdRQAwjNNK1JijFAEDJUTR1bIppWgCi0VRtDWjspPLoAzfs9Ktv7Vo+XTggoAhsE2CQf7X9BVqmogXOO9OoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAxRiiigAxRRRQAUUUUAGOc5/CiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows a person getting an echocardiogram (or \"echo\"). To do an echo, a doctor or nurse puts some gel on a person's chest. He or she presses a thick wand (called a \"transducer\") against the chest and moves it around. An echo uses sound waves to create images of the heart that appear on a computer screen. A test called an ECG is done during an echo. For an ECG, patches (called \"electrodes\") are stuck to a person's chest. Wires run from the patches to a machine that records the electrical activity of the heart.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34354=[""].join("\n");
var outline_f33_35_34354=null;
var title_f33_35_34355="Normal echocardiography values for prosthetic mitral valves";
var content_f33_35_34355=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Normal echocardiography values for prosthetic mitral valves",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Valve",
"       </td>",
"       <td class=\"subtitle1\">",
"        Size",
"       </td>",
"       <td class=\"subtitle1\">",
"        Peak gradient (mmHg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean gradient (mmHg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Peak velocity (m/s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pressure half-time (ms)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effective orifice area (cm",
"        <sup>",
"         2",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        <strong>",
"         Biocor",
"        </strong>",
"        <br/>",
"        Stentless bioprosthesis",
"        <br/>",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        13 &plusmn; 1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        14 &plusmn; 2.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        11.5 &plusmn; 0.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        12 &plusmn; 0.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Bioflo pericardial",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"        <br/>",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        10 &plusmn; 2",
"       </td>",
"       <td>",
"        6.3 &plusmn; 1.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2 &plusmn; 0.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        9.5 &plusmn; 2.6",
"       </td>",
"       <td>",
"        5.4 &plusmn; 1.2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2 &plusmn; 0.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        5 &plusmn; 2.8",
"       </td>",
"       <td>",
"        3.6 &plusmn; 1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.4 &plusmn; 0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        4.0",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Bjork-Shiley",
"        </strong>",
"        <br/>",
"        Tilting disc",
"        <br/>",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.7",
"       </td>",
"       <td>",
"        115",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        12 &plusmn; 4",
"       </td>",
"       <td>",
"        6 &plusmn; 2",
"       </td>",
"       <td>",
"        1.75 &plusmn; 0.38",
"       </td>",
"       <td>",
"        99 &plusmn; 27",
"       </td>",
"       <td>",
"        1.72 &plusmn; 0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        10 &plusmn; 4",
"       </td>",
"       <td>",
"        5 &plusmn; 2",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.49",
"       </td>",
"       <td>",
"        89 &plusmn; 28",
"       </td>",
"       <td>",
"        1.81 &plusmn; 0.54",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        7.83 &plusmn; 2.93",
"       </td>",
"       <td>",
"        2.83 &plusmn; 1.27",
"       </td>",
"       <td>",
"        1.37 &plusmn; 0.25",
"       </td>",
"       <td>",
"        79 &plusmn; 17",
"       </td>",
"       <td>",
"        2.1 &plusmn; 0.43",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        6 &plusmn; 3",
"       </td>",
"       <td>",
"        2 &plusmn; 1.9",
"       </td>",
"       <td>",
"        1.41 &plusmn; 0.26",
"       </td>",
"       <td>",
"        70 &plusmn; 14",
"       </td>",
"       <td>",
"        2.2 &plusmn; 0.3",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Bjork-Shiley monostrut",
"        </strong>",
"        <br/>",
"        Tilting disc",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        5.0",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        13 &plusmn; 2.5",
"       </td>",
"       <td>",
"        5.57 &plusmn; 2.3",
"       </td>",
"       <td>",
"        1.8 &plusmn; 0.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        12 &plusmn; 2.5",
"       </td>",
"       <td>",
"        4.53 &plusmn; 2.2",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.4",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        13 &plusmn; 3",
"       </td>",
"       <td>",
"        4.26 &plusmn; 1.6",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        14 &plusmn; 4.5",
"       </td>",
"       <td>",
"        4.9 &plusmn; 1.6",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Carbomedics",
"        </strong>",
"        <br/>",
"        Bileaflet",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.9 &plusmn; 0.1",
"       </td>",
"       <td>",
"        126 &plusmn; 7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        10.3 &plusmn; 2.3",
"       </td>",
"       <td>",
"        3.6 &plusmn; 0.6",
"       </td>",
"       <td>",
"        1.3 &plusmn; 0.1",
"       </td>",
"       <td>",
"        93 &plusmn; 8",
"       </td>",
"       <td>",
"        2.9 &plusmn; 0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        8.79 &plusmn; 3.46",
"       </td>",
"       <td>",
"        3.46 &plusmn; 1.03",
"       </td>",
"       <td>",
"        1.61 &plusmn; 0.3",
"       </td>",
"       <td>",
"        89 &plusmn; 20",
"       </td>",
"       <td>",
"        2.9 &plusmn; 0.75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        8.78 &plusmn; 2.9",
"       </td>",
"       <td>",
"        3.39 &plusmn; 0.97",
"       </td>",
"       <td>",
"        1.52 &plusmn; 0.3",
"       </td>",
"       <td>",
"        88 &plusmn; 17",
"       </td>",
"       <td>",
"        2.3 &plusmn; 0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        8.87 &plusmn; 2.34",
"       </td>",
"       <td>",
"        3.32 &plusmn; 0.87",
"       </td>",
"       <td>",
"        1.61 &plusmn; 0.29",
"       </td>",
"       <td>",
"        92 &plusmn; 24",
"       </td>",
"       <td>",
"        2.8 &plusmn; 1.14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        8.8 &plusmn; 2.2",
"       </td>",
"       <td>",
"        4.8 &plusmn; 2.5",
"       </td>",
"       <td>",
"        1.5 &plusmn; 0.2",
"       </td>",
"       <td>",
"        93 &plusmn; 12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Carpentier-Edwards",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        6 &plusmn; 2",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.3",
"       </td>",
"       <td>",
"        98 &plusmn; 28",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.7 &plusmn; 2",
"       </td>",
"       <td>",
"        1.76 &plusmn; 0.27",
"       </td>",
"       <td>",
"        92 &plusmn; 14",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.4 &plusmn; 2",
"       </td>",
"       <td>",
"        1.54 &plusmn; 0.15",
"       </td>",
"       <td>",
"        92 &plusmn; 19",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        6 &plusmn; 3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        93 &plusmn; 12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Carpentier-Edwards pericardial",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.6",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        5.25 &plusmn; 2.36",
"       </td>",
"       <td>",
"        1.67 &plusmn; 0.3",
"       </td>",
"       <td>",
"        110 &plusmn; 15",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.05 &plusmn; 0.83",
"       </td>",
"       <td>",
"        1.53 &plusmn; 0.1",
"       </td>",
"       <td>",
"        90 &plusmn; 11",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        80",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Duromedics",
"        </strong>",
"        <br/>",
"        Bileaflet",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        13 &plusmn; 6",
"       </td>",
"       <td>",
"        5 &plusmn; 3",
"       </td>",
"       <td>",
"        1.61 &plusmn; 0.4",
"       </td>",
"       <td>",
"        75 &plusmn; 12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        10 &plusmn; 4",
"       </td>",
"       <td>",
"        3 &plusmn; 1",
"       </td>",
"       <td>",
"        1.40 &plusmn; 0.25",
"       </td>",
"       <td>",
"        85 &plusmn; 22",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        10.5 &plusmn; 4.33",
"       </td>",
"       <td>",
"        3.3 &plusmn; 1.36",
"       </td>",
"       <td>",
"        1.38 &plusmn; 0.27",
"       </td>",
"       <td>",
"        81 &plusmn; 12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        11.2",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Hancock I",
"        </strong>",
"        or not specified",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        10 &plusmn; 4",
"       </td>",
"       <td>",
"        5 &plusmn; 2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.3 &plusmn; 0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        7 &plusmn; 3",
"       </td>",
"       <td>",
"        2.46 &plusmn; 0.79",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        115 &plusmn; 20",
"       </td>",
"       <td>",
"        1.5 &plusmn; 0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        4 &plusmn; 0.86",
"       </td>",
"       <td>",
"        4.86 &plusmn; 1.69",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        95 &plusmn; 17",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        3 &plusmn; 2",
"       </td>",
"       <td>",
"        3.87 &plusmn; 2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        90 &plusmn; 12",
"       </td>",
"       <td>",
"        1.9 &plusmn; 0.2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Hancock II",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.21 &plusmn; 0.14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.77 &plusmn; 0.11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.84 &plusmn; 0.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.15 &plusmn; 0.22",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Hancock pericardial",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.61 &plusmn; 1.39",
"       </td>",
"       <td>",
"        1.42 &plusmn; 0.14",
"       </td>",
"       <td>",
"        105 &plusmn; 36",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.57 &plusmn; 1.02",
"       </td>",
"       <td>",
"        1.51 &plusmn; 0.27",
"       </td>",
"       <td>",
"        81 &plusmn; 23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Ionescu-Shiley",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.87 &plusmn; 1.08",
"       </td>",
"       <td>",
"        1.43 &plusmn; 0.15",
"       </td>",
"       <td>",
"        93 &plusmn; 11",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.21 &plusmn; 0.82",
"       </td>",
"       <td>",
"        1.31 &plusmn; 0.24",
"       </td>",
"       <td>",
"        100 &plusmn; 28",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.22 &plusmn; 0.57",
"       </td>",
"       <td>",
"        1.38 &plusmn; 0.2",
"       </td>",
"       <td>",
"        85 &plusmn; 8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.63 &plusmn; 0.9",
"       </td>",
"       <td>",
"        1.45 &plusmn; 0.06",
"       </td>",
"       <td>",
"        100 &plusmn; 36",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Ionescu-Shiley low profile",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.31 &plusmn; 0.96",
"       </td>",
"       <td>",
"        1.36 &plusmn; 0.25",
"       </td>",
"       <td>",
"        80 &plusmn; 30",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.74 &plusmn; 0.37",
"       </td>",
"       <td>",
"        1.33 &plusmn; 0.14",
"       </td>",
"       <td>",
"        79 &plusmn; 15",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Labcor-Santiago pericardial",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        8.7",
"       </td>",
"       <td>",
"        4.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        5.6 &plusmn; 2.3",
"       </td>",
"       <td>",
"        2.8 &plusmn; 1.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        85 &plusmn; 18",
"       </td>",
"       <td>",
"        2.12 &plusmn; 0.48",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        6.2 &plusmn; 2.1",
"       </td>",
"       <td>",
"        3 &plusmn; 1.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        80 &plusmn; 34",
"       </td>",
"       <td>",
"        2.11 &plusmn; 0.73",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Lillehei-Kaster",
"        </strong>",
"        <br/>",
"        Tilting disc",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.7",
"       </td>",
"       <td>",
"        140",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.7",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.56 &plusmn; 0.09",
"       </td>",
"       <td>",
"        94 &plusmn; 22",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.38 &plusmn; 0.27",
"       </td>",
"       <td>",
"        124 &plusmn; 46",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Medtronic-Hall",
"        </strong>",
"        <br/>",
"        Tilting disc",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        78",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.57 &plusmn; 0.1",
"       </td>",
"       <td>",
"        69 &plusmn; 15",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.45 &plusmn; 0.12",
"       </td>",
"       <td>",
"        77 &plusmn; 17",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Medtronic intact porcine",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.5 &plusmn; 0.51",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.22",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.2 &plusmn; 1.44",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.26",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4 &plusmn; 1.3",
"       </td>",
"       <td>",
"        1.4 &plusmn; 0.24",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.2 &plusmn; 1.77",
"       </td>",
"       <td>",
"        1.3 &plusmn; 0.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Mitroflow",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        6.9",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.07 &plusmn; 0.91",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        90 &plusmn; 20",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.5 &plusmn; 1.65",
"       </td>",
"       <td>",
"        1.43 &plusmn; 0.29",
"       </td>",
"       <td>",
"        102 &plusmn; 21",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.85 &plusmn; 0.81",
"       </td>",
"       <td>",
"        1.32 &plusmn; 0.26",
"       </td>",
"       <td>",
"        91 &plusmn; 22",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Omnicarbon",
"        </strong>",
"        <br/>",
"        Tilting disc",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        8.0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        6.05 &plusmn; 1.81",
"       </td>",
"       <td>",
"        1.77 &plusmn; 0.24",
"       </td>",
"       <td>",
"        102 &plusmn; 16",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.89 &plusmn; 2.05",
"       </td>",
"       <td>",
"        1.63 &plusmn; 0.36",
"       </td>",
"       <td>",
"        105 &plusmn; 33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.93 &plusmn; 2.16",
"       </td>",
"       <td>",
"        1.56 &plusmn; 0.27",
"       </td>",
"       <td>",
"        120 &plusmn; 40",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.18 &plusmn; 1.4",
"       </td>",
"       <td>",
"        1.3 &plusmn; 0.23",
"       </td>",
"       <td>",
"        134 &plusmn; 31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4 &plusmn;2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         On-X",
"        </strong>",
"        <br/>",
"        Bileaflet",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        11.5 &plusmn; 3.2",
"       </td>",
"       <td>",
"        5.3 &plusmn; 2.1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.9 &plusmn; 1.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27-29",
"       </td>",
"       <td>",
"        10.3 &plusmn; 4.5",
"       </td>",
"       <td>",
"        4.5 &plusmn; 1.6",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.2 &plusmn; 0.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31-33",
"       </td>",
"       <td>",
"        9.8 &plusmn; 3.8",
"       </td>",
"       <td>",
"        4.8 &plusmn; 2.4",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.5 &plusmn; 1.1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Sorin Allcarbon",
"        </strong>",
"        <br/>",
"        Tilting disc",
"        <br/>",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        15 &plusmn; 3",
"       </td>",
"       <td>",
"        5 &plusmn; 1",
"       </td>",
"       <td>",
"        2 &plusmn; 0.2",
"       </td>",
"       <td>",
"        105 &plusmn; 29",
"       </td>",
"       <td>",
"        2.2 &plusmn; 0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        13 &plusmn; 2",
"       </td>",
"       <td>",
"        4 &plusmn;1",
"       </td>",
"       <td>",
"        1.8 &plusmn; 0.1",
"       </td>",
"       <td>",
"        89 &plusmn; 14",
"       </td>",
"       <td>",
"        2.5 &plusmn; 0.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        10 &plusmn; 2",
"       </td>",
"       <td>",
"        4 &plusmn;1",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.2",
"       </td>",
"       <td>",
"        85 &plusmn; 23",
"       </td>",
"       <td>",
"        2.8 &plusmn; 0.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        9 &plusmn; 1",
"       </td>",
"       <td>",
"        4 &plusmn;1",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.1",
"       </td>",
"       <td>",
"        88 &plusmn; 27",
"       </td>",
"       <td>",
"        2.8 &plusmn; 0.9",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Sorin Bicarbon",
"        </strong>",
"        <br/>",
"        Bileaflet",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        15 &plusmn; 0.25",
"       </td>",
"       <td>",
"        4 &plusmn; 0.5",
"       </td>",
"       <td>",
"        1.95 &plusmn; 0.02",
"       </td>",
"       <td>",
"        70 &plusmn; 1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        11 &plusmn; 2.75",
"       </td>",
"       <td>",
"        4 &plusmn; 0.5",
"       </td>",
"       <td>",
"        1.65 &plusmn; 0.21",
"       </td>",
"       <td>",
"        82 &plusmn; 20",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        12 &plusmn; 3",
"       </td>",
"       <td>",
"        4 &plusmn; 1.25",
"       </td>",
"       <td>",
"        1.73 &plusmn; 0.22",
"       </td>",
"       <td>",
"        80 &plusmn; 14",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        10 &plusmn; 1.5",
"       </td>",
"       <td>",
"        4 &plusmn; 1",
"       </td>",
"       <td>",
"        1.66 &plusmn; 0.11",
"       </td>",
"       <td>",
"        83 &plusmn; 14",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         St. Jude Medical",
"        </strong>",
"        <br/>",
"        Bileaflet",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4.0",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        160",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.5 &plusmn; 1",
"       </td>",
"       <td>",
"        1.34 &plusmn; 1.12",
"       </td>",
"       <td>",
"        75 &plusmn; 4",
"       </td>",
"       <td>",
"        1.35 &plusmn; 0.17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        11 &plusmn; 4",
"       </td>",
"       <td>",
"        5 &plusmn; 1.82",
"       </td>",
"       <td>",
"        1.61 &plusmn; 0.29",
"       </td>",
"       <td>",
"        75 &plusmn; 10",
"       </td>",
"       <td>",
"        1.67 &plusmn; 0.17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        10 &plusmn; 3",
"       </td>",
"       <td>",
"        4.15 &plusmn; 1.8",
"       </td>",
"       <td>",
"        1.57 &plusmn; 0.29",
"       </td>",
"       <td>",
"        85 &plusmn; 10",
"       </td>",
"       <td>",
"        1.75 &plusmn; 0.24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        12 &plusmn; 6",
"       </td>",
"       <td>",
"        4.46 &plusmn; 2.22",
"       </td>",
"       <td>",
"        1.59 &plusmn; 0.33",
"       </td>",
"       <td>",
"        74 &plusmn; 13",
"       </td>",
"       <td>",
"        2.03 &plusmn; 0.32",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Starr-Edwards",
"        </strong>",
"        <br/>",
"        Caged ball",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        10.0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        7 &plusmn; 2.75",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.9 &plusmn; 0.57",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        12.2 &plusmn; 4.6",
"       </td>",
"       <td>",
"        6.99 &plusmn; 2.5",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.3",
"       </td>",
"       <td>",
"        125 &plusmn; 25",
"       </td>",
"       <td>",
"        1.65 &plusmn; 0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        11.5 &plusmn; 4.2",
"       </td>",
"       <td>",
"        5.08 &plusmn; 2.5",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.3",
"       </td>",
"       <td>",
"        110 &plusmn; 25",
"       </td>",
"       <td>",
"        1.98 &plusmn; 0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        5.0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Stentless quadrileaflet bovine pericardial",
"        </strong>",
"        <br/>",
"        Stentless bioprosthesis",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.2 &plusmn; 1.7",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        103 &plusmn; 31",
"       </td>",
"       <td>",
"        1.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.58 &plusmn; 0.25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.7 &plusmn; 0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        1.42 &plusmn; 0.32",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.3 &plusmn; 0.4",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Wessex",
"        </strong>",
"        <br/>",
"        Stented bioprosthesis",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.69 &plusmn; 0.61",
"       </td>",
"       <td>",
"        1.66 &plusmn; 0.17",
"       </td>",
"       <td>",
"        83 &plusmn; 19",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3.31 &plusmn; 0.83",
"       </td>",
"       <td>",
"        1.41 &plusmn; 0.25",
"       </td>",
"       <td>",
"        80 &plusmn; 21",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Zoghbi WA, Chambers JB, Bumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009; 22:975. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34355=[""].join("\n");
var outline_f33_35_34355=null;
var title_f33_35_34356="Metastatic cancer of the distal phalanx";
var content_f33_35_34356=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F79595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F79595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metastatic cancer of the distal phalanx",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 656px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Metastatic tumors to the hand are rare and usually involve the distal phalanx, thus they can be confused with a pulp space infection or felon. Radiographs are useful in differentiating a tumor from infection. Primary lung tumors are the most common metastatic lesion to the hand. Other tumors include breast, kidney, colon, thyroid, and prostate. The photograph shows a case of metastatic renal cell carcinoma. The corresponding radiograph shows almost complete destruction of the distal phalanx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34356=[""].join("\n");
var outline_f33_35_34356=null;
var title_f33_35_34357="Urethral cancer in women";
var content_f33_35_34357=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urethral cancer in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Ralph Madeb, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Dragan Golijanin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Edward Messing, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Bridget F Koontz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34357/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/35/34357/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary urethral cancer is a rare malignancy in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Unlike other tumors arising in the urinary tract, urethral cancer is more common in women than in men. Differences in anatomy and etiology lead to important differences in the clinical presentation, diagnosis, and treatment of urethral cancer in women compared to men.",
"   </p>",
"   <p>",
"    The diagnosis and treatment of urethral cancer in women will be reviewed here. Urethral cancer in men is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/26/10664?source=see_link\">",
"     \"Urethral cancer in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the etiology of urethral cancer is not well understood, several factors have been associated with its development:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transitional cell carcinoma of the proximal urinary tract &mdash; Transitional cell carcinoma (TCC) of the urothelium is often multifocal, and similar lesions can develop in the female urethra. Urethral TCC may occur simultaneously with, precede, or follow lesions of the bladder, ureters, or renal pelvis.",
"     </li>",
"     <li>",
"      Human papillomavirus (HPV) infection &mdash; A close association exists between infection with HPV and squamous cancers of the anogenital tract, including cancers of the cervix and anus. HPV also appears to play a role in causing female urethral cancer. This was illustrated by a series in which HPV was identified in tumors from 11 of 18 patients (61 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/5\">",
"       5",
"      </a>",
"      ]. HPV 16, which has been causally linked to cervical and anal cancers, was present in 9 of the 11 cases (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=see_link\">",
"       \"Virology of human papillomavirus infections and the link to cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/33/1562?source=see_link&amp;anchor=H3#H3\">",
"       \"Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment\", section on 'HPV infection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31065?source=see_link&amp;anchor=H3#H3\">",
"       \"Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis\", section on 'Role of human papillomavirus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethral diverticuli &mdash; Cancers can arise in urethral diverticuli. Most typically, these have been clear cell carcinomas, although TCCs and squamous cell carcinomas (SCCs) have also been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Urinary stasis and infection may be contributing factors.",
"     </li>",
"     <li>",
"      Adenocarcinoma &mdash; Adenocarcinoma of the urethra may also occur in the absence of diverticulae. These cases often demonstrate immunohistochemical staining with prostate specific antigen suggesting that they arise from periurethral glands [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/8\">",
"       8",
"      </a>",
"      ]. Pathologically these lesions need to be distinguished from nephrogenic adenoma and vulval Paget&rsquo;s disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY AND PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female urethra averages 3 to 4 cm in length. The proximal 30 percent is composed of transitional epithelium, while the distal 70 percent is stratified squamous epithelium.",
"   </p>",
"   <p>",
"    The lymphatics of the distal one-third of the female urethra drain into the superficial or deep inguinal nodes, while the proximal two-thirds go into the pelvic lymph nodes (external and internal iliac, and obturator nodes).",
"   </p>",
"   <p>",
"    Case series of urethral carcinoma in women suggest that SCCs account for approximately 55 to 60 percent of cases, TCCs 15 percent, and adenocarcinomas 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. In contrast, an analysis of 492 women with urethral cancer, identified from the Surveillance, Epidemiology and End Results (SEER) database, found that SCCs, TCCs, and adenocarcinomas were approximately equally common (28, 30, and 29 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Less common neoplasms that have been described arising in the female urethra include neuroendocrine cancers (carcinoid, small cell), melanoma, and lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women with urethral cancer present with symptoms of frequency, dysuria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria. These symptoms are commonly mistaken for cystitis and this can cause a substantial delay in diagnosis.",
"   </p>",
"   <p>",
"    In elderly women, the new onset of tenesmus, dyspareunia, or other pelvic symptomatology, or the diagnosis of a new urethral-vaginal fistula should alert the clinician to the possibility of urethral cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high index of suspicion is needed for the early diagnosis of urethral cancer in women with symptoms. A detailed physical examination is needed to evaluate for the presence of a mass or regional lymph node involvement.",
"   </p>",
"   <p>",
"    Cystoscopy and urethroscopy should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/17\">",
"     17",
"    </a>",
"    ]. A biopsy for tissue diagnosis is generally obtained transurethrally at cystoscopy. Friable or ulcerated urethral epithelium is common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/3\">",
"     3",
"    </a>",
"    ]. These procedures are also important to identify synchronous tumors of the bladder or upper urinary tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/3,18\">",
"     3,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Locoregional tumor staging utilizes computed tomography (CT)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    magnetic resonance imaging (MRI) of the abdomen and pelvis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/2,3,19,20\">",
"     2,3,19,20",
"    </a>",
"    ]. The superior soft tissue resolution of MRI allows better delineation of tissue planes and identification of the extent of local invasion. In contrast, CT is better at excluding distant metastases. Care must be taken to include the entire groin area during imaging.",
"   </p>",
"   <p>",
"    Other routine staging procedures include a chest radiograph and evaluation of renal, hepatic, and hematologic function. Radionuclide bone scanning is indicated only if bone metastases are suspected (ie, unexplained pain, elevated alkaline phosphatase), particularly if the presence of such spread would alter management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TNM staging system, which is supported by both the American Joint Committee on Cancer (AJCC) and the International Union for Cancer Control (UICC), is used for female urethral cancer (",
"    <a class=\"graphic graphic_table graphicRef62556 \" href=\"mobipreview.htm?9/22/9580\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75772 \" href=\"mobipreview.htm?17/9/17564\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/21\">",
"     21",
"    </a>",
"    ]. Early stage cancers (Ta, Tis, and T1) are typically identified only after histologic study, while more advanced primary tumors are usually recognized on physical examination",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    non-invasive imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rarity of urethral cancer has precluded large series or prospective trials. Thus recommendations for treatment are based upon isolated case reports or very small series, general oncologic principles, and extrapolation from other diseases.",
"   </p>",
"   <p>",
"    The anatomic location and extent of disease dictate the approach to therapy in treating urethral cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Superficial distal lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small, early stage disease can often be managed successfully with a single modality approach, either surgery or radiation therapy (RT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical options include endoscopic electroresection or laser vaporization if the malignancy is at the meatus and remains superficial in nature. Circumferential local excision of the distal urethra and adjacent portions of the anterior vaginal wall can be performed for small, exophytic, well-differentiated lesions of the external meatus or distal third of the urethra. Surgically, spatulation of the urethra and approximation to the subjacent vagina and labia preserve urinary continence while helping to prevent urethral meatal stenosis. Single institutional series with surgery as primary or sole modality report crude local control rates of 67 to 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Definitive radiotherapy has also had good outcomes for women with early stage urethral cancers. Small series have reported crude local disease control rates between 60 and 100 percent using either brachytherapy, external beam RT, or a combination of both techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. RT has also been used as an adjuvant to surgery in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/23,30\">",
"     23,30",
"    </a>",
"    ]. Definitive RT may have a particular advantage for this group in avoiding the morbidity associated with surgery, particularly if a more extensive resection would be required to remove the lesion with an adequate margin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Proximal or bulky tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multimodality approach combining surgical resection with chemotherapy and radiation appears to provide improved ability to control locally advanced disease, compared to older single modality approaches. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1574668807\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, aggressive surgery with extensive resection or anterior pelvic exenteration (en bloc total urethrectomy, cystectomy with pelvic lymphadenectomy, hysterectomy with salpingectomy, and removal of the anterior wall of the vagina) has been performed. If there is tumor invasion of the pelvic bones, resection of the pubic symphysis and inferior rami may be required to maximize the surgical margins and reduce the risk of local recurrence.",
"   </p>",
"   <p>",
"    For patients with locally advanced disease, surgery alone yields poor results, with five-year survival estimated to be 20 percent in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/31\">",
"     31",
"    </a>",
"    ]. Treatment failures almost uniformly included locoregional recurrence, sometimes without distant metastases. Adjuvant or neoadjuvant radiotherapy or chemotherapy does appear to improve local control (43 to 67 percent) and overall survival (50 to 75 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/23,27,32,33\">",
"     23,27,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1574668814\">",
"    <span class=\"h3\">",
"     Combined modality approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;More recently, definitive chemoradiation to doses of 40 to 75 Gy (often using combination external RT and brachytherapy) have been used with improved results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/30,34-36\">",
"     30,34-36",
"    </a>",
"    ]. One of these series included less extensive surgical resection after chemoradiation, while others reserved surgery for salvage after recurrence. When case studies including locally advanced urethral cancers of both genders are considered, local control can be as high as 87 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The choice of chemotherapy regimen must take into consideration the histology of the cancer; SCCs are treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"       mitomycin",
"      </a>",
"      <span class=\"nowrap\">",
"       C/5-fluorouracil",
"      </span>",
"      or",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"        cisplatin",
"       </a>",
"       /5-fluorouracil",
"      </span>",
"      regimens, and TCCs should be given chemotherapy appropriate for bladder cancers, such as",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"        methotrexate",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?4/3/4152?source=see_link\">",
"        vinblastine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"        doxorubicin",
"       </a>",
"       /cisplatin.",
"      </span>",
"      &nbsp;",
"     </li>",
"     <li>",
"      Radiotherapy fields should include appropriate regional nodal beds, based upon the location of the tumor. Radiation morbidity can include urethral or vaginal stricture and fistula formation. Risk of these complications is directly related to dose, with few severe complications occurring when radiation dose is kept less than 70 Gy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/13,37\">",
"       13,37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors influence outcome in women with urethral cancer. These are illustrated by a series of 72 women treated at Memorial Sloan-Kettering over a period of 36 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34357/abstract/14\">",
"     14",
"    </a>",
"    ]. Multivariate analysis showed that stage of the primary tumor, the presence or absence of regional lymph node involvement, and the site of disease (proximal versus distal) were all independent predictors of survival. Patients with tumors &le;2 cm in size in the distal urethra had a 60 percent five-year survival rate, while those with proximal lesions &gt;4 cm had a five-year survival rate of 13 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral cancer in women is rare. The primary factors influencing treatment include the whether the lesion is proximal or distal and the extent of disease at presentation. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Anatomy and pathology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4\">",
"     'Initial evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For women with Ta, T1, and T2 lesions of the distal urethra (",
"    <a class=\"graphic graphic_table graphicRef62556 \" href=\"mobipreview.htm?9/22/9580\">",
"     table 1",
"    </a>",
"    ), we suggest either limited surgical resection or RT (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). Electrofulguration or laser vaporization are alternative procedures for carefully selected patients with small, superficial lesions. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Superficial distal lesions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with tumors involving the proximal urethra or for bulky (T3 or T4) tumors in the proximal or distal urethra, we suggest a multidisciplinary approach, using",
"      <span class=\"nowrap\">",
"       adjuvant/neoadjuvant",
"      </span>",
"      chemoradiotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radical resection (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See 'Proximal or bulky tumors' above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/1\">",
"      Forman JD, Lichter AS. The role of radiation therapy in the management of carcinoma of the male and female urethra. Urol Clin North Am 1992; 19:383.",
"     </a>",
"    </li>",
"    <li>",
"     Herr HW. Surgery of Penile and Urethral Carcinoma. In: Campbell's Urology, 7th, Walsh PC, Retik AB, Vaughan ED, et al (Eds), WB Saunders, 1998. p.3401.",
"    </li>",
"    <li>",
"     Messing EM. Urethrectomy in men and women. In: Master of Surgery: Urologic Surgery, 1st, Fowler JE (Ed), Little, Brown, 1992. p.495.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/4\">",
"      Mostofi FK, Davis CJ Jr, Sesterhenn IA. Carcinoma of the male and female urethra. Urol Clin North Am 1992; 19:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/5\">",
"      Wiener JS, Walther PJ. A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. J Urol 1994; 151:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/6\">",
"      Clayton M, Siami P, Guinan P. Urethral diverticular carcinoma. Cancer 1992; 70:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/7\">",
"      Seballos RM, Rich RR. Clear cell adenocarcinoma arising from a urethral diverticulum. J Urol 1995; 153:1914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/8\">",
"      Spencer JR, Brodin AG, Ignatoff JM. Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts. J Urol 1990; 143:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/9\">",
"      Herawi M, Drew PA, Pan CC, Epstein JI. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Hum Pathol 2010; 41:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/10\">",
"      Amin MB, Young RH. Primary carcinomas of the urethra. Semin Diagn Pathol 1997; 14:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/11\">",
"      Narayan P, Konety B. Surgical treatment of female urethral carcinoma. Urol Clin North Am 1992; 19:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/12\">",
"      Maier U, Dorfinger K, Susani M. Clear cell adenocarcinoma of the female urethra. J Urol 1998; 160:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/13\">",
"      Grigsby PW. Carcinoma of the urethra in women. Int J Radiat Oncol Biol Phys 1998; 41:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/14\">",
"      Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 1998; 82:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/15\">",
"      Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology 2006; 68:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/16\">",
"      Inuzuka S, Koga S, Imanishi D, et al. Primary malignant lymphoma of the female urethra. Anticancer Res 2003; 23:2925.",
"     </a>",
"    </li>",
"    <li>",
"     Fair, WR, Chi-Rei, Y. Urethral carcinoma in males. In: Current Therapy in Genitourinary Surgery, 2nd ed, Resnick, MI, Kursh, BC (Eds), Decker 1997. p.157.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/18\">",
"      Bretton PR, Herr HW, Whitmore WF Jr, et al. Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. J Urol 1989; 141:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/19\">",
"      Pavlica P, Barozzi L, Menchi I. Imaging of male urethra. Eur Radiol 2003; 13:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/20\">",
"      Vapnek JM, Hricak H, Carroll PR. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am 1992; 19:257.",
"     </a>",
"    </li>",
"    <li>",
"     Urethra. AJCC (American Joint Committee on Cancer) Cancer Staging Manual, Seventh edition, New York, Springer, 2010. p.507.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/22\">",
"      Koontz BF, Lee WR. Carcinoma of the urethra: radiation oncology. Urol Clin North Am 2010; 37:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/23\">",
"      Moinuddin Ali M, Klein FA, Hazra TA. Primary female urethral carcinoma. A retrospective comparison of different treatment techniques. Cancer 1988; 62:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/24\">",
"      Eng TY, Naguib M, Galang T, Fuller CD. Retrospective study of the treatment of urethral cancer. Am J Clin Oncol 2003; 26:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/25\">",
"      Micaily B, Dzeda MF, Miyamoto CT, Brady LW. Brachytherapy for cancer of the female urethra. Semin Surg Oncol 1997; 13:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/26\">",
"      Kuettel MR, Parda DS, Harter KW, et al. Treatment of female urethral carcinoma in medically inoperable patients using external beam irradiation and high dose rate intracavitary brachytherapy. J Urol 1997; 157:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/27\">",
"      Johnson DE, O'Connell JR. Primary carcinoma of female urethra. Urology 1983; 21:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/28\">",
"      Prempree T, Amornmarn R, Patanaphan V. Radiation therapy in primary carcinoma of the female urethra. II. An update on results. Cancer 1984; 54:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/29\">",
"      Weghaupt K, Gerstner GJ, Kucera H. Radiation therapy for primary carcinoma of the female urethra: a survey over 25 years. Gynecol Oncol 1984; 17:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/30\">",
"      Gheiler EL, Tefilli MV, Tiguert R, et al. Management of primary urethral cancer. Urology 1998; 52:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/31\">",
"      Grabstald H, Hilaris B, Henschke U, Whitmore WF Jr. Cancer of the female urethra. JAMA 1966; 197:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/32\">",
"      Foens CS, Hussey DH, Staples JJ, et al. A comparison of the roles of surgery and radiation therapy in the management of carcinoma of the female urethra. Int J Radiat Oncol Biol Phys 1991; 21:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/33\">",
"      Dalbagni G, Donat SM, Eschw&egrave;ge P, et al. Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol 2001; 166:1759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/34\">",
"      Tran LN, Krieg RM, Szabo RJ. Combination chemotherapy and radiotherapy for a locally advanced squamous cell carcinoma of the urethra: a case report. J Urol 1995; 153:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/35\">",
"      Shah AB, Kalra JK, Silber L, Molho L. Squamous cell cancer of female urethra. Successful treatment with chemoradiotherapy. Urology 1985; 25:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/36\">",
"      Licht MR, Klein EA, Bukowski R, et al. Combination radiation and chemotherapy for the treatment of squamous cell carcinoma of the male and female urethra. J Urol 1995; 153:1918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34357/abstract/37\">",
"      Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer 1993; 71:3102.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2965 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-87E6A227E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34357=[""].join("\n");
var outline_f33_35_34357=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY AND PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Staging system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Superficial distal lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Proximal or bulky tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1574668807\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1574668814\">",
"      - Combined modality approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2965\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2965|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/22/9580\" title=\"table 1\">",
"      Urethral CA TNM women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/9/17564\" title=\"table 2\">",
"      TNM stage group urethra",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/33/1562?source=related_link\">",
"      Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31065?source=related_link\">",
"      Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/26/10664?source=related_link\">",
"      Urethral cancer in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_35_34358="Terbinafine (systemic): Drug information";
var content_f33_35_34358=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Terbinafine (systemic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/46/9957?source=see_link\">",
"    see \"Terbinafine (systemic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/4/19526?source=see_link\">",
"    see \"Terbinafine (systemic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9566188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      LamISIL&reg;;",
"     </li>",
"     <li>",
"      Terbinex&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9480131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Terbinafine&reg;;",
"     </li>",
"     <li>",
"      Auro-Terbinafine;",
"     </li>",
"     <li>",
"      CO Terbinafine;",
"     </li>",
"     <li>",
"      Dom-Terbinafine;",
"     </li>",
"     <li>",
"      GD-Terbinafine;",
"     </li>",
"     <li>",
"      JAMP-Terbinafine;",
"     </li>",
"     <li>",
"      Lamisil&reg;;",
"     </li>",
"     <li>",
"      Mylan-Terbinafine;",
"     </li>",
"     <li>",
"      Nu-Terbinafine;",
"     </li>",
"     <li>",
"      PHL-Terbinafine;",
"     </li>",
"     <li>",
"      PMS-Terbinafine;",
"     </li>",
"     <li>",
"      Q-Terbinafine;",
"     </li>",
"     <li>",
"      Riva-Terbinafine;",
"     </li>",
"     <li>",
"      Sandoz-Terbinafine;",
"     </li>",
"     <li>",
"      Teva-Terbinafine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9566197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9567990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       U.S. labeling:",
"      </i>",
"     </b>",
"     <b>",
"      Onychomycosis:",
"     </b>",
"     Oral: Tablet: Fingernail: 250 mg once daily for  6 weeks; Toenail: 250 mg once daily for 12 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Canadian labeling:",
"      </i>",
"     </b>",
"     Oral: Tablet:",
"     <b>",
"      Note:",
"     </b>",
"     Mycologic cure may precede complete resolution of symptoms by several weeks (skin infections) or by several months (onychomycosis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Onychomycosis (finger or toenail):",
"     </b>",
"     250 mg/day in 1-2 divided doses for 6 weeks to 3 months (&ge;6 months may be necessary in some patients with infections of the big toenail)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Tinea corporis, tinea cruris:",
"     </b>",
"     250 mg/day in 1-2 divided doses for 2-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Tinea pedis (interdigital and plantar/moccasin type):",
"     </b>",
"     250 mg/day in 1-2 divided doses for 2-6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sporotrichosis, lymphocutaneous and cutaneous (unlabeled use):",
"     </b>",
"     Oral: 500 mg twice daily as alternative therapy; treat for 2-4 weeks after resolution of all lesions (usual duration: 3-6 months) (Kauffman, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9567989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/4/19526?source=see_link\">",
"      see \"Terbinafine (systemic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tinea capitis:",
"     </b>",
"     Oral: Granules: Children &ge;4 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;25 kg: 125 mg once daily for 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-35 kg: 187.5 mg once daily for 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;35 kg: 250 mg once daily for 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Onychomycosis (unlabeled use; Gupta, 1997):",
"     </b>",
"     Oral: Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;20 kg: 62.5 mg once daily for 6 weeks (fingernails)",
"     <b>",
"      or",
"     </b>",
"     12 weeks (toenails)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20-40 kg: 125 mg once daily for 6 weeks (fingernails)",
"     <b>",
"      or",
"     </b>",
"     12 weeks (toenails)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;40 kg: 250 mg once daily for 6 weeks (fingernails)",
"     <b>",
"      or",
"     </b>",
"     12 weeks (toenails)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9567991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F9567992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"     No dosage adjustment provided in manufacturer&rsquo;s U.S. labeling; however, clearance is decreased 50% in patients with  Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Use is not recommended in patients with  Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F9567993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hepatic cirrhosis: Use is not recommended in chronic or active hepatic disease.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F247741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL&reg;: 125 mg/packet (42s); 187.5 mg/packet (14s, 42s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL&reg;: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terbinex&trade;: 250 mg [kit includes Terbinex&trade; tablets (30s) and Eco-Formula&trade; nail enhancer]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terbinex&trade;: 250 mg [kit includes Terbinex&trade; tablets (42s) and Eco-Formula&trade; nail enhancer]",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F14457324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL&reg;: 125 mg [contains lactose]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9566193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9572845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablets may be administered without regard to meals. Granules should be sprinkled on a spoonful of pudding or other soft, nonacidic food (eg, mashed potatoes) and swallowed without chewing; do not mix granules with applesauce or other fruit-based foods.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F247742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Treatment of onychomycosis of the toenail or fingernail due to susceptible dermatophytes; treatment of tinea capitis",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Canadian labeling: Additional use (not in U.S. labeling): Severe tineal skin infections unresponsive to topical therapy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9566184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Terbinafine may be confused with terbutaline",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       LamISIL&reg; may be confused with LaMICtal&reg;, Lomotil&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9567971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Adverse events listed for tablets unless otherwise specified. Granules were studied in patients 4-12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (13%; granules 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (granules 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (6%; granules 2%), pruritus (3%; granules 1%), urticaria (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (6%; granules 3%), vomiting (&lt;1%; granules 5%), dyspepsia (4%), taste disturbance (3%), abdominal pain (2%; granules 2% to 4%), nausea (granules 2%), toothache (granules 1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Liver enzyme abnormalities (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Nasopharyngitis (granules 10%), cough (granules 6%), upper respiratory tract infection (granules 5%), nasal congestion (granules 2%), pharyngeal pain (granules 2%), rhinorrhea (granules 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Influenza (granules 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Angioedema, agranulocytosis, allergic reactions, alopecia, anaphylaxis, depression, generalized exanthematous pustulosis (acute), hepatic failure, neutropenia (severe), pancreatitis (acute), pancytopenia, precipitation/exacerbation of cutaneous and systemic lupus erythematosus, psoriasis exacerbation, rhabdomyolysis, smell disturbance (including loss of smell), Stevens-Johnson syndrome, thrombocytopenia, tinnitus, toxic epidermal necrolysis, vasculitis, vertigo, visual field acuity decreased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F247745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to terbinafine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F247730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Allylamine antifungal hypersensitivity: Use caution in patients sensitive to allylamine antifungals (eg, naftifine, butenafine); cross-sensitivity to terbinafine may exist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: Has been reported with use; instruct patients to report depressive symptoms/mood changes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dermatologic effects: Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported; discontinue therapy if progressive skin rash occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal effects: Taste disturbance (including loss of taste) may occur and and severe cases resulting in weight loss, or depression has been reported; resolution may be delayed (eg, several weeks to &gt;1 year) following discontinuation of therapy or in some cases, disturbance may be permanent. Discontinue therapy in patients with symptoms of taste disturbance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: Transient decreases in absolute lymphocyte counts were observed in clinical trials; severe neutropenia (reversible upon discontinuation) has also been reported. Monitor CBC in patients with pre-existing immunosuppression if therapy is  to continue &gt;6 weeks. Discontinue therapy if ANC &le;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic failure: Rare cases of hepatic failure (including fatal cases) have been reported; not recommended for use in patients with active or chronic liver disease. Discontinue if symptoms or signs of hepatobiliary dysfunction or cholestatic hepatitis develop and assess hepatic function immediately.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Although rare, changes in the ocular lens and retina have been reported; discontinuation of therapy may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory effects: Smell disturbance (including loss of smell) has been reported; resolution may be delayed (eg, &gt;1 year) following discontinuation of therapy or in some cases, disturbance may be permanent. Discontinue therapy in patients with symptoms of smell disturbance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic cirrhosis: Not recommended in patients with hepatic cirrhosis; clearance is reduced by approximately 50%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lupus: Precipitation or exacerbation of cutaneous or systemic lupus erythematosus has been observed; discontinue if signs and/or symptoms develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal dysfunction: Not recommended in patients with renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute); clearance is reduced by approximately 50%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage forms specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lactose: Some tablet formulations may contain lactose and should be avoided in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndromes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Due to potential toxicity, confirmation of diagnostic testing of nail or skin specimens prior to treatment of onychomycosis or dermatomycosis is recommended.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F9567975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (strong);",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F247734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Strong) may increase the serum concentration of ARIPiprazole.  Management: See full interaction monograph for details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: CYP2D6 Inhibitors (Strong) may increase the serum concentration of AtoMOXetine.  Management: Initiate atomoxetine at a reduced dose (adult doses -- patients up to 70kg: 0.5mg/kg/day; patients 70kg or more: 40mg/day) in patients receiving a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Strong) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Strong) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iloperidone: CYP2D6 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P88 may be increased. CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P95 may be decreased. CYP2D6 Inhibitors (Strong) may increase the serum concentration of Iloperidone.  Management: Reduce iloperidone dose by half when administered with a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May decrease the serum concentration of Terbinafine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saccharomyces boulardii: Antifungal Agents may diminish the therapeutic effect of Saccharomyces boulardii.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, strong CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Tetrabenazine. Specifically, concentrations of the active alpha- and beta-dihydrotetrabenazine metabolites may be increased.  Management: Tetrabenazine adult dose should be reduced by 50% when starting a strong CYP2D6 inhibitor.  Maximum tetrabenazine adult dose is 50 mg/day when used with a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: CYP2D6 Inhibitors (Strong) may diminish the therapeutic effect of TraMADol. These CYP2D6 inhibitors may prevent the metabolic conversion of tramadol to its active metabolite that accounts for much of its opioid-like effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Terbinafine (Systemic) may decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F247736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F247747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Avoid use in pregnancy since treatment of onychomycosis is postponable.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9567968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F9567969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Terbinafine is found in breast milk following oral administration. The milk/plasma ratio is 7:1.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9574689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (LamISIL AT External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (12 g): $8.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Terbinex Combination)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 MG &amp; 1% (1): $236.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (LamISIL Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (14): $172.01",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     187.5 mg (14): $258.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (LamISIL Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (30): $670.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Terbinafine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (30): $391.82",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F247739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     AST/ALT prior to initiation, repeat if used &gt;6 weeks; CBC",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F11390206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Antifin (PK);",
"     </li>",
"     <li>",
"      Camisan (MY);",
"     </li>",
"     <li>",
"      Dermatin (DE);",
"     </li>",
"     <li>",
"      Dermax (ZA);",
"     </li>",
"     <li>",
"      Fungitech (TW);",
"     </li>",
"     <li>",
"      Funzal (CO);",
"     </li>",
"     <li>",
"      Interbi (ID);",
"     </li>",
"     <li>",
"      Lamisil (AR, AT, AU, BE, BG, CH, CL, CN, CZ, DK, EC, EE, FI, FR, GB, GR, HK, HN, ID, IL, IN, IT, KP, MY, NL, NO, PE, PH, PL, PT, PY, RU, SE, TH, TR, TW, UY, VE);",
"     </li>",
"     <li>",
"      Lamisil Once (HK, KP);",
"     </li>",
"     <li>",
"      Lapiderm (KP);",
"     </li>",
"     <li>",
"      Lisim (MY, SG);",
"     </li>",
"     <li>",
"      Micoset (CN);",
"     </li>",
"     <li>",
"      Micozone (EC);",
"     </li>",
"     <li>",
"      Mycelvan (DO, GT, PA, SV);",
"     </li>",
"     <li>",
"      Nailderm (IE);",
"     </li>",
"     <li>",
"      Sebifin (IN);",
"     </li>",
"     <li>",
"      Tamsil (AU);",
"     </li>",
"     <li>",
"      Terbifin (HK);",
"     </li>",
"     <li>",
"      Terbihexal (AU);",
"     </li>",
"     <li>",
"      Terekol (AR);",
"     </li>",
"     <li>",
"      Terfung (TW);",
"     </li>",
"     <li>",
"      Zabel (AU)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F247728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Synthetic allylamine derivative which inhibits squalene epoxidase, a key enzyme in sterol biosynthesis in fungi. This results in a deficiency in ergosterol within the fungal cell wall and results in fungal cell death.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F247744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: &gt;70%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributed to sebum and skin predominantly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Plasma: &gt;99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic predominantly via CYP1A2, 3A4, 2C8, 2C9, and 2C19 to inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~40%; Children 36% to 64%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Terminal half-life: 200-400 hours; very slow release of drug from skin and adipose tissues occurs; effective half-life: ~36 hours; Children: 27-31 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Within 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~70%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abdel-Rahman SM, Herron J, Fallon-Friedlander S, et al, &ldquo;Pharmacokinetics of Terbinafine in Young Children Treated for Tinea Capitis,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2005, 24(10):886-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/16220086/pubmed\" id=\"16220086\" target=\"_blank\">",
"        16220086",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      De Backer M, De Vroey C, Lesaffre E, et al, &ldquo;Twelve Weeks of Continuous Oral Therapy for Toenail Onychomycosis Caused by Dermatophytes: A Double-Blind Comparative Trial of Terbinafine 250 mg/day Versus Itraconazole 200 mg/day,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 1998, 38(5 Pt 3):S57-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/9594939/pubmed\" id=\"9594939\" target=\"_blank\">",
"        9594939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Friedlander SF, Aly R, Krafchik B, et al, &ldquo;Terbinafine in the Treatment of",
"      <i>",
"       Trichophyton",
"      </i>",
"      Tinea Capitis: A Randomized, Double-Blind, Parallel-Group, Duration-Finding Study,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2002, 109(4):602-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/11927703/pubmed\" id=\"11927703\" target=\"_blank\">",
"        11927703",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gupta AK, Sibbald RG, Knowles SR, et al, &ldquo;Terbinafine Therapy May Be Associated With the Development of Psoriasis De Novo or Its Exacerbation: Four Case Reports and a Review of Drug Induced Psoriasis,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 1997, 36(5 Part 2):858-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/9146568/pubmed\" id=\"9146568\" target=\"_blank\">",
"        9146568",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gupta AK, Sibbald RG, Lynde CW, et al, &ldquo;Onychomycosis in Children: Prevalence and Treatment Strategies,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 1997, 36(3 Pt 1):395-402.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/9091470/pubmed\" id=\"9091470\" target=\"_blank\">",
"        9091470",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jones TC, &ldquo;Overview of the Use of Terbinafine in Children,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 1995, 132(5):683-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/7772471/pubmed\" id=\"7772471\" target=\"_blank\">",
"        7772471",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kauffman CA, Bustamante B, Chapman SW, et al, \"Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2007, 45(10):1255-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/35/34358/abstract-text/17968818/pubmed\" id=\"17968818\" target=\"_blank\">",
"        17968818",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9922 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-F7325097AE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34358=[""].join("\n");
var outline_f33_35_34358=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566188\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9480131\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566197\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567990\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567989\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567991\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567992\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567993\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247741\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14457324\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566193\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9572845\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247742\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566184\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567971\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247745\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247730\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567975\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247734\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247736\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247747\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567968\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9567969\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9574689\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247739\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11390206\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247728\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247744\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9922\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9922|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/46/9957?source=related_link\">",
"      Terbinafine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/4/19526?source=related_link\">",
"      Terbinafine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/47/6900?source=related_link\">",
"      Terbinafine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?38/53/39763?source=related_link\">",
"      Terbinafine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/30/1507?source=related_link\">",
"      Terbinafine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_35_34359="Indications for the use of transjugular intrahepatic portosystemic shunts";
var content_f33_35_34359=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Indications for the use of transjugular intrahepatic portosystemic shunts",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Arun J Sanyal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34359/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/35/34359/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transjugular intrahepatic portosystemic shunts (TIPS) involve creation of a low-resistance channel between the hepatic vein and the intrahepatic portion of the portal vein (usually the right branch) using angiographic techniques (",
"    <a class=\"graphic graphic_figure graphicRef72311 \" href=\"mobipreview.htm?3/10/3239\">",
"     figure 1",
"    </a>",
"    ). The tract is kept patent by deployment of an expandable metal stent across it, thereby allowing blood to return to the systemic circulation. The ability of TIPS to function like a surgical side-to-side portacaval shunt without requiring general anesthesia and major surgery led to its rapid acceptance into clinical practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the expanding use of TIPS has also led to its misuse in some instances.",
"   </p>",
"   <p>",
"    This topic will review the indications for TIPS other than variceal bleeding and ascites. It will also review conditions for which TIPS should not be used. The use of TIPS for variceal bleeding and ascites, and the complications associated with this procedure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39511?source=see_link\">",
"     \"Role of transjugular intrahepatic portosystemic shunts in the treatment of variceal bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35465?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of diuretic-resistant ascites in patients with cirrhosis\", section on 'Transjugular intrahepatic portosystemic stent-shunt'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/5/15448?source=see_link\">",
"     \"Complications of transjugular intrahepatic portosystemic shunts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A guideline issued by the American Association for the Study of Liver Diseases (AASLD; updated in 2009) is also available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/2\">",
"     2",
"    </a>",
"    ]. The AASLD guideline can be accessed through the AASLD web site at",
"    <a class=\"external\" href=\"file://www.aasld.org/\">",
"     www.aasld.org",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VARICEAL BLEEDING AND ASCITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;TIPS has primarily been used to treat the major consequences of portal hypertension (ie, variceal hemorrhage and ascites) (",
"    <a class=\"graphic graphic_table graphicRef75996 \" href=\"mobipreview.htm?27/35/28219\">",
"     table 1",
"    </a>",
"    ). These topics are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39511?source=see_link\">",
"     \"Role of transjugular intrahepatic portosystemic shunts in the treatment of variceal bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35465?source=see_link\">",
"     \"Treatment of diuretic-resistant ascites in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HEPATORENAL SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;When used in patients with refractory ascites, insertion of TIPS may lead to a delayed improvement in renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In one study, the average plasma creatinine concentration was 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (132",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    at baseline, was unchanged at one week, and fell to 0.9",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (80",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    by six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is much less information on the use of TIPS in patients who fulfill criteria for the hepatorenal syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/50/29482?source=see_link\">",
"     \"Hepatorenal syndrome\"",
"    </a>",
"    .) One report described 16 such patients, six of whom had severe hepatorenal syndrome (defined as a plasma creatinine concentration &ge;2.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [220",
"    <span class=\"nowrap\">",
"     &micro;mol/L]",
"    </span>",
"    or a creatinine clearance below 20",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/5\">",
"     5",
"    </a>",
"    ]. Within two weeks, there was an approximate doubling of the creatinine clearance with a proportionate reduction in the plasma creatinine concentration and an increase in urinary sodium excretion. Modest further improvement in creatinine clearance occurred over the ensuing six to eight weeks. Only three patients were nonresponders; all three died within six weeks after TIPS.",
"   </p>",
"   <p>",
"    Another series evaluated seven patients with cirrhosis and hepatorenal syndrome (defined as a doubling of the plasma creatinine concentration to more than 2.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [221",
"    <span class=\"nowrap\">",
"     &micro;mol/L]",
"    </span>",
"    or a 50 percent reduction in creatinine clearance to below 20",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    in less than two weeks despite volume expansion) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/6\">",
"     6",
"    </a>",
"    ]. Insertion of TIPS was associated with a gradual improvement in glomerular filtration rate (9 to 27",
"    <span class=\"nowrap\">",
"     mL/min),",
"    </span>",
"    reductions in the BUN and plasma creatinine concentration, and a reduction in the activity of the renin-angiotensin and sympathetic nervous systems in six, all of which suggest an improvement in systemic hemodynamics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21527?source=see_link\">",
"     \"Pathogenesis of ascites in patients with cirrhosis\"",
"    </a>",
"    .) The average survival following TIPS placement was approximately five months, which is longer than the expected survival of such patients.",
"   </p>",
"   <p>",
"    These results suggest that, in selected patients with hepatorenal syndrome, TIPS may provide short-term benefit. However, given the risks associated with this procedure (particularly the high incidence of encephalopathy), it should be considered only as a last resort in patients who are not candidates for or are awaiting liver transplantation. The American Association for the Study of Liver Diseases does not recommend TIPS for the treatment of hepatorenal syndrome, especially type 1 hepatorenal syndrome, pending the publication of controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS USES OF TIPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;TIPS has been used in a variety of other conditions. In most cases, only small series have been published and the indications for TIPS remain unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Budd-Chiari syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of Budd-Chiari syndrome depends on its cause and clinical presentation. The role of TIPS is described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/22/3434?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome\", section on 'Transjugular intrahepatic portosystemic shunt'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hepatic sinusoidal obstruction syndrome (veno-occlusive disease)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic sinusoidal obstruction syndrome (SOS) is an important complication of bone marrow transplantation. The pathophysiology of this condition is related to increased sinusoidal pressures from occlusion of microscopic hepatic venules and central veins in the hepatic lobules. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=see_link\">",
"     \"Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Insertion of TIPS has been performed in small numbers of patients with SOS, some of whom had regression of the hepatic and renal symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/8\">",
"     8",
"    </a>",
"    ]. Patients with milder disease appear to be more likely to respond, but long-term survival appears to be uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/8\">",
"     8",
"    </a>",
"    ]. Furthermore, it is unclear whether these patents would have improved spontaneously. At present, the use of TIPS for SOS should be considered experimental and individualized until more data are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hepatic hydrothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of a persistent symptomatic hydrothorax in a patient with cirrhosis is an ominous sign and warrants urgent liver transplantation. However, treatment is required as a bridge to transplantation. The therapeutic options include repeated thoracenteses, pleurodesis, or a peritoneovenous shunt in patients with significant ascites. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/29/37334?source=see_link\">",
"     \"Management of refractory nonmalignant pleural effusions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several groups have reported a beneficial effect of TIPS in patients with hepatic hydrothorax. Unfortunately, very few of the studies described the rigor with which the refractoriness of the hydrothorax to medical therapy was determined. Mortality is high in patients with a Child-Pugh score of 12 or higher [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/9\">",
"     9",
"    </a>",
"    ]. We consider liver transplantation to be the definitive treatment for refractory cirrhotic hydrothorax. TIPS may be used with caution in selected patients with a Child-Pugh score less than 10 (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?27/26/28065?source=see_link\">",
"     calculator 1",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?28/28/29121?source=see_link\">",
"     calculator 2",
"    </a>",
"    ) (",
"    <a class=\"graphic graphic_table graphicRef78401 \" href=\"mobipreview.htm?8/21/8540\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=see_link\">",
"     \"Hepatic hydrothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Portal hypertensive gastropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Portal hypertensive gastropathy is characterized by venous and capillary ectasia in gastrointestinal mucosa and submucosa with minimal associated inflammation (",
"    <a class=\"graphic graphic_picture graphicRef75725 \" href=\"mobipreview.htm?35/5/35935\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41865?source=see_link\">",
"     \"Uncommon causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .) It is principally described in the stomach, but may also exist in the colon and other parts of the gastrointestinal tract.",
"   </p>",
"   <p>",
"    Portal hypertensive gastropathy is a common finding in cirrhosis, but only occasionally causes recurrent bleeding requiring frequent transfusions. The treatment options include beta blockers, portacaval shunt surgery, and TIPS.",
"   </p>",
"   <p>",
"    Only limited data on the efficacy of TIPS for portal hypertensive gastropathy are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In one series involving 40 patients, TIPS was associated with an improvement in endoscopic findings and a decrease in transfusion requirement in 89 and 75 percent of patients with mild and severe portal hypertensive gastropathy, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/11\">",
"     11",
"    </a>",
"    ]. Endoscopic improvement in patients with mild gastropathy was visible within six weeks in most patients, and by three to six months in approximately 85 percent of patients. The response was slower in patients with severe gastropathy. However, more than two-thirds had endoscopic improvement by three months. TIPS may be a reasonable option in patients with troublesome bleeding from portal gastropathy who do not respond to therapeutic doses of beta blockers and nitrates or are intolerant of them, and who are not suitable candidates for a surgical portacaval shunt [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Prior to abdominal surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with portal hypertension have an increased risk of bleeding during intraabdominal surgery. Case reports have suggested that the risk might be reduced by preoperative placement of a TIPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/12\">",
"     12",
"    </a>",
"    ]. However, other studies have not found a decrease in the need for transfusion, ICU stay, or mortality with preoperative decompression of the portal vein with TIPS in patients with cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Based upon current evidence, TIPS cannot be routinely recommended prior to nonhepatic abdominal surgery in those with cirrhosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CONDITIONS FOR WHICH TIPS SHOULD NOT BE USED",
"    </span>",
"    &nbsp;&mdash;&nbsp;The widespread availability of TIPS has led to its use in the context of virtually all aspects of cirrhosis. Needless to say, many such indications are not warranted, particularly when one considers the frequent complications associated with this procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/5/15448?source=see_link\">",
"     \"Complications of transjugular intrahepatic portosystemic shunts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Primary prophylaxis of variceal hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only one-third of patients with esophageal varices will experience variceal hemorrhage. Pharmacologic treatment with nonselective beta blockers achieves a decrease in bleeding frequency with relatively little morbidity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27418?source=see_link\">",
"     \"Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis\"",
"    </a>",
"    .) By comparison, TIPS is an expensive, invasive procedure with significant morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/16\">",
"     16",
"    </a>",
"    ]. It also requires close follow-up due to the high incidence of shunt stenosis, and recurrent portal hypertension.",
"   </p>",
"   <p>",
"    Thus, TIPS is not indicated for the primary prophylaxis of variceal hemorrhage. Similarly, TIPS does not affect the outcome of liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/13,15,17\">",
"     13,15,17",
"    </a>",
"    ] and is not indicated for preoperative portal decompression prior to transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Prehepatic portal hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prehepatic portal hypertension results most commonly from portal vein thrombosis or tumors at the porta hepatis. Several anecdotal reports have documented that TIPS can be placed into a collateral vein, or following dilation of a thrombosed portal vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. However, since the low-resistance tract is being created downstream from the site of obstruction, it is unlikely to adequately decompress the portal system. There currently are not enough data to support the use of TIPS in such patients.",
"   </p>",
"   <p>",
"    There have been cases of acute portal vein thrombosis effectively treated by placement of a TIPS followed by aggressive thrombolysis or anticoagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. However, it has been our experience that this is associated with occasional morbidity due to bleeding, which can be severe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Correction of hypersplenism and thrombocytopenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombocytopenia in patients with cirrhosis has primarily been ascribed to splenic engorgement and sequestration. However, other factors such as a low thrombopoietin levels may also contribute [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16680?source=see_link\">",
"     \"Biology and physiology of thrombopoietin\"",
"    </a>",
"    .) In addition to these chronic factors, the consumption of platelets and dilution by blood and plasma transfusions during episodes of bleeding can cause an acute fall in the platelet count.",
"   </p>",
"   <p>",
"    Several small series have noted an improvement in the platelet count within a few days of TIPS placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, a problem with these studies is that the baseline values were obtained during active bleeding; thus, the early increase in platelet counts may have reflected a return to baseline values in such patients. In a systematic prospective study of 60 subjects in whom \"true\" baseline data were obtained, the mean platelet counts remained unchanged after TIPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/26\">",
"     26",
"    </a>",
"    ]. Although a small number of patients did experience a long-lasting increase in platelet counts, there were no clinical markers that could identify these subjects. Similar findings have been reported in other series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/27\">",
"     27",
"    </a>",
"    ]. These data corroborate those obtained after surgical portal decompression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Thus, TIPS should not be performed simply to increase platelet counts in cirrhotics with thrombocytopenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pulmonary hypertension and hepatopulmonary syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cirrhosis is sometimes complicated by the development of severe pulmonary hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/30\">",
"     30",
"    </a>",
"    ]. The pathogenesis of this syndrome is obscure. Many patients are diagnosed only during evaluation for liver transplant, and the true incidence in unknown. The presence of severe pulmonary hypertension is associated with a poor outcome after liver transplantation.",
"   </p>",
"   <p>",
"    The hepatopulmonary syndrome is a separate condition that is characterized by arteriovenous shunting within the pulmonary bed, producing a right-to-left shunt and systemic hypoxemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/35/3640?source=see_link\">",
"     \"Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of TIPS on the pulmonary circulation is complex, and depends upon the dynamic interaction of the changes in venous return, effective circulating volume, systemic vascular resistance, and myocardial reserve. Following TIPS, there is an immediate increase in venous return to the heart [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/31\">",
"     31",
"    </a>",
"    ]. Simultaneously, systemic vascular resistance decreases, further worsening the hyperdynamic circulatory state already present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Cardiac output increases in response to these changes. When the heart's ability to handle this \"volume-overload\" is exceeded, pulmonary venous pressures rise, with increasing",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    mismatch, hypoxia and pulmonary vasoconstriction; pulmonary edema may ensue.",
"   </p>",
"   <p>",
"    The varying outcome of patients with cirrhotic pulmonary hypertension and hepatopulmonary syndrome after TIPS is due to differences in the interactions between these variables [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/7,34,35\">",
"     7,34,35",
"    </a>",
"    ]. TIPS should not be performed for these conditions. The outcome is not predictable, and TIPS may actually be detrimental. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35064?source=see_link\">",
"     \"Portopulmonary hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/35/3640?source=see_link\">",
"     \"Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Portal hypertension associated with polycystic liver disease or Caroli disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both polycystic liver disease and Caroli disease (a variant of choledochal cyst disease characterized by multiple cystic dilations of the intrahepatic biliary ducts) may be complicated by portal hypertension and variceal hemorrhage. The creation of an intrahepatic tract may involve traversal of a cyst, which is associated with a high risk of severe hemorrhage. TIPS is therefore best avoided in such patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34359/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30233?source=see_link\">",
"     \"Extrarenal manifestations of autosomal dominant polycystic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/53/2902?source=see_link\">",
"     \"Caroli disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38798044\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transjugular intrahepatic portosystemic shunts (TIPS) have primarily been used to treat the major consequences of portal hypertension (ie, variceal hemorrhage and ascites) (",
"      <a class=\"graphic graphic_table graphicRef75996 \" href=\"mobipreview.htm?27/35/28219\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39511?source=see_link\">",
"       \"Role of transjugular intrahepatic portosystemic shunts in the treatment of variceal bleeding\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35465?source=see_link\">",
"       \"Treatment of diuretic-resistant ascites in patients with cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It is less clear if TIPS is helpful for:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hepatorenal syndrome (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Hepatorenal syndrome'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Budd-Chiari syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/22/3434?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome\", section on 'Transjugular intrahepatic portosystemic shunt'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hepatic sinusoidal obstruction syndrome (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Hepatic sinusoidal obstruction syndrome (veno-occlusive disease)'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Hepatic hydrothorax (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=see_link&amp;anchor=H9#H9\">",
"       \"Hepatic hydrothorax\", section on 'Transjugular intrahepatic portosystemic shunt (TIPS)'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Portal hypertensive gastropathy (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Portal hypertensive gastropathy'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Prior to abdominal surgery (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Prior to abdominal surgery'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TIPS should",
"      <strong>",
"       not",
"      </strong>",
"      be used for:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Primary prophylaxis of variceal hemorrhage (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Primary prophylaxis of variceal hemorrhage'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Prehepatic portal hypertension (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Prehepatic portal hypertension'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Correction of hypersplenism and thrombocytopenia (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Correction of hypersplenism and thrombocytopenia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Pulmonary hypertension and hepatopulmonary syndrome (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Pulmonary hypertension and hepatopulmonary syndrome'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Portal hypertension associated with polycystic liver disease or Caroli disease (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Portal hypertension associated with polycystic liver disease or Caroli disease'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/1\">",
"      Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124:1700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/2\">",
"      Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology 2010; 51:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/3\">",
"      Somberg KA, Lake JR, Tomlanovich SJ, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/4\">",
"      Ochs A, R&ouml;ssle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/5\">",
"      Brensing KA, Textor J, Strunk H, et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997; 349:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/6\">",
"      Guevara M, Gin&egrave;s P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/7\">",
"      Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/8\">",
"      Fried MW, Connaghan DG, Sharma S, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996; 24:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/9\">",
"      Chalasani N, Gitlin N. TIPS for patients with refractory hepatic hydrothorax: what is the take-home message? Am J Gastroenterol 1997; 92:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/10\">",
"      Trevino HH, Brady CE 3rd, Schenker S. Portal hypertensive gastropathy. Dig Dis 1996; 14:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/11\">",
"      Kamath PS, Lacerda M, Ahlquist DA, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/12\">",
"      Azoulay D, Buabse F, Damiano I, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 2001; 193:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/13\">",
"      Somberg KA, Lombardero MS, Lawlor SM, et al. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation 1997; 63:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/14\">",
"      Vinet E, Perreault P, Bouchard L, et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 2006; 20:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/15\">",
"      Millis JM, Martin P, Gomes A, et al. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transpl Surg 1995; 1:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/16\">",
"      Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics 1993; 13:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/17\">",
"      Abouljoud MS, Levy MF, Rees CR, et al. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation 1995; 59:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/18\">",
"      H&auml;nig V, Stenzel G, R&ouml;ssle M. [Acute portal vein thrombosis in liver cirrhosis: successful recanalization with the use of a portosystemic shunt (TIPS)]. Rofo 1996; 165:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/19\">",
"      Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993; 186:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/20\">",
"      Ferro C, Rossi UG, Bovio G, et al. Transjugular intrahepatic portosystemic shunt, mechanical aspiration thrombectomy, and direct thrombolysis in the treatment of acute portal and superior mesenteric vein thrombosis. Cardiovasc Intervent Radiol 2007; 30:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/21\">",
"      Kori I, Bar-Zohar D, Carmiel-Haggai M, et al. Budd-Chiari syndrome and acute portal vein thrombosis: management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS. J Gastrointest Surg 2006; 10:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/22\">",
"      Peck-Radosavljevic M, Zacherl J, Meng YG, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997; 27:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/23\">",
"      Alvarez OA, Lopera GA, Patel V, et al. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 1996; 91:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/24\">",
"      Lawrence SP, Lezotte DC, Durham JD, et al. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 1995; 40:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/25\">",
"      Pursnani KG, Sillin LF, Kaplan DS. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. Am J Surg 1997; 173:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/26\">",
"      Sanyal AJ, Freedman AM, Purdum PP, et al. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996; 23:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/27\">",
"      Jabbour N, Zajko A, Orons P, et al. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci 1998; 43:2459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/28\">",
"      Mutchnick MG, Lerner E, Conn HO. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci 1980; 25:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/29\">",
"      Felix WR Jr, Myerson RM, Sigel B, et al. The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 1974; 139:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/30\">",
"      Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/31\">",
"      Azoulay D, Castaing D, Dennison A, et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/32\">",
"      Colombato LA, Spahr L, Martinet JP, et al. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996; 39:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/33\">",
"      Rodr&iacute;guez-Laiz JM, Ba&ntilde;ares R, Echenagusia A, et al. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results. Dig Dis Sci 1995; 40:2121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/34\">",
"      van der Heijde RM, Lam&eacute;ris JS, van den Berg B, et al. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt (TIPS). Eur Respir J 1996; 9:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/35\">",
"      Willoughby PH, Beers RA, Murphy KD. Pulmonary edema after transjugular intrahepatic portosystemic shunt. Anesth Analg 1996; 82:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34359/abstract/36\">",
"      Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995; 22:1591.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1262 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-168C04E0CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34359=[""].join("\n");
var outline_f33_35_34359=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H38798044\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VARICEAL BLEEDING AND ASCITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HEPATORENAL SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MISCELLANEOUS USES OF TIPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hepatic sinusoidal obstruction syndrome (veno-occlusive disease)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hepatic hydrothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Portal hypertensive gastropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Prior to abdominal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CONDITIONS FOR WHICH TIPS SHOULD NOT BE USED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Primary prophylaxis of variceal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Prehepatic portal hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Correction of hypersplenism and thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pulmonary hypertension and hepatopulmonary syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Portal hypertension associated with polycystic liver disease or Caroli disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38798044\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1262\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1262|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/10/3239\" title=\"figure 1\">",
"      Transjugular intrahepatic portosystemic shunt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1262|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/5/35935\" title=\"picture 1\">",
"      Portal hypertensive gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1262|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/35/28219\" title=\"table 1\">",
"      Indications for TIPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/21/8540\" title=\"table 2\">",
"      Child Pugh classification",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?27/26/28065?source=related_link\" title=\"calculator 1\">",
"      Calculator: Child Pugh classification for severity of liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?28/28/29121?source=related_link\" title=\"calculator 2\">",
"      Calculator: Child Pugh classification for severity of liver disease (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16680?source=related_link\">",
"      Biology and physiology of thrombopoietin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/53/2902?source=related_link\">",
"      Caroli disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/22/3434?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/5/15448?source=related_link\">",
"      Complications of transjugular intrahepatic portosystemic shunts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30233?source=related_link\">",
"      Extrarenal manifestations of autosomal dominant polycystic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=related_link\">",
"      Hepatic hydrothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/35/3640?source=related_link\">",
"      Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/50/29482?source=related_link\">",
"      Hepatorenal syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/29/37334?source=related_link\">",
"      Management of refractory nonmalignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=related_link\">",
"      Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21527?source=related_link\">",
"      Pathogenesis of ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35064?source=related_link\">",
"      Portopulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27418?source=related_link\">",
"      Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39511?source=related_link\">",
"      Role of transjugular intrahepatic portosystemic shunts in the treatment of variceal bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/40/35465?source=related_link\">",
"      Treatment of diuretic-resistant ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41865?source=related_link\">",
"      Uncommon causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_35_34360="Coccidioidomycosis silver stain";
var content_f33_35_34360=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77193%7EPULM%2F64404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77193%7EPULM%2F64404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coccidioidomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 188px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph of a silver stained slide showing multiple organisms of Coccidioides spp. Some spherules contain multiple small endospores (arrow). Large empty spherules can resemble the round yeast of Blastomyces dermatitidis, but the spherules of coccidioides tend to be larger, lack basophilic nuclei, and do not bud.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coccidioidomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 183px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows multiple necrotizing and nonnecrotizing granulomas in a patient with coccidioidomycosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34360=[""].join("\n");
var outline_f33_35_34360=null;
var title_f33_35_34361="Screening for asymptomatic carotid artery stenosis";
var content_f33_35_34361=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Screening for asymptomatic carotid artery stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Mark O McCarron, MD, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Larry B Goldstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     David B Matchar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/35/34361/contributors\">",
"     H Nancy Sokol, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/35/34361/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke is the second leading cause of death worldwide and the fourth leading cause of death in the United States (US), behind heart disease, cancer, and respiratory disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevalence of stroke has been rising gradually with the increasingly aging population, despite evidence of a decline in stroke incidence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of stroke is often devastating, with a 20 percent mortality from the acute event and 40 to 50 percent survival at five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Among survivors, data from the Framingham study reveal that 18 percent are unable to return to work, while up to 4 percent require total custodial care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/4\">",
"     4",
"    </a>",
"    ]. One-quarter of those over age 65 years require long-term institutional care after a first stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/1\">",
"     1",
"    </a>",
"    ]. Thrombolytic therapy can salvage brain tissue in some patients who present acutely with an ischemic stroke, but such patients represent only a small fraction of those suffering acute stroke. For the majority who go on to suffer a completed stroke, there is little that can be done to reverse the devastating effects of brain injury. For this reason, the greatest impact on this disease comes from prevention.",
"   </p>",
"   <p>",
"    Patients who have had a stroke or transient ischemic attack (TIA) due to carotid stenosis are considered symptomatic and often benefit from early carotid revascularization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients with carotid artery stenosis are considered to be symptomatic if they have had recent (within six months) transient or permanent focal neurologic symptoms related to the affected artery (eg, ipsilateral amaurosis fugax, contralateral weakness or numbness of an extremity or the face, dysarthria or aphasia). In contrast, nonspecific neurologic symptoms (eg, dizziness or",
"    <span class=\"nowrap\">",
"     syncope/near",
"    </span>",
"    syncope) are not considered in the definition of symptomatic carotid stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21530?source=see_link&amp;anchor=H3#H3\">",
"     \"Management of symptomatic carotid atherosclerotic disease\", section on 'Carotid endarterectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Carotid stenosis may also be identified in asymptomatic patients. It should be noted that the cutoff used to define clinically significant carotid artery stenosis varies among studies, ranging from 50 to 70 percent stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Optimal management of patients with asymptomatic carotid stenosis to prevent stroke is not established. The therapeutic options, which are discussed in detail elsewhere, include medical management to address risk factors for atherosclerosis, focusing on control of hypertension, diabetes mellitus, smoking, and dyslipidemia; the administration of antiplatelet drugs to prevent platelet aggregation; and surgical revascularization by carotid endarterectomy (CEA) or carotid artery stenting (CAS). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is evidence that CEA in selected asymptomatic patients (medically stable men with asymptomatic carotid stenosis of 60 to 99 percent who have a life expectancy of at least five years) can decrease the risk of stroke, provided the perioperative risk of stroke and death for the surgeon and center is less than 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Because of advances in medical therapy that have occurred since clinical trials of endarterectomy were conducted, the risk of stroke with medical therapy may now be appreciably lower and the 3 percent risk threshold high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"     10",
"    </a>",
"    ]. For the reasons described below, routine screening for carotid artery disease is not generally recommended in asymptomatic individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H240467881\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of asymptomatic carotid stenosis in a review of 40 studies varied with differences in demographic factors, cutoff points used to identify stenosis, and methods of grading stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pooled prevalence of moderate stenosis (defined as &gt;50 percent stenosis) for men and women aged less than 70 years was 4.8 percent and 2.2 percent respectively; for men and women aged 70 and older, the prevalence was 12.5 percent and 6.9 percent respectively.",
"     </li>",
"     <li>",
"      The overall pooled prevalence of severe stenosis (defined as &gt;70 percent) was 1.7 percent.",
"     </li>",
"     <li>",
"      The prevalence of severe asymptomatic carotid stenosis in individuals age 80 and older was 3.1 percent for men and 0.9 percent for women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the analysis for the United States Preventive Services Task Force (USPSTF) recommendation regarding screening for carotid artery stenosis, the prevalence of carotid artery stenosis (60 to 99 percent) was estimated to be 1 percent or less in the general population and 1 percent in persons 65 years or older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6615983\">",
"    <span class=\"h1\">",
"     STROKE RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;The percentage of strokes that are related to carotid artery atherosclerosis is unknown. Ischemia, due to thrombosis, embolism, or systemic hypoperfusion, accounts for 88 percent of strokes. Thrombosis may involve large or small vessels, and large vessel disease is further classified as extracranial (common and internal carotids, vertebral artery) or intracranial (circle of Willis and branches). It is estimated that carotid artery stenosis is the cause of fewer than 15 percent of strokes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/13\">",
"     13",
"    </a>",
"    ], with a population-attributable risk of 2 to 7 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest randomized trial in patients with asymptomatic carotid stenosis (defined as &ge;60 percent stenosis) compared carotid endarterectomy with non-surgical treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/9\">",
"     9",
"    </a>",
"    ]. The projected five-year rate of stroke or perioperative death was 11.8 percent for patients receiving medical care and 6.4 percent for those assigned to the surgery group. It is important to note that patients in this trial, conducted between 1993 and 2003, did not receive the intensity of medical therapy (statins, aggressive blood pressure management, antiplatelet agents) that is currently recommended for asymptomatic patients. The annual risk of stroke in medically-treated patients with asymptomatic carotid stenosis has dropped in the last 25 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/14\">",
"     14",
"    </a>",
"    ]; it is estimated that the risk of stroke in these individuals is less than 1.0 percent per year, and may be as low as 0.3 percent per year (",
"    <a class=\"graphic graphic_figure graphicRef82860 \" href=\"mobipreview.htm?21/48/22286\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SCREENING TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for carotid artery stenosis may be accomplished in two ways: by auscultation for carotid bruits during the physical examination, and by noninvasive studies of the carotid artery. Cerebral angiography is the gold standard for imaging the carotid arteries, but is not appropriate for screening. It is invasive, expensive, and associated with significant morbidity (approximately 1 percent) and mortality (approximately 0.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31033?source=see_link\">",
"     \"Evaluation of carotid artery stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Carotid bruit",
"    </span>",
"    &nbsp;&mdash;&nbsp;A carotid bruit is an audible sound arising from turbulent blood flow. Interobserver agreement in detecting a carotid bruit by physicians is relatively high (kappa = 0.67, meaning that physicians agree in two-thirds of cases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/18\">",
"     18",
"    </a>",
"    ]. A meta-analysis suggested that the presence of a carotid bruit increases the risk of cerebrovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/19\">",
"     19",
"    </a>",
"    ]. However, a bruit alone is a poor predictor of either underlying carotid stenosis or stroke risk in asymptomatic patients, as illustrated by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The proportion of patients with asymptomatic bruits who go on to have a stroke is low; the annual incidence of stroke (not preceded by a TIA) ipsilateral to a bruit is 1 to 3 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/20-22\">",
"       20-22",
"      </a>",
"      ]. Only 35 percent of patients with a carotid bruit have a hemodynamically significant carotid lesion (70 to 99 percent stenosis). Conversely, among patients with hemodynamically significant stenosis, only about one-half have a bruit detectable on physical examination.",
"     </li>",
"     <li>",
"      The Framingham Heart Study found that an asymptomatic carotid bruit was associated with an approximate doubling of the expected stroke risk [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/23\">",
"       23",
"      </a>",
"      ]. However, the majority of strokes occurred in a vascular territory different from the carotid bruit, suggesting that a carotid bruit is a marker of generalized atherosclerosis.",
"     </li>",
"     <li>",
"      The Systolic Hypertension in the Elderly Program (SHEP) found that the presence of a carotid bruit was associated with a nonsignificant overall relative risk of 1.29 for stroke over a mean follow-up of 4.2 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 241 older nursing home residents (mean age 86 years) found that 12 percent had asymptomatic carotid bruits [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/25\">",
"       25",
"      </a>",
"      ]. The three-year cumulative incidence of cerebrovascular events was similar for patients with and without bruits (10 and 9 percent respectively). Furthermore, baseline carotid bruits disappeared in 60 percent of surviving residents; loss of the bruit was not due to a cerebrovascular event.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The poor predictive value of carotid bruits in asymptomatic individuals is in part related to the low prevalence of significant carotid stenosis in this population. The estimated positive predictive value that an individual with a carotid bruit has more than 50 percent carotid stenosis is less than 40 percent when the prevalence of this degree of stenosis is estimated as high as 15 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/26\">",
"     26",
"    </a>",
"    ]. The actual prevalence of greater than 50 percent carotid stenosis in the general population in the Framingham study was only 8 percent in individuals between 66 and 93 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bruits are a better indicator of atherosclerotic disease in general than of stroke risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/23,28-30\">",
"     23,28-30",
"    </a>",
"    ]. The rate of myocardial infarction and cardiovascular death in patients with carotid bruits is twice that of patients without carotid bruits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients with carotid artery disease are more likely to die from cardiovascular than cerebrovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Nonetheless, risk stratification to identify patients at high risk for cardiovascular disease is most commonly based upon the Framingham risk score,",
"    <strong>",
"     not",
"    </strong>",
"    the presence or absence of carotid bruits. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/8/39048?source=see_link\">",
"     \"Estimation of cardiovascular risk in an individual patient without known cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/50/26409?source=see_link\">",
"     \"Screening for coronary heart disease\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Noninvasive testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many noninvasive techniques available to identify and quantify carotid stenosis. Indirect tests, including supraorbital Doppler ultrasonography and oculoplethysmography, have been superseded by more direct measures of the vessel: carotid duplex ultrasonography (DUS), magnetic resonance angiography (MRA), contrast-enhanced MRA (CEMRA), and computed tomographic angiography (CTA). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31033?source=see_link\">",
"     \"Evaluation of carotid artery stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A meta-analysis found little difference between carotid DUS and MRA in the detection of either complete carotid artery occlusion or 70 percent stenosis, which are important cut-off points for making appropriate decisions about endarterectomy for symptomatic patients (",
"    <a class=\"graphic graphic_figure graphicRef60499 \" href=\"mobipreview.htm?9/8/9359\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/31\">",
"     31",
"    </a>",
"    ]. Sensitivities were 86 and 83 percent, and specificities were 94 and 89 percent for MRA and DUS, respectively. A subsequent systematic review found that an MRA had slightly greater sensitivity and specificity than DUS in detecting 70 to 99 percent stenosis (sensitivity 95 versus 86 percent; specificity 90 versus 87 percent) although the two tests were comparable in detecting complete occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of CEMRA was evaluated in a third meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/33\">",
"     33",
"    </a>",
"    ]. CEMRA was more sensitive and specific for detecting 70 to 99 percent stenosis than DUS, MRA, or CTA (sensitivities 94 versus 89, 88, and 76 percent, respectively; specificities 93 versus 84, 84, and 94 percent, respectively).",
"   </p>",
"   <p>",
"    Published reports of sensitivity and specificity data may not be directly applicable to routine practice, as they depend upon the kind of patients examined, criteria for defining stenosis, interpretation of the test and possible reporting bias. As an example, in one study of testing in clinical practice, the misclassification rate was 28 percent for DUS alone and 18 percent for MRA alone compared with catheter angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/34\">",
"     34",
"    </a>",
"    ]. When concordant, the combination of DUS and MRA produced a misclassification rate of nearly 8 percent.",
"   </p>",
"   <p>",
"    A program of one-time screening by DUS in a population with high prevalence (20 percent) of &ge;60 percent stenosis would cost $35,130 per incremental quality-adjusted life year gained, a value that is in line with other screening strategies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/35\">",
"     35",
"    </a>",
"    ]. However, it has not been possible to set criteria to identify such a target population. Efforts to identify high-risk patients with asymptomatic carotid artery stenosis have combined extracranial Doppler studies (to identify patients with more than 60 percent carotid stenosis) with transcranial Doppler to detect asymptomatic emboli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/36\">",
"     36",
"    </a>",
"    ] and B-mode or three-dimensional ultrasound to characterize plaque morphology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Although such patients are at increased risk of ipsilateral stroke or transient ischemic attack, there is currently no evidence that such two-stage screening is cost-effective. In addition, clinical benefit from revascularization in this subgroup has not been demonstrated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     THERAPEUTIC OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic patients with significant carotid artery stenosis theoretically may benefit from four different interventions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduction of risk factors for atherosclerosis",
"     </li>",
"     <li>",
"      Antiplatelet drugs",
"     </li>",
"     <li>",
"      Carotid endarterectomy",
"     </li>",
"     <li>",
"      Carotid",
"      <span class=\"nowrap\">",
"       angioplasty/stenting",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risk factor management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major treatable risk factors for carotid artery atherosclerosis are similar to those for coronary atherosclerosis. Carotid artery atherosclerosis is a risk factor for coronary disease. The risk of cardiovascular disease is also increased in patients with progression of carotid stenosis, compared to patients with non-progressive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hypertension -",
"      </strong>",
"      Reducing the blood pressure in hypertensive patients, even those with mild hypertension, lowers the risk of stroke (",
"      <a class=\"graphic graphic_figure graphicRef52231 \" href=\"mobipreview.htm?43/29/44509\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. 2011 guidelines on the management of carotid disease from multiple US medical societies advise that patients with asymptomatic carotid disease have a blood pressure goal",
"      <span class=\"nowrap\">",
"       &lt;140/90",
"      </span>",
"      mm Hg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=see_link&amp;anchor=H15#H15\">",
"       \"Blood pressure management in patients with atherosclerotic cardiovascular disease\", section on 'Goal blood pressure'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Diabetes -",
"      </strong>",
"      Strict glycemic control reduces the risk of microvascular complications (eg, retinopathy, nephropathy, and neuropathy) in patients with diabetes mellitus, and has been shown to reduce the risk of macrovascular disease in type 1 diabetes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/43\">",
"       43",
"      </a>",
"      ]. There is no direct evidence, however, that glycemic control decreases stroke risk in patients with type 2 diabetes, and intensive glycemic control for patients with type 2 diabetes led to an excess of cardiovascular deaths in the ACCORD trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/44\">",
"       44",
"      </a>",
"      ]. Stroke is reduced in patients with diabetes with blood pressure control and statin treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=see_link\">",
"       \"Glycemic control and vascular complications in type 1 diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link\">",
"       \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=see_link\">",
"       \"Overview of medical care in adults with diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Smoking -",
"      </strong>",
"      In the Nurses' Health Study, smokers had a relative risk of stroke of 2.58 compared with never smokers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/47\">",
"       47",
"      </a>",
"      ]. Evaluation of former smokers found that the excess risk disappeared within two to four years after the cessation of smoking. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=see_link&amp;anchor=H19#H19\">",
"       \"Cardiovascular risk of smoking and benefits of smoking cessation\", section on 'Stroke'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Dyslipidemia -",
"      </strong>",
"      The efficacy of lipid lowering in the prevention of stroke has been assessed in meta-analyses of trials in which statins were given for primary or secondary prevention of coronary heart disease and data were reported on the incidence of fatal and nonfatal strokes. A meta-analysis of 24 trials with 165,792 patients (combining primary and secondary prevention) of statin use found a significant reduction in fatal and non-fatal stroke risk (RR 0.82, 95% CI 0.77&ndash;0.87) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/48\">",
"       48",
"      </a>",
"      ]. Regression of carotid atherosclerotic lesions with statin therapy has been demonstrated with high-resolution MRI, suggesting that statins induce vascular remodeling [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/49\">",
"       49",
"      </a>",
"      ]. 2011 guidelines advise that statin medications be used to reduce low density lipoprotein (LDL) cholesterol below 100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5576?source=see_link\">",
"       \"Overview of primary prevention of coronary heart disease and stroke\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=see_link\">",
"       \"Secondary prevention of stroke: Risk factor reduction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the potential benefits of risk factor modification, arguments can be made that these risk factors should be addressed in all patients, regardless of the presence or absence of carotid artery disease.",
"   </p>",
"   <p>",
"    Studies of whether patients are more motivated to make lifestyle changes upon learning that they have carotid stenosis have generally found little evidence that communicating test results significantly modified health behaviors or increased compliance with lipid lowering medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/50-53\">",
"     50-53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Antiplatelet drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    is beneficial in the acute phase of ischemic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], and in patients at high risk for stroke because of a previous transient ischemic attack (TIA), stroke, or coronary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/35/2618?source=see_link\">",
"     \"Antiplatelet therapy for secondary prevention of stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, there has been no observed reduction in stroke risk for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    in men (including those with a carotid bruit) without a prior history of cerebrovascular or coronary disease. For example, the Physicians' Health Study found that aspirin therapy was of no benefit for stroke prevention in a group of 22,071 asymptomatic men with an unknown incidence of carotid artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/57\">",
"     57",
"    </a>",
"    ]. Similarly, a prospective trial comparing aspirin with placebo in 372 asymptomatic patients with a carotid bruit and carotid stenosis greater than 50 percent showed that aspirin had no significant effect on stroke rate (11 versus 12.3 percent for placebo) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/40\">",
"     40",
"    </a>",
"    ]. The Women's Health Study, however, did find that aspirin 100 mg aspirin dose on alternate days for asymptomatic women &ge;45 years of age reduced the 10 year risk of stroke (RR 0.83, 95% CI 0.69-0.99) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite conflicting data, low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    is likely to be beneficial for high-risk individuals. The American Heart Association and American Stroke Association guidelines recommend aspirin for cardiovascular (\"including, but not specific to, stroke\") prophylaxis in men and for stroke prevention in women with sufficient risk such that the benefits outweigh the risks of aspirin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"     10",
"    </a>",
"    ]. Guidelines from 2011 recommend aspirin (75 to 325 mg daily) for patients with obstructive atherosclerosis involving the carotid artery for prevention of ischemic cardiovascular events, but acknowledge that &ldquo;the benefit [of aspirin] has not been established for prevention of stroke in asymptomatic patients&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"     42",
"    </a>",
"    ]. The US Preventive Services Task Force (USPSTF) encourages women aged 55 to 79 years to use aspirin to reduce the incidence of ischemic strokes when the benefit outweighs the potential harm of gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Carotid revascularization",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H193251\">",
"    <span class=\"h3\">",
"     Carotid endarterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of controlled randomized trials have demonstrated the efficacy of carotid endarterectomy (CEA) in selected patients who have carotid atherosclerosis and",
"    <strong>",
"     symptoms",
"    </strong>",
"    such as a transient ischemic attack (TIA) or a nondisabling stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21530?source=see_link&amp;anchor=H3#H3\">",
"     \"Management of symptomatic carotid atherosclerotic disease\", section on 'Carotid endarterectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal management of patients with",
"    <strong>",
"     asymptomatic",
"    </strong>",
"    stenosis of the extracranial carotid artery continues to be debated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/63\">",
"     63",
"    </a>",
"    ], and the benefit of CEA in asymptomatic patients is highly dependent upon surgical expertise.",
"   </p>",
"   <p>",
"    As discussed separately, CEA may be indicated for medically stable men with asymptomatic carotid stenosis of 60 to 99 percent who have a life expectancy of at least five years, provided the perioperative risk of stroke and death is less than 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"     10",
"    </a>",
"    ]. However, 33 patients require CEA to prevent one stroke over three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/8\">",
"     8",
"    </a>",
"    ], and the absolute benefit is not as great as it is for symptomatic carotid stenosis. Additionally, modern medical therapy that includes rigorous and compliant use of statins and antiplatelet agents, along with treatment of hypertension, cigarette smoking, and diabetes, has probably narrowed the gap between medical and surgical treatment of carotid disease for reducing the risk of stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/15,64\">",
"     15,64",
"    </a>",
"    ]. Guidelines from 2011 further note that &ldquo;the benefit of surgery may now be lower than anticipated based on randomized trial results, and the cited 3 percent threshold for complication rates may be high because of interim advances in medical therapy&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"     10",
"    </a>",
"    ]. Thus, medical management may be a reasonable, if not preferable, alternative to CEA in patients with asymptomatic carotid disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H3#H3\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Endarterectomy trials'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H10308274#H10308274\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Medical management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H23#H23\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evidence supporting CEA for the treatment of asymptomatic carotid disease is less compelling for women than for men, and a meta-analysis of the major asymptomatic CEA trial data showed no benefit for women in subgroup analysis. Thus, some experts suggest medical management rather than CEA for women with asymptomatic carotid stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/65\">",
"     65",
"    </a>",
"    ]. However, this issue is controversial, and other experts favor CEA for both women and men with asymptomatic high-grade carotid stenosis. Multisociety US guidelines from 2011 state that &ldquo;it is reasonable to perform CEA in asymptomatic patients who have more than 70 percent stenosis of the internal carotid artery if the risk of perioperative stroke, MI, and death is low&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"     42",
"    </a>",
"    ]. They note that patient selection for revascularization should take into account comorbidities, life expectancy, and patient preferences. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Gender'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H23#H23\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Carotid angioplasty/stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carotid angioplasty and carotid artery stenting (CAS) have been developed as an alternative to carotid endarterectomy. Although it was hoped that these procedures would avoid the risks of surgery and improve safety, a systematic review of thirteen randomized trials comparing carotid endarterectomy and stenting (7484 patients, 80 percent with symptomatic disease) found that stenting was associated with an increased risk of stroke (RR 1.45, 95% CI 1.06-1.99) and a nonsignificant increase in mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/66\">",
"     66",
"    </a>",
"    ]. These findings reflect results in symptomatic patients; outcome data in asymptomatic patients were too imprecise to draw conclusions. In a report from one center in which the decision to perform stenting or endarterectomy was based upon individual patient characteristics, there was no difference in thirty-day stroke or death rates for the two procedures; the overall stroke or death risk for asymptomatic patients was 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21530?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of symptomatic carotid atherosclerotic disease\", section on 'Carotid stenting'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link&amp;anchor=H16#H16\">",
"     \"Management of asymptomatic carotid atherosclerotic disease\", section on 'Carotid stenting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    European guidelines advise that carotid stenting should only be performed in patients at high risk for endarterectomy in high volume centers, or as part of a randomized trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/68\">",
"     68",
"    </a>",
"    ]. Multisociety US 2011 guidelines advise that &ldquo;it is reasonable to choose CEA over CAS&rdquo; when revascularization is indicated in selected older patients, particularly those with unfavorable arterial or neck anatomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"     42",
"    </a>",
"    ]. Indications for prophylactic CAS in 2011 guidelines from the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    Stroke Association also suggest consideration only in highly-selected patients and note that the advantage of revascularization over current medical therapy alone is not well established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Patients undergoing other surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endarterectomy for patients with asymptomatic high grade stenosis who are about to undergo noncardiac surgery does not appear to be warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/69\">",
"     69",
"    </a>",
"    ]. Data from controlled trials comparing combined",
"    <span class=\"nowrap\">",
"     endarterectomy/coronary",
"    </span>",
"    artery bypass grafting (CABG) procedures with CABG alone are not available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/70\">",
"     70",
"    </a>",
"    ]. In observational studies, patients with high grade carotid artery stenosis who undergo endarterectomy combined with CABG surgery are at increased risk of stroke for death, even after adjusting for comorbidities, compared to patients undergoing CABG alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. However, observational studies are subject to bias and the degree of carotid stenosis may have been different between patients undergoing the combined procedure and those having CABG alone. A systematic review and meta-analysis of observational studies found a 2.9 percent risk of stroke in cardiac surgery patients with asymptomatic unilateral carotid stenosis (50 to 99 percent) compared to a 6.5 percent stroke risk in cardiac surgery patients with bilateral carotid disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/72\">",
"     72",
"    </a>",
"    ]. One randomized trial has suggested that delayed carotid endarterectomy is associated with increased risk of stroke in CABG patients, but this result relied on just nine outcome events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/73\">",
"     73",
"    </a>",
"    ]. Better evidence is required to help manage these patients.",
"   </p>",
"   <p>",
"    Despite this lack of evidence, noninvasive evaluation of the carotid arteries prior to CABG is often performed for patients who have a carotid bruit, are over 65 years of age, or have a history of TIA or stroke. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/9/10394?source=see_link\">",
"     \"Perioperative care of the surgical patient with neurologic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     RISKS AND BENEFITS OF SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no randomized controlled trials of screening for carotid artery stenosis.",
"   </p>",
"   <p>",
"    The potential harms associated with screening include risks associated with the screening procedure itself, and risks associated with endarterectomy or other interventions. The risks of screening studies include false positive findings and the need for confirmatory testing. The reliability of carotid duplex screening is variable among laboratories, and operator-dependent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/74\">",
"     74",
"    </a>",
"    ]. False-positive tests cause patient anxiety, and the potential for unnecessary surgical procedures unless confirmed by invasive testing. Angiography is associated with risk of neurological complications including stroke, with rates ranging from 0.1 to 1.0 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/13,75\">",
"     13,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both endarterectomy and carotid stenting are associated with an increased 30-day risk of stroke and death. These risks are variable between surgeons and centers, but are in the range of 2.3 to 3.7 percent for endarterectomy performed in the context of randomized trials for asymptomatic carotid stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/13\">",
"     13",
"    </a>",
"    ]. Complication rates are likely higher in community settings. &nbsp;",
"   </p>",
"   <p>",
"    A probability model attempted to estimate the outcomes of three screening strategies: carotid ultrasound followed by catheter angiography, carotid ultrasound followed by MRA, or ultrasound alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/76\">",
"     76",
"    </a>",
"    ]. Each strategy was followed by CEA if severe stenosis was detected. At the prevalence of carotid stenosis found in the general population (less than 1 percent), screening was found to cause more strokes than it prevented. Only at prevalence rates of over 20 percent were significant benefits seen, and then only in centers with high test sensitivity and specificity and very low angiographic and surgical risk. Groups with such a high prevalence have not yet been reliably identified. Furthermore, screening individual subjects from high prevalence groups would have limited public health impact, with at best about 100 strokes prevented for every 10,000 screened at 20 percent prevalence.",
"   </p>",
"   <p>",
"    General screening for carotid stenosis in asymptomatic individuals does not appear to be warranted based upon the following observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/12,77-79\">",
"     12,77-79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prevalence of asymptomatic carotid stenosis in the population is low; for severe (&ge;70 percent) carotid stenosis, the prevalence increases with age from approximately 0 to 3 percent.",
"     </li>",
"     <li>",
"      Clinical characteristics cannot be used to identify asymptomatic individuals likely to have carotid stenosis.",
"     </li>",
"     <li>",
"      The annual risk of stroke in patients with asymptomatic carotid artery stenosis is relatively low.",
"     </li>",
"     <li>",
"      Surgical complication rates are quite variable and even modest rates of surgical complications can outweigh benefits from carotid procedures. Reported rates of surgical complications in clinical trials are generally lower than those found in observational studies, and may not reflect surgical outcomes outside the research setting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS FOR SCREENING BY EXPERT GROUPS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The United States Preventive Services Task Force (USPSTF) recommends against screening for asymptomatic carotid artery stenosis in the general population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The American Heart",
"      <span class=\"nowrap\">",
"       Association/American",
"      </span>",
"      Stroke Association indicates that population screening for asymptomatic carotid artery stenosis is not recommended [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Joint guidelines from multiple US societies (including the American College of Cardiology, American Heart Association, American Stroke Association, American College of Radiology, and the Society for Vascular Surgery) advise that carotid duplex ultrasonography &ldquo;is not recommended for routine screening of asymptomatic patients who have no clinical manifestations of or risk factors for atherosclerosis&rdquo; [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"       42",
"      </a>",
"      ]. They also suggest that it is reasonable to screen asymptomatic individuals who have a carotid bruit, and that screening &ldquo;may be considered&rdquo; for asymptomatic patients with known atherosclerotic disease (peripheral arterial disease, coronary disease, or aortic aneurysm), or with two or more risk factors for atherosclerotic disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who have had a stroke or transient ischemic attack (TIA) due to carotid stenosis are considered symptomatic and often benefit from early carotid revascularization. Patients with carotid artery stenosis are considered to be symptomatic if they have recent (within six months) transient or permanent focal neurologic symptoms related to the affected artery (eg, ipsilateral amaurosis fugax, contralateral weakness or numbness of an extremity or the face, dysarthria or aphasia). Patients with nonspecific neurologic symptoms (eg, dizziness or",
"      <span class=\"nowrap\">",
"       syncope/near",
"      </span>",
"      syncope) are not considered in the definition of symptomatic carotid stenosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The low prevalence of asymptomatic carotid stenosis, low annual risk for stroke in patients with asymptomatic carotid stenosis, and the variability of surgical outcomes dependent upon surgeon and center are factors influencing recommendations for population screening for carotid stenosis. In the absence of a practical strategy for targeting screening to individuals with high risk, we suggest",
"      <strong>",
"       not",
"      </strong>",
"      screening asymptomatic individuals for carotid artery stenosis (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Risks and benefits of screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A carotid bruit is a poor predictor of carotid stenosis or stroke risk, but is an indicator of ischemic cardiac disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Carotid bruit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with evidence of carotid artery atherosclerosis benefit from risk factor intervention, including management of hypertension, smoking cessation, and use of statin drugs. Low-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      may be beneficial for high-risk individuals, although data are inconclusive. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Risk factor management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Antiplatelet drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carotid endarterectomy (CEA) may be indicated for selected medically-stable patients with asymptomatic carotid stenosis of 60 to 99 percent who have a life expectancy of at least five years, provided the perioperative risk of stroke and death is less than 3 percent. However, long-term outcomes for patients with carotid stenosis managed by intensive medical therapy may be similar to surgical management. The benefit of surgery may now be lower than anticipated based on randomized trial results, and the 3 percent threshold for complication rates may be high because of interim advances in medical therapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Carotid revascularization'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=see_link\">",
"       \"Management of asymptomatic carotid atherosclerotic disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/1\">",
"      Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012; 125:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/2\">",
"      Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925.",
"     </a>",
"    </li>",
"    <li>",
"     Messina L, Zelenock G. Cerebrovascular Occlusive Disease. In: Surgery &mdash; Scientific Principles and Practice, Greenfield L (Ed), Lippincott-Raven, Philadelphia 1997. p.1745.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/4\">",
"      Gresham GE, Fitzpatrick TE, Wolf PA, et al. Residual disability in survivors of stroke--the Framingham study. N Engl J Med 1975; 293:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/5\">",
"      Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/6\">",
"      Lanzino G, Rabinstein AA, Brown RD Jr. Treatment of carotid artery stenosis: medical therapy, surgery, or stenting? Mayo Clin Proc 2009; 84:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/7\">",
"      Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/8\">",
"      Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005; :CD001923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/9\">",
"      Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/10\">",
"      Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/11\">",
"      de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009; 40:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/12\">",
"      de Weerd M, Greving JP, Hedblad B, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/13\">",
"      Wolff T, Guirguis-Blake J, Miller T, et al. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 147:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/14\">",
"      Naylor AR. What is the current status of invasive treatment of extracranial carotid artery disease? Stroke 2011; 42:2080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/15\">",
"      Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40:e573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/16\">",
"      Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010; 41:e11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/17\">",
"      Hankey GJ, Warlow CP, Sellar RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke 1990; 21:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/18\">",
"      Chambers BR, Norris JW. Clinical significance of asymptomatic neck bruits. Neurology 1985; 35:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/19\">",
"      Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits and cerebrovascular disease risk: a meta-analysis. Stroke 2010; 41:2295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/20\">",
"      Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986; 315:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/21\">",
"      Heyman A, Wilkinson WE, Heyden S, et al. Risk of stroke in asymptomatic persons with cervical arterial bruits: a population study in Evans County, Georgia. N Engl J Med 1980; 302:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/22\">",
"      Meissner I, Wiebers DO, Whisnant JP, O'Fallon WM. The natural history of asymptomatic carotid artery occlusive lesions. JAMA 1987; 258:2704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/23\">",
"      Wolf PA, Kannel WB, Sorlie P, McNamara P. Asymptomatic carotid bruit and risk of stroke. The Framingham study. JAMA 1981; 245:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/24\">",
"      Shorr RI, Johnson KC, Wan JY, et al. The prognostic significance of asymptomatic carotid bruits in the elderly. J Gen Intern Med 1998; 13:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/25\">",
"      Van Ruiswyk J, Noble H, Sigmann P. The natural history of carotid bruits in elderly persons. Ann Intern Med 1990; 112:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/26\">",
"      Rea T. The role of carotid bruit in screening for carotid stenosis. Ann Intern Med 1997; 127:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/27\">",
"      O'Leary DH, Anderson KM, Wolf PA, et al. Cholesterol and carotid atherosclerosis in older persons: the Framingham Study. Ann Epidemiol 1992; 2:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/28\">",
"      Bogousslavsky J, Despland PA, Regli F. Asymptomatic tight stenosis of the internal carotid artery: long-term prognosis. Neurology 1986; 36:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/29\">",
"      Autret A, Pourcelot L, Saudeau D, et al. Stroke risk in patients with carotid stenosis. Lancet 1987; 1:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/30\">",
"      Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008; 371:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/31\">",
"      Blakeley DD, Oddone EZ, Hasselblad V, et al. Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med 1995; 122:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/32\">",
"      Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 2003; 34:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/33\">",
"      Wardlaw JM, Chappell FM, Best JJ, et al. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 2006; 367:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/34\">",
"      Johnston DC, Goldstein LB. Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography. Neurology 2001; 56:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/35\">",
"      Derdeyn CP, Powers WJ. Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke 1996; 27:1944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/36\">",
"      Markus HS, King A, Shipley M, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 2010; 9:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/37\">",
"      Madani A, Beletsky V, Tamayo A, et al. High-risk asymptomatic carotid stenosis: ulceration on 3D ultrasound vs TCD microemboli. Neurology 2011; 77:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/38\">",
"      Topakian R, King A, Kwon SU, et al. Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology 2011; 77:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/39\">",
"      Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke 2007; 38:2887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/40\">",
"      C&ocirc;t&eacute; R, Battista RN, Abrahamowicz M, et al. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med 1995; 123:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/41\">",
"      Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/42\">",
"      Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke 2011; 42:e464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/43\">",
"      Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/44\">",
"      Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/45\">",
"      Shepherd J, Barter P, Carmena R, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 2006; 29:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/46\">",
"      Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens 2011; 29:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/47\">",
"      Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/48\">",
"      Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009; 8:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/49\">",
"      Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001; 104:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/50\">",
"      Wyman RA, Gimelli G, McBride PE, et al. Does detection of carotid plaque affect physician behavior or motivate patients? Am Heart J 2007; 154:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/51\">",
"      Hollands GJ, Hankins M, Marteau TM. Visual feedback of individuals' medical imaging results for changing health behaviour. Cochrane Database Syst Rev 2010; :CD007434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/52\">",
"      Johnson HM, Einerson J, Korcarz CE, et al. Long-term effects of carotid screening on patient outcomes and behaviors. Arch Intern Med 2011; 171:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/53\">",
"      Rodondi N, Collet TH, Nanchen D, et al. Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch Intern Med 2012; 172:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/54\">",
"      The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/55\">",
"      CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349:1641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/56\">",
"      Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/57\">",
"      Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/58\">",
"      Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/59\">",
"      US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/60\">",
"      Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/61\">",
"      MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991; 337:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/62\">",
"      Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/63\">",
"      Schneider PA, Naylor AR. Asymptomatic carotid artery stenosis--medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. J Vasc Surg 2010; 52:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/64\">",
"      Woo K, Garg J, Hye RJ, Dilley RB. Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis. Stroke 2010; 41:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/65\">",
"      Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke 2004; 35:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/66\">",
"      Murad MH, Shahrour A, Shah ND, et al. A systematic review and meta-analysis of randomized trials of carotid endarterectomy vs stenting. J Vasc Surg 2011; 53:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/67\">",
"      De Rango P, Parlani G, Verzini F, et al. Long-term prevention of stroke: a modern comparison of current carotid stenting and carotid endarterectomy. J Am Coll Cardiol 2011; 57:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/68\">",
"      Liapis CD, Bell PR, Mikhailidis D, et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/69\">",
"      Evans BA, Wijdicks EF. High-grade carotid stenosis detected before general surgery: is endarterectomy indicated? Neurology 2001; 57:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/70\">",
"      Dubinsky RM, Lai SM. Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology 2007; 68:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/71\">",
"      Hill MD, Shrive FM, Kennedy J, et al. Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada. Neurology 2005; 64:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/72\">",
"      Naylor AR, Bown MJ. Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2011; 41:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/73\">",
"      Illuminati G, Ricco JB, Cali&ograve; F, et al. Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg 2011; 54:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/74\">",
"      Jahromi AS, Cin&agrave; CS, Liu Y, Clase CM. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis: a systematic review and meta-analysis. J Vasc Surg 2005; 41:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/75\">",
"      Heiserman JE, Dean BL, Hodak JA, et al. Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol 1994; 15:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/76\">",
"      Whitty CJ, Sudlow CL, Warlow CP. Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful. J Neurol Neurosurg Psychiatry 1998; 64:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/77\">",
"      Matchar DB, Pauker SG. Endarterectomy in carotid artery disease. A decision analysis. JAMA 1987; 258:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/78\">",
"      Feussner JR, Matchar DB. When and how to study the carotid arteries. Ann Intern Med 1988; 109:805.",
"     </a>",
"    </li>",
"    <li>",
"     Matchar DB, Pauk JS, Lipscomb J. A health policy perspective on carotid endarterectomy: Cost, effectiveness, and cost-effectiveness. In: Surgery for Cerebrovascular Disease, Moore W (Ed), Saunders, Philadelphia 1996. p.680.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/35/34361/abstract/80\">",
"      U.S. Preventive Services Task Force. Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 147:854.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7571 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-36135ECCB4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34361=[""].join("\n");
var outline_f33_35_34361=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H240467881\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6615983\">",
"      STROKE RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SCREENING TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Carotid bruit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Noninvasive testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      THERAPEUTIC OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risk factor management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Antiplatelet drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Carotid revascularization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H193251\">",
"      - Carotid endarterectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Carotid angioplasty/stenting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Patients undergoing other surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      RISKS AND BENEFITS OF SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      RECOMMENDATIONS FOR SCREENING BY EXPERT GROUPS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/7571\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7571|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/48/22286\" title=\"figure 1\">",
"      Stroke rates asymptomatic CAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/8/9359\" title=\"figure 2\">",
"      Noninvasive carotid tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/29/44509\" title=\"figure 3\">",
"      Benefit of Rx of mild HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/35/2618?source=related_link\">",
"      Antiplatelet therapy for secondary prevention of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=related_link\">",
"      Blood pressure management in patients with atherosclerotic cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/8/39048?source=related_link\">",
"      Estimation of cardiovascular risk in an individual patient without known cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31033?source=related_link\">",
"      Evaluation of carotid artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=related_link\">",
"      Glycemic control and vascular complications in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/33/16922?source=related_link\">",
"      Management of asymptomatic carotid atherosclerotic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21530?source=related_link\">",
"      Management of symptomatic carotid atherosclerotic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5576?source=related_link\">",
"      Overview of primary prevention of coronary heart disease and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/9/10394?source=related_link\">",
"      Perioperative care of the surgical patient with neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/50/26409?source=related_link\">",
"      Screening for coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_35_34362="Malig nephroscl Light I";
var content_f33_35_34362=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F82156%7ENEPH%2F61658%7ENEPH%2F78330%7ENEPH%2F75317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F82156%7ENEPH%2F61658%7ENEPH%2F78330%7ENEPH%2F75317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing malignant nephrosclerosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph reveals fibrinoid necrosis in the preglomerular afferent arteriole (arrow) in malignant nephrosclerosis. The normal muscle layer of the media has been replaced by the fibrinoid material.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing malignant nephrosclerosis II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 248px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD4AXoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3vUbDRY3Kw3MdtPyQC2MnFV9I0CaHUbe7S8ikEkgYqo3fIBnOT0OQBx61h/EH4faprWqWt/pl6rGGNVMMjlOQMZBHrXLaJoHxA0zVFKRvFwF3mUOu0c+vvXrwgqlK0aq+Z1f2g+R05Sa9dT13xJHeXC+RaTSRrJGy5QA5J6/pXApY/wBl27yX1nm1t03S3E0edvrXdSeGxPPBcyXc8dwMM4U5G/uR6VQ1/WNGvBd+GLm5JuJojGWYcbj05PfNZUKnKlCGq66FUcfKhFwUdDzPwx4vs4r29j0u/jsjNMqiOZNm4npg5OBXosuj+IL25R2vnhiVchPMwM+uRn8q4Lwv8Grm3177RqskJtA27KNuLjt9K90VQqhV6AYFa43EU4SXsWmyaeZ1ZO7ir97Hl1/CIL8rrd4ZVDBWCgM3HfPerFutpNYzNod1LevHCx8mSEndxkKD2NYPxV1K50/xdHFbBbeKWIFpigOW9if5V3/w51Y6v4Ygnmx56kxu23G7HQ1VVyhRjW7/ANdhzzKtKSjHT8vuPDtUudQdWjvP3Cr82Fb5kJPAwa6D4d6zqtnqSx7fPKhtyMvzPnuSOT+Nex339iaiZI777FOUJVvM2kr7Z7VX0bRtAtr37VpUdt5+CAY33YHtzTnj4SpuMoWMpYmdSXNWipeexiaj8R9Nsg8c9tdJcLgMpUYTPcmvEfEV3JJqV5JJKdQguHLLIwIZcnvn06V6740+FGn+IdUmvoLq4tJ7jmUq2Vz6gf0qh4Q+E02j6iyapqY1LSdp/cOpBLdu/H4VWGr4ahHng9ewfWKT9x02vRknwJsGh0ye5kuZmL8LEx4AHevQdT1qCymNuFeW5wCI0GSR7VasrGDTrEW+nwpEiLhVAxk+9YukaWzT/wBsak0h1L5kUMQoQdMY6VwVKka9SVWW3RGErJ8sLnF/EbxFrdnpFtd6EZ40LHziFyyegPtWB8L/AIm6/qfia30rVVW4tZn2eayYdSenI612uu6ybKe5tppoZGGWAVt27PY1yzeKrLR0Z9J0uxhuxyJo4eTnr16V6MIRlS5OS7ezPSeVYmqlKDVvuPRfiJJa/wDCNTw3pHky/KfXPbHvXhGi+Gb291QyWMjzyLzGu3gY74rp57s6ncWuo+Mb5ra0mO6C2T70gBwTz0Fey6Fb2MOnQ/2bAsUDICp28ke57mslVeBpcq1b+4256GDXLbmmvuX+Z5/a/D++n0/dretTxggHZGAQpPrVTQ/D/wDwhd3HqV1JNIzuyfcxtUcfrXp+qTiOAxqu+UjIXGRwaZI0N7phF5BmMj50PaudYuo176un0M5Y2vUg+Z6M4iS88MXWvHU21CJryTbGiXLYAOMAgVseLtJuLrwFqdhbN+/uFOxQ+cjcDtB+grnte+HOlW/2vVJPMlOQ6Rg7SpzXf6MkE+jWi7CYxEFCyYJAxVVqkIqM6bbSfXyOBzunFaK54/8ACnwjfaNfx6hrEU8EQ3IA3DMT0B9sV3Y0KG41VbrQrpLcY3yIDn7309Qa6xLeCMGCPg4zgnJxn3psNxapdm1jb97tzwPSoq4ydSTmv6Q4e7H3bto5r4h6xP4Z8JXd/aLJJfMAi4JOzJxnHTiuM+C9pe3OpTX+qtILjaWVScHafWvSfEukvqWmfZ4QjspztkPDc/zp2lWUGh6dJc3jRxssYM0h4CqB6+lOFeMcO4r4pGFTmlLfQxfipcONCtrGPdm9uUjODj5R8x/kKx7LxZJ/wmVz4W0u1itrKwRhNO/OQFHzD8a6CTVfDXjCL7FDew3UqESKgyrgjuAR71zOjeBJtE1bVdQ1G5NzFdMI028ttZskn6AAVdDkVP2dVWavo+7tr8iYRcqqS62JvHphHw7FxEv+kSsFDP1JOcn8hXHeAfFCeF9KjDksLu52kBc44xn866j4vxBNAtbWxy8dqpZ9nJUHjJx+P515rbaTJHounaxBIpkjuPLMLuFDA12YaEalK0tm3/wD6JNxy9ynq3/mepePBAmlwXQAMlwmeCeOK8wvZINJsIb9md47mQQFVX5V49a9G+KOtW8Vta6azLG7wru44TI4/CvOb4Ne+ELvRy22ZZVniGOGx/nrWmFUvZpvr+RvQc6uEUqesou5RtbYy3DzQ4HGW3NxXQ+HtQ1fTyq2uoz7wu1YoVyGPbPWuf8Ahsn9oaoLDUg6ssoEinO419K6RpFtp1pHHaxpGw4LBQTj60sZiVRXLJXuRiMThIxVVQvJ/wBamd4R0aa2gXUNYYz6vOMvI/JjHZV9Pwpt34z0228WRaCXBuGTLtnAQnoK3tRlS3sJ5pgGjiQuQTjOBmvnPQDDrXj2a7mBVDLvWRunHvXnYaisU51KmyR4FScqkk+rZ9CvfIZZEg+Zl+/zwKztRuJVS32HK/e64GPep7C8t42YLHtwMl933h/kU2I2urWjf2dP5TYwVZen1FYxSg9VodkYqnLVaGd/aMWzbkLEytl88f8A1q5HW9aJePycFWHzA8YFbWpeHtSRDCoWVSdxeMH5vzrk77SdR0+cfa7GUx8KjDGM9q9Ciqe6Z7WEhh73UlczfEbrci3FnOFSM7zz3qv9qe7dZbaSaaWIDI3MVQjvk1pXFpM6xxSw+WcluFqbRdP0yGe4ku5FhtQCXeQkL+XeurmUYnouUIU+aXQl0a3toj59+o898AIvLD3rtrDUry1iVbSxjdSMhy45H9Kr+HJ/BV/IsenXdpczoMEFsHI9q6DVL+xtUS3gEUkx4EUeC2K8+tV55cri/noeFicZHES5VFv12KenR2uuDztr2k6Nl4cgkH+8PTNaz6NbOoBefI/iEpzWdpSrYB7h4P8ASZ8AorcL7VFL4jvUlbytDurlAM5gkVuPpxXNONSUv3e3qcFWlKUm6fwrzMzVfhhoeqXxurt7xpMYH7zgD06VrweC9JhhjiVJtqKFH7w9hU9p4n0+ZSJ/Ns5Rx5VyhQ59uxrU+22/aQEe1TKtiEuWTZwyoNu8lc8f8a+I9S1Tw8ktg7CSEFnVHwWBA5yD14P51zOkeNdWuI7fN9eyXysEIVuSPQdvTNVbHSrhJFlgnnMqnM8MaljtB6AevWum8OTae+pRmC/+xT+YQ0d1CARxnk//AF69zkp04cvLdI9OpgqeKXtKfuPqj1rSdUA0y0/taaKC8dBvRmAOa4eX4f6ne3t2x1u3FnNIXR0j3SAE5xnoK4mfxtbz+K3sdUku8LJ5aeQgKuM9Rz/+uu0WyhGm3K6ddXlvNJ/qXYjEbDoQvGRXEqE8O24u1/LQx+o0qseWM22t9Op31jZy6focNtaSyTSQJhTMCC/sa818TeNfEdq9xb7BbXR4jgji+bP1P9KZq3iXxQtysOm6hHdTKMMqQBVyPc965vxS9z4Ysxr+ur9v1S4kA8mRiFXI46emKMPh+WV6qTbNJZcoLmrTsl0W50Wlaxd3kY/4SGJ7mILlUnwWVunH61unVtGa2VbqC609SOJQmB+Fef8AhH4owyxyPN4ft0MbjDQuS4JPBGf6V7NYeItJvQlrdzxR3hUM1vcgKwz7Hr6UYjmhryO3kyIYqhBctNXfrZniviC40+bWZRp5ubiKUZa4AIXPqRVjwRLa6HrdtLe38vkxHepCtub2+leneMr/AMK6fZeTqE9payzDMbRoCwI78VyHh2/8P63dtZtdO9yPlhC2/lmYexPetoYh1KTvF2/ryNuXA1Y3qJxkavjz4lix0lH8LGG7unfa24Z2D1xnk1mfC34kazrOqTafr1sjEKXSZQI2HsR0P86sXHgSw1Qv9jW+WUPtZnCgD1qhqfw0vdPaOS0vY3BIG51Iwc4ArJQwvJ7Pr57jlg8LOSUarXyPVb7W7OxgaS6mjiwCVUtya87vfE174h1I2enktGGwvlc5/wA+tYdj4OuZ9Vb+3ryOCwthvmePJyB/Dn1rsPB+q+F7LWYtJ8NK00lyzPJIykbMD1IzWaowoJuC5n+CNJSw2Afu+9LpfYcfBh+xrPdxeZOQXcLy2fTNaVt4b0x4GWW0FuSvLsec/nXnGo/FHWV+K8uiNCF0pbn7GY0GJAM4359e9ema1IlvC6QTDIxje2T04P41MvbKym7X7GEMfUr6OVjn/H3w1HitdKNvfrDFaQiL51JJXOcjHeuv0q3Oi2tvp8GZkhgSNcvgkjjJ9K566utRbwbdnS5ClzFJgGPJJHfFYNsniK1itribTHuZLl8Ku/DAY+8aOSdSHJOSsnt+JyOFOFSUqktz0u0FxcTmedViUAp5YbcfxNEstvp7K1zKkYYkLlsCqfhX7cdOZdSijik3H5Ubp/8AXrA8eaPpPi8JpI1pLPUYCSFjkBf6EZrkUE6nLJ2XkE5JNrp5HbTLHJbuJVWSMjlSMgiuc1nVtL8EaFLfXr4R2/dxJ1duyrVjwpotxo3hqLTL+9a8aIEeaePl7Cna/wCHrXVLqxup4EuWss+XDJyhJxz+FKHJGfJKV43+8wTfLpuzz/T/AB14j8UgroOiDT3DhhdXEmUI9CCBweOlWLrxXrWlXttJ4q0UWa+YAt1afPG5zyD3Ga7HxFozeIfDd5Y2s72LS4VCEACEdsDqM15XoGn63pmv2Gj3EFwZfOVZxIGaGWMZywPI/GvQoeyqJ2ilbp1t6mftZ0ZKTf8Al6HtU6yXn2S4s5gI1O/2dSOlc98WLS+vfBF7HpYJuFZJNv8AeCtkj9K09MmfT9SfS5QTC2ZLdz2X+7+Brcboc8ivOUnSnGS1S1R0Vouyj06Hzd8MNM1TUfHFndmCS3W3fzrpwgVRx0z2J4GK+jZkSaFlY/Iw6g1Qu7b7TpzRLAsYY5aNflyAfal1RkeyFrDIIppcJGO46Z49hW+KrvEzjK1raEUaHLrfVv7jkvHd/YQeEtYt0CrOyHZsGSwyBk/rXifl3epf2bBbsRDEuWJOFBz1Ne7fEPSIl8H3a2ynzUQktjJfAzyf1rzDwVpt1e+DdVWwgkluWk8vKDOBivQwVSMafMu/X7j2FOE8HO21+vyJPihpDr4YttYd3kRVW3cA/eOODWZ8OdD1XXtOV7UOY42ALuMDOPf8K9v8JaSE8IWFjq8CSSIo3pInRv8AGty3js7GAx26wQQqclUwoBrCWYOEXTSu09GcFHF1qFZzpbM4nwh8PodK1E6leFTdN/Cpzj8a78DAxUFxcJHatMrqVxwwORWPdavPb7zDEbrH8IGCT7VwTdXEvmkDjVxMnJ/5EvjNZn8LaklsgeZ4SiqTjk8V474K8OzaQzHUIwJncgZOa9Tg8XWF6PKMbo+D5scnBU1y+p6s17cmSDyyYl2Koau7B+0pRdNq1zpweCqRqqc1sV7fxpp9hdzreq5dG2ptG4DB6Ve07xJpuqX6izuViuoyRtkGwSZ79eDmuX1/QLa7to7nzkt72TuvOOvB7V5rcWt7pWqeVLmXe2FmXOGHb8a7oYalVu09TpxHPTk58uh9R29y8TRxS3CSYXcySDknrwf/AK1VpPF+j7JlmlYbOGR1xn8+1YugxSyaTZSXOVuXiBLPxzjvVbWfClnq0WGlH2gH5WU9PWvM9hS5vff3HNKhTkua+p0GlLouuWH7iSKbrja2GTNc74o+HH2+x8rT7tlx821gOSOn51h6L4XlgvmspJXSYtuUocfL712KeJtJ8N2Itru7kmmDHonU960nGdKd6Em/KxLdeneK1T3XQ860f4PakuqJczXP2UoQd6sDnHsK9WsdHs/DloZLeI3F0xOZZD8xz/IVSg8YG5nXyLJjbyKDHIWHzfhXM+NPGE2l6taRyyRqZn+SIsSMevtTk8TiJKNTRdio0KknyytGO/kdparcXNzGZCqhTlkUdj/9am6W82nSXLTKRY7jtLdfY+4riPEN/wCJdKt/7Q06W7dEwz27xqyMvfDg56e1at/q954h+HC6hoKu8rKVljQ5ZCOGxUTouy2s9PQmtPkTUlo/09CTxF8RPCqX76VeE3eB85RAwTP+e1ZhttPc7re+uBC3KAPwF7d/SvJ9P8Caxq14Jra2aKN5S7zzZGweg9TXp0HhuWCGOIwOxjUKTgc4GK63RpUEoxlqZYGvrJJaHC63rnirRNc0rUbGN4Le4VWFvGuFJHBUrjnP9a9Kt9c0Hxtexw2sQi1WFsklAykjqrccjNaGmarYeNvC0F3ZHyb8wEBAMmNsc9vxFS/DXwPbeFLF5ZU3ahIzO8h5OD2+tY1q1Pk5pLlmtP68jgp1KlOakupyvhj4c3Uvji/1TVoY4bEMWgWMjn029wK9H1O1sdS+2WEPlLfxwYDAfMgbOOfwrw3xjrfjC5+JNvY273kMEU6/Z1XIVlHVuOvvXTfDzxNcyfEnXhqo2vcFUBPAXbwMVVajWqL2rey0SG8Q1N2fU9C8D+HZdC0n7PfPDcT7iRKF+bb6E9+9WNa8Mabq0jNfQvMrkZQEAA+takt9BHIFZjycZAJFc54l8aW2lsILRDc3R/gUf069a8+Lr1anNHdm8VUSu27d2ZFxp0OkamsEPh231RIcMs4REeMdsnHJrN8X2Nv4p1wPa2skOpWVmZAGG1mIb7vv7Gu38OXN5qtq0+oWj27HoJU2t+HtU91ZvayPdWzwC6kYDdIvXpx+Wa3WIdOevxLzNF7CSdoq7W679ziNY8C/8Jj4U06S+gWy1iHGJBxlc85Hv1rYtdOh0gJYWOmRrfRoAt2QGxxgEcZz14rqn1OyRZd91Evlgl/m5A9a4bXfFMr+KbCLR7VpVjBEk7odu0+hopVK1W8WtNX5f8MY04wjLmqq/r3Oy0q8hW2jgeRvNjwr71IJPqauXsPn2cse9lLKcOOoPY1yurW9zhLsguD/AKxw2C3tgcdM1taek5tElt5HdOvlynnPcZrnqU0vfTNZezb5ouz8yCXQ/tFilnMq7GTbcPnPmgjBH41S0TwPo+kakbu1MrXKZ8su+THkY/Hj1rbivzd+fBGphuAh2hyM5xXzpD4d+IeheNINQSC6klabLSrIXSQE8g89PY10UI1ailHn5fLuc2Lm017VbHumt6HZSXbXK2Nr/bE0ZSO+aIZDYwM/hxXKWvw51aW8a8utYMErnLIgLZ/pXprRie3AlUBiAcddprnb/VJodVaKR5EZdqgJ91ieR/PvUUK9W3LB6/ea06Lqq1PR7i6To17o1gfKmWaWNi21RjzF7j61qW+t2cyIS0kTtgbJI2BB/LFXbbe0SvISWYDI9K5nxJqlxZafq50pXee2gyoVN+1vUDv3rJXryalqzRWknz9DZ1PfNJbraOVcPkup4A9K+X/Eelavpvje7WaO5Go/bBJFOVOHG7IYN3GK9b+EnijX9Y0a8ufEsRiMLBYrlo9hf1BHevQ7W3t9U06FrxY7r5iwLDO0+3pXXSqvBNxmrrYwmlWppxeiJ9LklutMgklYFpIxuyuDnHOefWs+11R7K8+yasnlHBEU652SAc8+hxVvXdXtdBsUubtWEBkWP5BnGe+KqeIbaDV4La3O5o51Yq6dgRwf6/hXFCN91ozSk024Mv6bqtjqiMbGdZVBIJX61ZglSVpVVWzC+wllI5wDx6jkcisDwZ4di0CyMYkLyrlHY9+4P5c/jVr/AISG2NzHFGjSLIxVXXnP+TSnTTk1S1SMU9PeMX4ha5Fo9zpUkwbasyuzKuflzgg+2K7BTHc24ZGDRSLlWU9QehFcV8TNNnnis9Qt7d7iOAlLiJV3ExtwSB361L8KJrg+HWtLkHFrIUjLHnYeRn8K3nSi8PGpF6rcftJSfJ2OvQeSpM0oI7FuAKc8MbzRyMoLpnafTPWvKfjdbaxqE+nWVle29rZP82Wl2M0men0roWv9T8JfD77XqCi5u7S3GRu3bj0HP5VH1ZuEZqWsugo1OabS6G/4o8xtOuEKboGhcN9SOPwrhPgHIv8AZGqQlgZBOGI74Ix/Sk+F/jyfxitzo+tKgvQnmLJGuFkTPQj1GRXP+AL6fw9441LTSMC4Loo7bgeK644eUaU6Mt1ZnqYRLEYacI7qx6R4j1iOaR7C2ufKVCVmYDpj37CuYh8P+G9daS10fUQ18qlyouA6t6ggcjr2rO8T6T9l0G7sWvHlW8O+6cD585zu/A1N8J/huui6lba8dQ+0gxsIxGBtIIxkmtFGFGk5KVu3my68qmFjH2S0fXz8yUJqPhTdFPvbTLhfKkjLZ8s9Nw9q3vDXiGLTZ3sNcHkT8eTcH7kqEZyGrs7/AE+1v4mjvIElRhtO4dvrXLazoZ0+xcCA6rpCDJspT+8i9426/h+tc6xEK65ZrV/1/VxvGU8RHlqKze/9f5mT8XdPtLjw++r2ZI1CNf3UkXSQejeo4rwDQ/FV3BOWUES9HY5Jb/OK9N168sU0wtpd5ewGRgFspWDriuM0qwfS5ZoGtlmvZgTlRuKj0r1cJH2VPllqdMcBW9yMJNJX36HoPhWwu/Et0rRuVt0VcsBwDjPesf4iyHw3rMNgrNNIoExlxt2gnge9dt8K5Do3hoy3AAjmdpCSeRgVx/i/XdA8ceI7eGNPs0ygxJdSsCsnoCO3saypym67VvcQsXjq9KraC906zwXq0mr20Yup2bDAoSRlvY1S0bSfFkXxFcSwzR6W1wZDJuzGYh0UfXisvT9Ifw3q+nTrJ5lsLoQToDw3TkV7CNc046gLL7VH9oPAXPU1zYio6Tfs1dNP5HPml7xlSdkzL8cW23TTfWw23VmPPUjowHUGuK8b6NJq32G502JY1v4wxd2zg4ydv516D4yI/wCEdvV3BS8ZH1Hesaw0u4uvDPh/KBpLYKxPQhcY/lWGGquEIyb62/Ayoy/dR53pdoNN0uLTbC3EsbsIUCrkgbff2rz74r+EL/xU8FzpCoHtV2tlvv8A0P512Ou6lc3OYcotvwEzwWIPpWv4PMaRbN/ms7H5f7v+ea2U50l7V7muIo3ovnevZHB/DbSfEVr4dvxrM0pjhjbygW+7hen0rufhZp89j4VQ3SIjXErTBVGPlPT88Z/GtbUZfsaOoVfKZSoj6789sUzwe7DRIoJWTzICUKqc4Gfl/TFYYitKrTcrWTaOSSaoeV/n1L17PZaZAZZykSM3fpn+lee3HiR/Pk8q5iMe47TgdM8V23jG3trrw5d/akSSNU3jPYivCGsYSxKXa7Scj58cVeBpRnFyluellOHp1ISlJXZ674IF1fJJMbG20/S8/uoYk2sx7nPpXa9BXJanrNxpAi03T7WFpx90PJgbDnkVZ0iTV7zTGaRViYuVGTu3L6jPSuetCU37R2S6Hz0Gk+S5y19N4ufx0DDbSCwV/kygKbPr69a0ZPBEC+IptWu5lJmfcWUbdmOnH1FdglyVnFrIR52MqezDuRVmWNJUKSKGU9Qe9N4qUbKKtpbTqU6bjK766me2lpLA6yOJMr+7bptqPR/D9hpbGSCBDOxyZCMn8M1pQ7QWjj4VMDGOn41ynxPs9avfDvl6BKUcPmZA+wuncBu1ZQlOpL2fNZMUtdWaWt+I7XTjJG0saFB88sjgJGPU/wCFY2g6nb+JdLu7zSrmS7uIX2NuG0Z6/KK8y8N/Dae83XWsyKuXLCFJd270yQefSvY/CGi2mk2RW1h8kEg7QMDp+veuytTpYeHuO8jf34Wla35nB3vh68t5/tBI3tu81SMKfY89K63wJDqaaYUm2RQIcRqRnd68/pXXPGkn30VvqM1GUEYRUGxAexrGpjHVhyNEKTuRRSSs8gnhRYgcK3XJ+lOinlYzGS3dFQnbyCWqoZdRE7RGOMqekueFHuK5fx54kfRPKtWkR2nGNzHAUfhWVOi6kuWNtTV00nd2Nu4tYdS1BZ7hmtyFCRBGwxOc/MR9OlaSW99EvyXaS46LJHjj6g15l4Y1m+1DUHh2L9hs1FwZEXDFh0xnqDzXZ+APEk3iLSLme/gW2uba5e3kUcDjGDz7GtsRRnTXdIutP3Y8r02Ntb5kKLdQPG7EAkEFfzqnqximNxbwY+2MoZWYfKCMd6kndL+4NsjF4wPmcdBTL7R4mtn8t33KowCeuOevv/SsYqMWm9GOCjTab0ZLZ6ravaSgXMMktqAkwRhgNj+tWNLSRbRVnXLsNzNn7xPJrz3TtAfUbm8mguIbY7trKrHB9CQe9dpBdXUVlFHE8NzOgCMRnnHBNaVqMY6QdxSp3vFb31JbyazZ0tLtE+zu21Q64BYZP9DVyFU2RvZ+X5TYzgcEe1VxZC4eGa8kMjjovRQcc1dSIRrGsWERONoHGK55tWSTMJRjFWW5xfje4m8QaZLZeFtQspb63lzPCHDPgdgPrWT8PPEY1fUl07UB9n1azXYYjwCE44Hr6iuf1jwF4g0Tx+df8PlZrR5zOVDYdcnLKR3FQfEbT72x8S2/izSFeKGTY8hAOVkHUH2Ir1aNKEoeyi07rR9U+zM4VakbyS02PbIZ4zcSpv5JHBGOcDioW0+zgLzmPaBlzjoO/QV5z41+IOi+H7DTpngnuZdRjFwEifbsHQ89ucioNT8dXN54ZstU8O6jbojMUeC+UFi390n+tcccJUfw6XLmqcvhZc1L4oCPxJBZWduHs2JBlP8AEfauvsUjTWI71X2JeJxtPyseMA9s8V5X4Y1jw/Nefatd023i1USARRW0pdHJ77RnHNeuiO8u7VFe2ghjXDqA5J45HGK3xNOFK0Yxt0fmPDuV3dqz+/7jyb4v6Pqeu+PbPTrE5EtuGUE4HBOfp0r1rRNL+z+GbTTNRAn2QCGUOdwbjBHvVe1tt1wb/UImN/AjFSB/DycA15l4G8WeMPF/i6eNgLfSY2YSr5XyqnIA3dd1TLnrU1TjZKC1ZzzgqNR8zuegeEPC+i6NdTXel6YttM4KGUMxyM9s9jiuD+KFkfD/AIk03WoBz5xZueoz0z+deyoFjREGFAG1R/Svnr45eLLibWxoaRhLa2kDeZ1ZyR/n8qeClUrV77979j0sFXhh6l7Wi9GeyW2l6Xruni8MasLhMttJx+VVfhsph0i5tQQYYbhxFjspPSsf4Wa1BJplvbz3UccxAiWJ3ALEDsPWrugX1vo3irUtMuXEX2iTfETwpPXA/OpqQnadPe2qOqvSmlVot35bNeh2yKweQs5YMflGMbRinMQASeg60oGBSOodSp5BGDXmnkHz3ql3pNnrF28mwETMGZlJBG7sO1TWU0UmuafqGlsGQllO3sMd/wAqTx/4Hv5/Ekv2ePYlw27KnKk+tT+EtE/sp47KeQNLLJlnQZ59K+o5oOmpJ30PosBjqte8akdEtzpfHtlIdDWS3lRbCZg0jNwqP+HY8V41oPhd01Il+ZBJhEj53fj2r6dsrB/7Ka2kjDRt9+OZclhWRZeHUXUpLyeNLaBTlIwMcD+XauOhjVTi4s4eahKX7zVrYqf8InPJ4Qls/vXbSfaVctzu4wPyFY3g7w/ptvfpdar9rl1IyGQDYdqbexr0DQ9TW+kvI12hIGAHPYjPNMvZdLT97cSeWjfLv5AB+tcqxFRc0JX17GVS9STp1ot9dPM5xVu9R1CS1ubmSYyysUBX5Y0z09OlddJNFYxw2yY3FcKM+lJbi1063QRf6kjcZc7u2ck968+17WIG8SxXHm7beTI3hsYCjr+NTGP1iVkrRRqmsTNQtaK2Ok1qxaZibSJHVTuAZckds1m6TrNjN4ttdKs5VM0AZ5wnRTtPHpVTxBrwsvBt1ewT7UYFY5Q2Que+a8a+Fuo3p8cQXNnHNtlcbvkLZBwDnH4110qDnTnzPZMl1rS9j3vr8j3nx7LeR26XsEAZbUnzBnOVPRuOnT9a4jw5c6kLS8Ezyosyg4H3lJbOM12w1AXVzqf7jam5o5gwIZlHA4NZeoQ/2UlsltJEz3R2RR5zz0HFZ4WdqfI1/W5thqftIwUumxkWjavrkl9pdrLNJbQLhpCwTjHQ1nJ4Cu9i4SM8dfOzn9a7a58L/ZLG9imdhbSwYkkjfaS2ckn/AD0riP8AhFfDZ6XcwHYGTp+lbQrJ35XZel/1RnHNa1JWpRVj2XUrGwnhEl7bxSLANylh93HPFcn4W+I2m61rcmlugs5BkQiQ/wCsxxgen0rpNGt51e5N40j5IAD8jj0rz7xl8IotT1n+1dDvfsVwz73Rs7Qc9Vx0+lefRjRd6dWXo+iPLrL2Xw6s9AMaXniBZVZl+zxdR/FkmtVyy42ruHfnmsa1e50u1tTqTxSSELDI68E4zz+tak93FFtGdzspZVHf/Oawmm2rao0blPl06DQ5imAEKpG3LNkdfesfxhcXUOlOlud7zOE2LjPl/wAWK2IGaaJ3baQxxtz09eapXPl3Wn+SzpH8/lGTg455x9aqnZTTa2KULu2xh+F7C6a4mubwrHaIQUVWznA6fzry+1+IXiGb4pmFmlFr9o8j7GF+Ty84z9e+a9k8SzPonhi9vLeRv9FhLojAbePX1rzfwF4z0bVtQgkvrS0g1eVSfM24Gfb34r0KD9pGdVx5lt6EV71Uknr0PU9Z1i00iEPO3zOcKi9S1c7Yav8A25dETW1yV5UrGxAXHt/Wr1tpMVzdLerEZNh5SYHDHrkZ/OtSwmtUllZNgkJw+0dCO1ciUKcXyq7OrljSvy6u34l23hSO2SMbgMfxdfxrPv8AT7K6VxJDBdXaLtUOFJ9RnNRXl5JfSvaQ4iiH+tlPVR7H16Vzk19DFfGCCV55yfuxS/eUe9KlRm3e9mEMO5fG9X0N6208Ii2YSCN2bzJGgHH0x2GMD/8AXXmXj1Nc8OeK55dM0/fol5IszAAsrS/xZ9Ca9R8MWrQRXE8zuWdujnJUDtmpry8lui9vaJnsWZM/zrSlVdKo0lddTKqpKXLTlbl6/mJa3ixWdlMtqYlljUuAMlM9s/WpLzWI7ZG3wTFsZAwMEfWqVrLdmQo8KgjhUIz/APWFUNS+1yboLiPyZG/1RzgN7VCpRlL3vzNqdGMrc2vz1Zc0ptLvXMUSW6FxkxIeQf6/hWrFpdtDtMQdGUEAhuma4/w/od0bw3clusS25YRpu2ljjrkV1elXgufMTbNHNHjIkYYbPce1KvHlfuS0JnzJNwehDm6gvVhZkbJ3qzNjcBwR+RrYDAkjoR2qhqdslxApfAlX5hnk46kcVV0/UEMZKh5UBwvc7vSs3H2keZbkyh7WPMt0eb/GP4lav4S1yGw0q1QIYlkMsi5DZJ4Fdj4d1C38WeBUutRQQfa7cvPBnOw/3h3GcZFaOq2Ol68wt9W01ZjGu4O6A7fx60WWmxxXpis0VLYfKwBz8uM8ficYro5qfs0krSWtzGFKXM1UdlY55/BXhrUvDNjp+rwtcGIHZLyrqSecHpj2rO1nwFo9l4Vk0vw/E6TyyblaVySSB613viXU4/D/AIdvdRMDSpaRF/LXqcVwPgrxgvje8lubaza01WyAYxF96Mp4z+XHFaUataV6ib5U++lyFGi52tb5l74X/Dy38OWn2rU4lm1Vmzuc7tgHpW34gvWg8Qaey3Qjt1YCRGz8xz0H4c1si8knY2rg20zDhuv5e9WbixtrieKaeFHki+4x7VzzrylU56utzOVB042W5LMyrCzPymOeM5rL0QJHJLHbQRxQKfmwMEse+K1ZnEcTuwJCgk4rjNX1yC5uLdNKYhCSZWHyD0x+FZ0YOacUjqo0+dWt8+xF44gmn1C1uLOcqCNgkWYr5TA9SOlRan8PtK8Q61HqF+7GeBiGCdJVPPPcHk81SuLmezjLraiWQbQ8pkx36KPxr0KQrFZJNGvKKuM9cccV1VJ1KEYqDt0uc/LDnlTi73PmPX9Nu7ZtQjtWZm025Y7lPzAK2M/yr1zwZdwfEDwi0Wqqn9p2/wAhnCgNnHyvWK9oulfFO9kugstndSMsqNyNsq5H68V0z6Z/whCXUuiRfaBcD5YmPK8njjrXZXqqcIxXxaNP8z1cXzurCpB7pa+hHaaf4z0HctvcRanbLwqyP82PxrSbxJrqIEbw7OZ84O1sqPQ1reEr7UtQ0wXGq2628jH5UHpW3Xm1K1pNVIptdv8AgHNPE8z9+Kb+489k0zxLqshkkEVkMn753sc+g6CtPQfCdrpF8Lqe4nurkDcocfdPtXXAcmo5ZY4hucjIwPfmpeKnJcq0XkVLG1ZrkWi7IYrujyySHEQ4AxzWBDeTazql1ZFQkER+dh1A9PqetWbm+lXU7q21CKJtOWMSBgDlQO5Nc/pGqta6JrOt2UJc3F5thWY4G3gDJ9Mk1VOm0m7a6W+ZMP3dOVRrtZkes6Y+ieJo57HzRaXsYR41Y4LL6/gR+tad/osd3oN39sVxE6gorE/Jx19qg8NeNotRuo7PWbQ2V4zFYmYfu5COu1jXaSoskTo/3WBB+lXUq1KTUZqzXXuVHHyajbddTkNIjeHwo9n5rPFb/uvMxksvr7jBry3X9LuNMkUrDLcRMwMY2Ft3sT9a9K8M6sbTWptFuxvR8tBIAMOvbp+IroINHtXl3yJuIJJRjnvxmt41/q83zLR6nVVkqMpKWl9fW55tpOiT+L7AaXe+VBYBxJcCAZK4HCemc9cV3mg6VoPh2KWDSYBG0KASEZLfiTxUGsyz3uoDw9ohNnHt33dzGADGp/hX/aPrWN4r0i08M6YlxZvJvlYxN5jnL5HfHfj9Kic3Xag3ZPp/mYRpRrVIw2v0/wAyzL5N3qV7LEGh/cB2boCef8B+VcX4amn1TxpYI5d1s5tycckdz9OtXPBWqJqIurNZGQGPykL9Sf6Cu98IeGIdH8y6kw95KMFx029gK2qTWHjJP5Hp1qkcJTnB9VZf5nTsqspDAFT2PeuZl8F6dJK7hpVDEnaDwPauhu7iO0tpJ5jtjjGSa486xqcpMkNrcGJ/mQlcZB6V59CNR3cHY8OjRlUu07Fj4j+Kk8I6ILkwGZpW2BV9+9O8A+MLXxVo6S2qgXcYAmhzjZ71b8YeGrPxPZfZb8M0aAnCNg54x/n3rk9Q1Lw18JbW2ihspF+2MfM2tlgAOvv1rSEKdSkoxTcznm2mn0O/mt2ubiL7SieTGdwHXJ96y9RvdR/tKS2sIo5FAGefu1W8MeNdH8WWU/8AZkriQRlvKmXY2PUeo+lWNBtCsU1080gEygswYHGOvNRGLhfnW3RnVSknFz7aEniG8TSvDkjzSrFI643dPmI5rj/hPqtz4s0+7l1C32W1vJ5cJAI388nnrT/ig0+o6WrLBOLBX2PLtyEAIJYj8Kx7LWNL1DR10Twpq0kWoYykEiGISn+6D68V2UqP7nzb37GdWr7NKF7dX/ker30dpqFncWdxslikUxyR55Oe1cfpfgDw34ZvPt+JJJFyUWZg2PYDHNbHgyW+TQkbXrRLK7iYx9fvL2Pua0LiOOOQ6hdgF0G2EEcjPt61yxlOk5U4y08upNOMalpGamrPfxyySh7CGAlpA/3in/164XStfvNQ167TT7dxDI4RFyRtA6Y9a7j+woZIL5dQMhN4wd2kkwxx0GB2HpUmlSabbvdXsKxoq/u4wFx8oA5H1P8AKuiE6cFLljc6VFy1itF2OA+J3ieXRoLbw1o2H1S5UNcPGdzJk9KteFIIdH0UrlTqDDMp6Pn8elVpdCsdO1xtWnYz6heSs4DyAlSeQc9gPSp31CKFmSDbLM4y7Rrkk/WuxRXs1CPq33f+R6OGwcpe/U1Naw8V3NramFIEbB3GSRsnntTP+E3NvOSYj83zct/Sse3kggDNcW8sikn5S/Q/TFU7tVnmV2iTaqfKjY9f8ip9hTbd4noQwVHVOB6JpPi3Rr8K00sNvPno59vU1fv9S0a7MVpPdws0p3JtbOCPftXkscJmk2RxoiFuAknA/OtS88OPp8C3Zi3SNnayzbh+lYSwdNSTUmjiq5ZSjNcs+VvY9IjnWzikhYGSDtIh7Ed6ht4Yru+SS3mKiFeGDfMc9iPSuI03UL6xWOeECF5lKBpiWi9g348ZqXw5LqcumXzajcIs9yWRDERtUdiCO1Q8M0m7/wBehy1MPKm2uvfudvZ6sk9zLY3KyQ3KkqrFeHHqDXOeMtaXwzFBaabCt74ivzi0s0ONxB+aVz/BGueW98DJIFcPceMtV8IRx2Mdv9v1dmZYLOTJMgA+Zy3VUGclvwGSQK9D+H+hQwac+sX0zahrmqIr3l7Km0n0iRf4I1yQFH1OSSawrQdGXu7HDzcmsXoze0+KeWFHu5U+1iMLN5S/IXwMlc87T2qqlmdOuDc/aC7En92OjZ9at3AiihWCSR48/LGyZBHtx2p2mMJ1czNFJIj4yrZxxxmslJpN9C1OUYt9Dm7jxIuo69deHb7SZxZTR7DOTkMCOe3SjwF8PtN8Hz3NxZzTXE04xvkwMLnOOOvbmuvuAFiZtgbA6e1eN/Fnx9r+gR2drpMSW0M8ZzdbfMwBxweg4/GtqfPWXs6Ksnvrv5nDKnvUlsj1uHy/7SuHdVEg2qjHqy4zxVpnADtgjaM5PSvHfhv46t/7BtbzxbqH+meY0cTmP53XAxkAdvWvWI7u01TTPOtLqOS2nXCyxsCCD6VlWoTpytNf5GinztHN+JPEtj4e8PNqGpbp4pCdsQbr9awNM8WaV4k8OarHptrBa3K252r/AHhjr9RT/i54Mvta0JYNIkCxRfMYgOTgdK5b4P8AhC/idv7Rtmt0cESHpke1ehShRdF1W9Vr/SNPrKjWXbct6+7WXh62ur+1uIJQ8cwlDf63I+77V2Pgrxva+INLvZ7yAWNrZFN0kkmQR2z+Irpde8P2GuaYtjfRkwoQU2nBUjpiuO8X6HZr4Z1Xw/oNm6TGITkRH5nYcjOetZ+2pYiCg171/uV0c/JN1HKG2rMb4rXFjctpmr6PdRSSGXyZTG3XGGXP5GvU7Qre2ltO64ZlVwe9fNem6bqtl4MkvNSs5oYzeIF81SMEA84P1r6K8J3Edz4esZYRhDEOKMbSVKnGMXezsei58+Dpz7No1V7kdKdSHPGPxpa8o4Q6VR1MQrEWmKqDxuY4Aq6awPEM9vKTb3RXyU5YE9TitaMXKWhvh4Oc0kc7dapP4muJtK0i2lWP/VT3TcKseecHuTXRaj4cik8MnSrErCBggkcMw55+prO8AS6dDHcW1tcRPPv+6G5A9K6K7vcTLb27IZyehPOPaumtKUZqFNWS1/4Jvivfm6NP4V/V2cJfWQivtLk8S3lnALBi0SwfNJJ6fKBW9qGs6hqum3UWiaZON0ZUXF1+7XBHUDqa3bTS7eEs7xRyTMxYuVzyfTNXXYJGzHooycVNTERk1pe33fd/wTmg4UpXgrvz/wAlY4Twb4QvLS/i1PWLhWuI02RxIvTvkn19q6HxDdzW6brUHepAJzjNaxlR4BIHCgjIY1nXN/p0EYieVJSwLcHcT+NT7WdWpzSV/I6FVqVqvPNcz7HMR3B0PVZb91Di5X58nknjua8x+KXjtvEV1a2WnBoYIW3Ek8l/Wuq8VvHeGSSW/IRQUSJOcmvPV0iynv4z9riNwpAaIdQvqfevYw9GHMqk1qj2/qq5VOPx7drG98KLWSXUNKd2w00jq+erBeSf8+9e3avrtnYJKrSqZkGSoPT615arjw3pr6tEA32W3keCMjGCR/8AXBrjvh7p/iXxjr1xqLXLmFmIlkc/IM54x371lXoKvJ1Ju0YnBj2nVhGq9Etz2SwvD4s1Hyi8n2KDEkgXhW54X9D+FduAAAAMAcACs3QNKi0fTo7aI7mHMj/3m9a0dy+o/OvIr1FKVobLY83EVIzn7itFbHM+JdUbT7+ys4AWmu7hGwG5CDANch8W57G+uoNK1DSRdAhpBMr7XjUYyVPftXd3GkxS+JotQmJJWLagxwCDzWd480fTtS06a5vZfs0lohcXHTaCMEH1rqw9SnCcH5fic1VOSa8kYHw38NeG9F0+TWbSeUqV2s1w4xEO68cV3NibC8ts2UqSQuvysjZGPb8a8S8NPp2peDte0bRNUEupPtkto3O1nKckAGu4+Cfh/VtG8Lzf247rc3EvmKrfejHcc+9Xi6fxTc9bmVCpyWiup2muW8b+H7yCQv5fkMpKdcYrynw98NX07XbLVpNUgNoGW4JfPmeuBmvX2k8gIlzKrmRtoBAGc9qdcQp5TkRLJ8uAhAxWFHEzoxcY9TeVONRJTKs9xFcyxbJFMC/OzY4OORWNrev6daQXF/e3QhjtkPlKSMu3Xgd+cVjeL9f/ALPhbyVG8D5RnAY+grnVls/EOnaXe6lYkyosgRN3yFxgZI/HNdNHC6KUtj04UFpBfE1oYngy+1bUNYutY1y+mEc3yRoxJAGemOgrsJ79ZMLbyKsCsQqDIz71QniUbIFiklKKc7egJ/lUbzxw26wvBiTdtOT90/QGu6VpO6R6+GwsaUFHdldLY6ndylpNsYbKjPQ4rs9L0rSrKyk8uZLm5TOcNnaPpXD64t1b2sdno4DX0uZJnJGFGOMVm+H7C9sZvPnE5diGcISfzFKdN1I35rGeMqVpyVOknY6vUZZbN1itFSRpiWwE5VfftVC6M7hXkSPjqA2B+Q7/AONbel6dqOqx3JRI0jmlzIGGGUexrV/4RdlXmZZY2BUsCCAe1Ze1hB2b1NvrNOi+WbVziHs4s7pGXbz80XJ/KmS315pNzF5V0ShUSBc5O09Djr2xXUDT0s7yW0fMYLHZ33/Qj8c1seFLG1uPtUd1aW5KnaAyZbGSevpzRUrqMeZq6Kq4yMYc8lzL/M4LxDrct5YJFaqIFuTgspyit7jsOteYePPiVqnw9jsNI0m4try8mdbmUOgYCLkeWe4LH8QB7ivoTxV4Os2hlurKPy1CkyxL0YD0HY14S3gHTbe/uNQ1TfqNxdsDJdNy8fGAFHRQvT1wOtQrYiHLSdl18jgnRWLj7TCuz7P+tz0b4XW9vc+G11vxDZ3U2vXpQ3jXkZSZR/BGq/wRhTwvocnkk17FZRLDaxRpjaq4GK8f+HEV400uh61cSSI0YNleA/6xV6A+pAr1XS7mQObK72i4iA5Xo6+orjxVJw9xPbX/AIJ5VWHu6Kz6op6xK9vqSrIgktrhMY7gr3H5ijRJ4mllljMaRsAGU/K2c9cU/XbV5Cl7JIUis9z7AuSwxzXLWWvW+o63LNawN5HlAyKSFKqPT1Of506cPaU9PmLnSio33PQpF3oQDgkcEdqwnjthpTpq8UL/AGRipUoCHz0IBHfNbcDpLDG8JBjZQVI6YrP1W0W4v7BnUsquSV7HAyCfpXLTdnZmVOzfLLY8k+LHgbUXig1bRLXzNindawrjyTnIYDv7gVpfCXw7qY8PXNrrBkiiunMw2HBibjGPTvxXrbsqIWcgKOST2rz/AOI/jubw4lhb6NapcXd2GcFwdqKO+BXdTxVatBUYq77nPJ8tT2l7HfW0Rht44i7OUULubqcd6rpqFi872yXMPnIcNHvAIP0rh/AnxCPiGFV1C2W0mQsjshJR2A7elcX4U8P3/iPxTLezzCW1jnLtIH+7z0x6/wCFRDBP3vbPlsVOdoqe9z3cAAADoK53U4orLxNbalJKVWSPyGB6Drg10ZqCe3t7obZo0k2nuM471x058j12ZpBqL1M7xfpsereG7+0kXduiLLjruHIx+Irh/g7qMghuNMuyUMYBjU5Bwea1/FnxJ0Dw9rUWj38sguJfldlXKxA9C1cd4c1JdI1rSJncGC6R4nlHcBiB+hFd+HpTlQlGS31R6WBXtaNSl13/AK+49oBwvGTgfiaHcIVB/iOBTLeEQQrGhZgOm45rnptRkjvdzS71Em1cjaBjrXDClzt2OCFPnbs9jpWbaCT0AzXk/wAR7qaWyj8ggNO2CV4zz/8AWr1dxuRl9RivPb61ttSRreYMu2QjaR90+1dWBaUnJ9DrwC+Jrc838OTXSxGONhDMjHb5YIJ57kda9PsdM1FLCHVLJ0u7pMt5cvDc9dpHf2NYp0Gz06VC5fdGe44Peuv0/wARWwi8iGOWac52iJPvGu3FVXNJ01cKeGq0E6kOv3Gzo+opqVmsyjZIOJIyclD6VQ8Ua+mjwhUUS3LDITPb1pnhfSntUkuLpHjuJXJKbu2cjPvya5TWrqE63dNfK6ESlQT/AHe1cNKhCVVpapGmGw1KpiGlrFGPrLeLNaZZTbrFbkAJEjdc8ZAz70P4L8SxRwRRXCqZDyzEHaOuM11Wi6mjpJ9jlUJCC2XH3iOcAVa0/wAXpLHbG58pvOmZMICPLUH7zZ6V1yq1YaU4qyN8Tj6uGapRil8jynxNpt3Y6o1hdMFaRfmkxktx6eteaW1rcaZro2tKV3dVz8wr6Ctzb+KviLDcxKzWlqhIY/x4zz+Z/SuJ8daBc6P40jben2aXMy443L0I+tduHxGqhLe1zprtYlwjLSaSf37nY2kX23RoHuUDRPBt2svGD611vw60m20jwtBDaxhFkd5GwOpLH+mK4T4c6sJ7OfTbxv3KkhC/bJ6frXq2kQLa6fDAjq4jGMqcivMx0nFOHmcmarlfLJa309DnPHHiiLRkS3S7ggkchGZ2xsz79uOa5FfD+izKJW8ZwFnG44vRjn/gVUPj5pUmozQHyH2Im5XUcM3Tk/lXh6+FdXKgi0XH/XVP8a68Jhk6SlCVr77HLKvVwsIqlHRq911/DofaUkIe6BeQ8DIUdqxNb/s7xLDfaPDqEEkvlFXhRwSp9aTxd58mkXc9jKlqWQxSTS/KAp7isr4Y6VoNtbSXOk3UV5eglJ5VbJB9Pp715sIqEPa31W3/AATgnPZLU898D/DHVNN8eWt3N8lpZPu80HDN6ZH9a92urjyFXCl3Y4VQcZNUtQ+0R36SwAhPLIZv4Rz3q4yiaFHcAtjPHI/CjE15V5RnMcKMafvXumcfrBvNQ8YWNsY2SOErISD0AOSa7YMGUFeQfSuX1GQ2cUy3BWOEuNz7iCc8AE1d0Kz1O0lc3t4strtyiKoAX2z14A6+9FaKlBO6VvxNq8VFJ9zzL4rwTXF7YadZR+ZO0xc7BnvxxViGOfSLTT7MshuIwQcdFJ5P88fhWfdeI5oPEU4AVriVwVbg5zn5f0rd8QyCO1EkrbXmIADdRgZ/rXrWlGMYNaHrYWnB4m97tKxo+HdO1G7eS5jUR2zjAdjy/XkVhXqKutx5ZdxfL9eNp6V2GmaldWmmLBFGhREGwvwemT9euK4vSZPtGuyzXJ4DEtzwOe351jTcnKTlsduHdSUpzmtFtYntlzrF3cRxtIGbbnHY9un0robSHVo2BitFgiY8SOOenpT4540hC2gDTu25V6fL0AraubSS5EL3d+0BC/Ki4Ix7nFZ1att0c+IxFrJrTbXXbyMeee80uYSTMDPINxRcgMPQe/8AjWKtzOs8jx3T20JbcUDnHUV1NyNOSNlvTJcN08wdh2qm6WmoQeS8PlnbwwHfsTShNW1QqNVWvKPzsSyWssukx3LzRTEEHzHOW4Pasky39hqEVxFKhMh+82SrDpihb+70Ux2tym6PflHx8uPTH+elbV01vewbXAQsMbh/e+lGsd1dMPep/Erxd/uEfxBOk6W+oRRBJwRgZ6YrgtU0wW91cxI/+jygywhu2exGPwrpLiWWKUfboDJFE2UkzmtHxvbQ3WkJewgiSEAZQcbT1/KqptUpJJbmlCUcPUioqyl22v0OG06U2kVt5glMULb1lUfOoB+bB9R1/OvRdSuVi1S3u4pP3yxgN8pKyKRwf89K4mAoDCjBTHKw4xnkjn86u3N7dy6rpmnJGxMQaJiP4lUBgfwFaVYc8k/UvF04uam9tb/M7HxNqOzwXf3seWP2c5C8nJ4I/WvLvA9xFdalDLMXaC4le2dAPnUEAhj+Ir0kQ/bLKWzkLm1uQY3XHTPcVyXw38ISaDrmDK08KvMSx7MrbRn3wc1jQcKVKab1PmMVRlCfu7Fvx34yk+Ha21vDaC6tJRuj3sQU9Vz+orpvDPiWx8Ti0udPLhfI84q45Xdxj6isT4geGT4vsbiwncRnzR9mlI6HHI+lW/B/h238EaDA2oX8Si2jZZZW+VNpOep96wmqPsVJv3/zLknGdntb8Ts3VXQq4BUjBBrgfiP4Oi1dbO8ieSM2mUcRn5ijdcVftfiN4evbPVrmxujcR6aoeQqPvg919ateAfGVh400ua906OWIRSeW6SdR6GsKXtaD9olt+pg+WW5zy+Frey0qK2g3W1vgshPUtjufxrjPDuv6h4LtdbL26zSIGlC5OCeg/wAa9w1K3Se2beCSnzDHXiuM07w7Dd+JZp54BJa+UUnRzkF/6giu6jiY1Kcva7G8or2C5d0/zOE+GfxB8Ta140trW/mjurS4B8xEjwIeCc8D2717usaK7OqgM+NxA61i2Wl6F4ccNZWVtZNM23dGmM/jWR4/+IOleD1gjvPNlnuVJjWEA4HTcTXLX5cRUSoQsc0OaKfOzzbVvh4/j7xPrF7c6nHbXNpP5Ug2ZBXqP0ql4msBo+pHTrObzILJhNCQchlKru5/A11PjCG8h+G2rajpVytw+oSrcGSIfM8ZAz09O/0rzvwRomu6xpl9fQpKVs49ymQH5weqjPXjJ/8A1169Ftxc3Jcq0t9x6OU16eGrc1R/EfSfh++XUtHtbpXVy6DJX1rmfiVpV3NpiXmmSCKeCXecfxLjofxrmfhNrv2EvY3kqrbyYKFj91u3516hBeWOpCaGC4hn2jDqjA4z615M4ywtbmS0HjsPLDVWls9jmfh/rUuu6K9tqDbb2A7HCnBwOhqLXtPe214SRlVhnj4z/eHX8TxUWh+H9U0nxpc3hLPYyrs3ZHIz1IFdB4gS2uXgVrgJPG3y98ZrRyjGten8LXToLBV3Ceuzucfq0V7rOqRWVlGJMLiWXnC+hJrs9D8PWukQ7YGcyt9+Rjkk98Z6Va0S2tra0ItNxVjlmYEFj681oVhXxDl7kdEisTjJVF7OOkV/WojDIIPcYrlNc8JnVGkkF20UvIXcN6n3rrKwZ9bebUZrLT4jJLCcOff0rOg6id6ZlhXVjJuk7HFR+DfE1qVitrqx27sGXLDj1xith/Alzc2yQ3utSuq87I4gq/zq/e+JJ9JvrOPU4DFbzvsaQ9Fz0Oai8ca3JpT2ljZjbLebzvycjHQD6mut1a8pJK2p3Sq4uc4pta7Oy/MltLLTPCVnKbWRZLx0wN5GWx0HHQVx3jaaFltNS1FxHOX/AIm4C4xgDsOlcTYav4ju9YeIaf3YoyqTtXvuP4da0PFWjarr2m2rW777tB5UkbtjYcV3U8M6c+actX1OijamnXi+eXXuQeGtb0y68QyWNtuZblTFuZcKCeM8981f+BviK8s/Et1oF88kkMzO8bMS2GHv+FYvhzwRqOmpZ3V6qb5LkQfu33EtnOR+Heut8MaFJpfjrUdTljK2Ns5RX78kZwfzrWuqTjON73X4nDjZ1MSoVJb3enY9fvrG2voTFdxLLGeoNcbP8O7F5pGTCozEgZPAzXco6ugdCCrDII706vn6dapS0i7HLSxNWjpB2MTxdoq+JPDt1pwuTAJgMSrzgjkfhXm3h/4Vaj4bknu9P8SPFeIpcLHHkEc8EE+1M+DN7q51Cawmgmi0ownaJcna49M+tWdWXVvDnjmz1iSSVrWQiG5jBJBU55Hb0r0oU6tFyoKS72stTj5FVjzrodR4P13WNUuYrfWLMRSIhLsBtD++Pwq94v8AE8fg6yjuLqzmmsi20NDjKH3zWrZyxya1eYcM4jjxgfwnNVPEI0/V7W50a5eN55YyVhb7xPYgVyNwlVV42j1RvZpcrOa1GaLxrpEWqWAujZxgiW2dAN+Ocj3FcfpfxDf/AISqx8ORC6vrWZxHN5qbPLXONo74A71e0DV/Emj+C9Vs9L00TXWnkiMleg78dyB2rE+G3jR9V1i6t9fsrSDWpYz5M6wCIn1B44OM88V6MaTjGUWrxW2pmq0qkVSbSdzY1vS9JtvEE127SrLFLuhRRlXx0q3qiLfai0cnyxREMPxAOP0rk21OZNaujc3LyxyyNGyMPljHQY9O1dtqG14GkBxHJGko2gk4xzW0oyhy8z6H0+ElSu3Ba7M1yUnWNFGWIG0k5+U//q/SueuJUtJbkmLjO0EdCc1rXZEyRS2YkGVBYEY3Af5NStp8mpaTdARhmjG+MjnJxkCsIyUdXsaQnGmry2ZLpVghuI5HkELbQo+bHQe1XNQuw92lnpUXnzNw8m4ke5/Ouc0S8nPmb4gqAHZJsJO7H3R+Vdr4VtbZbFbuNU8x1wzenr9Kxrv2fvS1OXFv2L5569l0Mm90G8e3zIZp5xgnDBUH0FZQttQt/NJdodi/dY9QPSu4s9d0q9v5LK11C2mu4/vRI4LCuc8Yefp9k+Z/MVnLqjYJ5GMc81nRrzlLkkjnw2LnUkqUktSvFfrf6G8VwEmQLlWHXB9KXTpEh06MBgzIfvMPvZOKy9PUWdo10qgweWdibcAtkZ+g5q6ThLdio2PGflH94c5ro5UtEdip2vHpc6KxlgOnXkV2m5Ry4HcHtSKkMXhScXCgJsYlen0qrodpNcubyQLFGy7UjPIJ9cVX8dMlrYGOIH5x82D39xXLyp1ORPrc41BSrKlF7tP7jkdMKyqqucxqwY54PU8VYuLK5vNUhurNd7R3yhnzjYpTDf0q9penpLokRA2ySfOAechRgn6Va8LSNCmJUAeSVnyTnqe/4V3SqWu4no4tqpGXL0/r9DqNA2jzIn5dTu3HvXKRtf6X4z1CLOdMmbzQMEEBuWAP1H61132NUIZWO+Zv0Hp9asukct6ElVGUxcZ7815yqqMm7XTR4NZ80nOLEvrpLWyjuFBKDBH0Ncd4r09/Hdn/AGU8klpYzxl1cLklh0PPbP8AWr/xHvrjTtBlnt7YTRQ4xH/fcnAGB2HWm+BtTv8AW9M0m81G1W2YxvgR5w2DgfQe1OlBwp+2S+YoShFcr1k0zB8C/Ci20Dw9q2n6lci5l1AbGljG3Yo6Y/Hmt/4beDIvBlnd2sMjSpM4cO3U9a0fHi6nN4T1OHw/82ptHtjAIBGTz+OM15z8HNJ8eabrkg8RvONL8skrO4bLdttVz1a9OcpSSXb07HnWhCSXU9nrOgjt7fVXjjYrLJH5hTHBGetaNUdVt2kgE0ORcw/NGV6+4+hrig9bdzrhvZ9TkPi34dvvEml2sGlXccV1DIX8ppNu8EYrzL4r+D/snhDQm1G+dtbiJiCAFg6kk9e2KyPFsfiAfF1lQXTXf2kPFnO3ZnK4/wBnH9a9j+J2g654hi0+DSltwkJMknmNjLcADP517NJPD+zjKS5Xd9jilacpPXQ870TW38N6V4LN7Ij2gSczRcElC2ASPzruPhp49HijV72wtrCKGygBdHQbcg9iKi0/4e6doNlJqGrN9qaG18sJgMI2JOSufrVv4Xz6fBDqqWlk9usX7xpHChnHPPHTp0pYiVKrTnKKu116av8AS4oSl7sWrfmcZ8SfDU3h26nurBSLG4JMTKceWTyU/POK5f4Z+I7jTdehDyyMzPtcMevrmvWbLxFpfxGs73RpoJLWQjfFuYHdjuP8K8r8N+EBeeK5reS/SwuLBt0hfjcFODj3/wAa6MPUvTlTxCs0tT3Z1Hi8Musqf4o+l4pBLErrnDDvXNweHrg6/Pd3NxvtWOVQfjXM6B8RfO8Y/wBiTRK1kxMUNwOCCOm7616bXjThUwrs1a6POknGWjIXeGzt8sQkSVzeqeJELGG3cJk43HqfpWr4ivba1svLucHzflC/1rzjW9MmW7hAYIkki5YnGFJ61rhKMZ+9M9XL8NTqe9U+Rf1DxFqOmS7IWWRZskGU9fYGq3ws1x5NbvoLuPa14fMVz6jtWd40todKtFlsLw3EAYK8UoyUPYg/hXKWurw/aIR9oNtOG3qw9e/NeiqMatNpLc9f2FGrh30v12PU/jG0baBboxy3nb8A8gAHmse91Yz2PhTUXHnOIzvfH8SnAJ/WuS17V7nUbf7NcSMZncLzjAFbGj+FtWFjHFEzuo5RSc7O/wCRqYUVSpxU3tf8Qp4OGHpwjVktL/id1e+JtKhtmNo0cNxMp3YQDGB1JHX2rxqTVdRU+WbhlV23MqfeGD71b1mCfT777PdALMp6nIPPaqTW8wvluCm7euBxnr1yK2oUIU1prc6cNhIYaN6etzrfh5cXF34qiVma4S2jbbvONpPfFehX0dqlrcpGXM06mUxlwRkdQK8q0DTtalvBqmgQywyx8b9g2H2Ir1Lwnqc+oRyDVoYre+jIB+XG7jn+lcuLVpc66Hm5lC1T2sLNK17MbpOomBoIEdEZjgRse3pXX15hcQiTWpR8ghRj064zXax6tZLGoF6cAAfdP+FceJpXs4nBjsPrGUFuX5bGJjujBikH3XTjFYGonUEV7e9Rbu3I/ugGuqprIr9Rz2PcVzQquL11PPhU5d9TltNnRFDpv/dgBgwwVx6mvJNWsfEMnxbt5bQsYbmdWhuFHyhFPQEegzxXrXiXTpoY5ZYHLxSxtHIo67TXmfhZpfBfieG11Kee4s5QZoN/yqp5BPPfFephn7spw1dtgxdp07r7z2uOEW1zO0KgecN5H+1XLanp1g2vre/ZLc3igkzbQCRjGfqK2H1Wx1SHFlMksyNzFuAcfhVPWrzR9Pggl1iUwxyfKzuSNh98dK46PNF9b7GlNQa55anmHi7SJrCZyXIhugWhAGdz/wD6619LuVewt5IyjNbqAw9AR/MGu417SrfXNP8As0L71MQlt5UOdp7EV5/aWc2m3UjspICkMD94+v54r06dZVoWe6PSwT5qjktmaul3aSW7wMwDgkROeM+361r6RdtamBVLEH5WUE/K3+TXMxStAHWU/I5zBIB8uPf0rQZhcpGzMBNCMOBxkdj+NTOCfoelVpKV10Zvahp8Fpo13bSSfZpRKbiCVMgHuP8APvVPQtQOjXcq3pZbS6G8bRkAnHOPz6Vf08pe2q6Tq54lXMEobkZ/h+v/AOqsm/0y5s1Fjqc2YOUt5WTcpHYE9q542d6c3v8A1oefGKnzUpvV6+vmjj9S8N6Xo/jWHWdNvGMe8TlEJJLdSOOQM5rW1TxHLqd6DcRSImfkJXGT7VPNYX24RotpNwNsu0ZP5GoLPR7k3MdzqUrgrny4QvA//Vmu1OLs5atKxNPBeyneNret2a9rK91aRW6jEKRkEE+o/wD11ffTTb28aTyq0SNvB/2fesizvYLK4JaYSSq4XYMnj0H61auNUWV5UlaQB3AMSJ91RjvWEoyvpsd06c+b3Vob018un21rcQ4mVicRbuD/APXrm/El8+r3kEgiCKp2qo7+ufWrOoXUSRxLbqDKUyEX+EDp9K5+acWMLyTPtnxlFHUZ7/SilSSfN1DC4dJ89ve/r+rm1DfbtMeNDgM/kJzyRnJx+NbXh2zDXcKOY3VULPkc5GMf0rktBjnmtoppFBhVgkYP94n/ACa9O0u0RC1x5ZUuoC7uu2scTJU4tI58fNUIuK6j4HN5dM+3/RkGEYjG5u5HtVNbiE67Faxyp51vGd6A/NtPStgsqxFh90DPFYunaTazXy61Kn+muDhgcYTsDjrXBCSs29jxVJpOXTb7y7dyRXN01jwZRH5oB6dcUjRs00M0TL5durjy0H3mI6fSm6mELrPC482Hh9hy20joQPel0mNHs1YncokZlJ7c8f5+lG0LhypQ516Hm97rfjDR7h764s4VtJJPNZJnUOVH8I59KzPi58SZU8M6a/hm5lgnupCJNq4dMfw5+vpV34y2sHirT7eTQZPtt/YSnzIIictH/Fj1wQOnrVH4dW5h8NxWWr2UTu0hkiFzDu2HOO/PrXqwp05wjVnHVdP+HOOPNUm4R3PS/h5c6leeDNLuNabffSRbnbGCRngkeuMV0dVLGTbp6PIipsX5lQYAx6CvONG8T63qfi+J4wn2OZzGluGzsjA++344rzVQlXlOUdEh83s0oy3L/izwrreo60bqwvGSNMeWQ+1gO4z6UeLPE8/w78JWU15C19PJN5Zy3QYycmu9gnSZpERtzRkByBgZrn/G1tDqcFppt5pL6jZXMuJSpx5WOhz2rSFZ1HGlUWi+RM1a80zU0m+s/EGiWt7AFltLuIOFbngjoaZFo1jp9jdx2MCQJKCX296zfDOpaPYxDRrGKS1W1+RYnyeM9fzrR8SWt9dWIXTrkW8inLE/xL3FZOMoT5L2TfUunK9pPVo8X8a2EvhLxRpOt6BJstZv37qxwu9Thh+IPT61qeObSM61b+IdOQ+RcwJcTqvUochz9QMU4arDe+MLLw/eQi4tJXHEg4zjqP1r0XXtNWbSDb2IjFxbZEQbptxyv0INepOr7Nw59+/kd2DqKliJST0ej+ZzHhfwDBa3kepQXSXMMxEsbgkEL1Br0LUHkisLh4SBIsZYE+wrxbw14nvNDNxoFy80MDHFuSMvEx/gB9K9h0i4S/0tGLFsrsfPXPeuPGRqqSlUd0VisLPDyvLY4XW7qV7NL0yLLOrDakhAAP8AnFUbPxBB4mhv7S6tBbXMcRaMb8hgvcY7ZzVnxPaQS6JNYOxD5PqM/iPavHbPWbbRtTNtZSMIQ3zE/eODyFJ7e1ejRoqpHTdbHU6jp8klsdBqF5LeaHNbrMHckjpyR/kCuS0q4mZLdbmFEc5VJiudwGf8a6lreO5R59NQmCRt4fsuahewEVwXkESSN8u0dGrrhJRuj3MTg1i3CSdktzRht7e4htIpMwsCELt3OeD9K9t0lpLbRYRZSw3iqmd5bb+ded+F/C326ZFnkDZTOTzziu10fw7NokflWl98r5ZonU7T7CvLxk4S91vU4cznRklSUtuh5l4sWfUfEE8l5JC2XCnyxgdOn6Cu28O+HbeLwzNcXCM8rsxyDxjoPfGar6l4QutS1EXRhEW8/OqtgEg9efrXcXEUxtYYPJxGAAwQ54x0+lTWrpRjCDOarjp8sacWkk+j6IztIhSxjJsnDoMbkwBnj/PNc14s1W30/VImh2lpyVYE7dp7H2rrf7PMMjt9qjgRk5TAzXl3jixF1q6TwSrd7n8vcq4GP8f8KWHUalRts0wMY1qzk3fT+rm1qHmvcQpaRR3M7oFAiP8AF6nNaS6H4gKgm2tAccjzBWL4Fuk0nxAtvesqyOoiQOcYbJ4r1rB7EflU4mtKjJRSuTjsVPDTVOKT03YtFFFeWeCRzxCaIoTjPQ+lcrrvh/TtZktrXU4lMsBLQOeAwPVc11rEhSQCT6DvWH4mSIeQ7yeXIWwh963w82pWTsaQ973Hsee+OPArW5S+0cmKZSCyRZB4PUYpvhuCDxlo97peuTSCVZFWGSTh/XB9a1L34gafpmvw6JfOZJ1cBWPbPQVsSL4d0O7i1KeKWB71twJ+Zd39K9P21RQ5Zp83Rozqw5HzRfqcd4i1ifwJqGn21tIZLa0Vd6MCWZO+PbAp/i3xBp+p6fFNp9ztF+Q8LheAc/MD6V6H4h8MaV4m05I76JiNu6OZTh1yPWuFu/BNu3hx9LsFUpbOSrIcsT64ooV6M+WUtJLc3oVJxleGisSWemx29pHaX8pmtJFGZl5MTev0OeRVe80y406TM/761ZPkuI/mXb2qDQbLVNHikXVJhc2GDls/vIz6YPUda6bS5tumebbsLmyJPmQSjH4pnoa0nJxd07/1+Z7NHFy369U/zX9WMq3mhubcL5ymWMErzjb9K0W1TVLS2dZQ11F/Esyb1YZ9ayzp1nfvJcWEqsGyWiwFkH1Xv+FLpeu3mnKLUlpbQkqVk/hPtnkDpSlFSWiv5M65wVVe6r26MZHfSWl1I1g8duJuGhMe4IeMbTV28h1PVp43muo5DjC4QgDI9qq32o2k0gaVhFKxP+rIIIHrUKatawsHhu5GZM43DH8jVcvVLUvkbtKMbS9L/ibVpo8Ond8yHhpWH6YP86t2dpYWO+6vZc9o485J/CuPuNUdyUabZnLKXYkis5tUDSho1aZwcDJLEn1pOjOS1YfVKtRPmkdXd3EU873ckbxwDjPcDPPHv0rm5rafxDqQiWMpEz7c9MD0/Ktmztbi9NuZlZQvRMdT610Vh4WmkfzjJ9nRmyUU8ketDqRpbsmVenhlq7Mn0TSla8igEm6107H3PutJjp74rM+J/wAQovCQgtLWJLi/mG7aW4RM4ycd661oHs47ez08RxoeCPT1NeHeJNEutS+JF75lrPcGOZY4VYfeAA5/3TzXNhoQxFXmqPRI+bxVVz9++vT/ADZ7dbzNd6faAL5bTRrI6HquRnBrPsJ3OoW8UsshtuWTcMDIHrV+y02WMvcX0672+YhOAvGMfQCqVhd2N1YI5JuBBIRGynIJ9c1zq1mo6miipQ5U77EhtnimklgEhE7fPKeDgVq2Nq0VpJFKc72bvzg9qIr0Syqipxs3Ek8CvEde8SeKl8SzzWLzsiyYjRT8gXPpVUqFTE3irKxjXnJQ1Rrw+CNc8N6q2rpfwvBby7lJJB8snGCPyru7CebWL2GV7ZI41XcX9T3IPeqfiq01bxF4Ij/s2QC6mjVpIj8of1APbmublvvF/hbwvfXrwrJDBboIYDiRkOQNxxzjrXQ3KvG7a51p2MaNWFGNktX17I9W2ptMWFxjlfasnQ/DenaLNPLYw7ZJTkk84HoK85+DPxFvvE+qXOnapCrzeWZVnVNvTGQ2PrxXq9/cx2dnLcSk7I13HFcNWnVoSdJ9fxIvCfvdhuowzy6fcxWUot7mRGEcu3OxiODivm7RrXxT4K+IkEerX8y25cs8rvmOZDySPr+de3+GvHFhr1wYYY3iYcEtyAfSovHfg+PxLcafcBtsts+Gz0ZOpH1zXThZfV5unXVkyZxbtKJpWehwvqJ1J3jk8794MJjORxz6VlfFzV9W0TwVdXugqTdKyhmC7tiHqcVyXxKHim11ixOgR3k2mrbosRtycZHUNjpxXd6Vqlyvglr/AMWWywvHCzXEZXOUA7j1I7VM6bShWm1JdjOMopuMdGeV/CS2l8QaTP4hvhM+r6dKTFIv/LXK5wfp/Wux+HWoahdeIdSh1eYySOomUFcAHgcDt3pngH4jeFtQW7stIs3sEt43n2CMAOqjJPHfisn4U/EGLxZ471hTZ+R50YNuV5OxOob3Oc101Zzn7S8LK2nkv6uyoycba69S18UbPRW1AR2t/Db65Jg/Z93L9xj0bP5/jWr8K9fa/tZbWXaJojiSMD5g3976H9K4n4lfDTWtU+IH9tafLG9jI6SSOz4MBUDOc9uM8Vu3Mlr4Z8e2Or2T+Zp+pjy5GX7meASPx5o5YzoKnzczav6eR6+GxMsTCWFmrtar/I3viJcnT9MWKAKs9xcbAWHBB9D2614/4q+EOsWaJfwSw3MMj5f5sMg65PbFe++NdIOs6MPs6JLPC3mxA/xcdPxrxnxDrmoxWKw20lx9iThomP3SOqmrwFSTilT3vrc6KVGGLoJN25W79w8O20UOnwaXDMZ5WbePLTgUye1k/tNYJl/exsNy85Ye4pfAur2tt4mgkbESPMg29AM169440H7bbDUbCIf2lbjcGXguo6r+WcVtWr+yqqMuvXzPUeKjg6kKX2WtDQ8I2q22jQnIZnG4nHb0rC8ReJ7GPWY7Y3ZjWBxvZFLAH0rS065+yeCXvI51P+jvKjdlOOB+eK4n4X2kN7q0sl4waRMyrGxzvY/xH868+nBc1SrPoeZSpxcquJqaqJ6NpevaXqjiO0vI5Jh/AQVYn2B61laumsatq1xaWd0tnZwKucffkY989hVT4owWiaHFPhYr5Zk+zyIMOGz6jtiquja/MNS0+7v1wLm2EcpH97dw2PSop0vd9rTX3nPToPk9vTXffujO1zw3r0CyXEYW7bqQHJJH0615Tr/im+0iXMY3Sk/KvICEH069K+plIZQQcg9CK8a+K/hBzqi39pbiZLhslcZKvwOPrXVg8WqkuSojsw2PqYiMqDajJrRnmHhnXrnVLyQXkjPPu81ZSvGR2OOfxr12Px/cKij7QBgAf6sVz2leALDTIk1DxBqMWlh1J8t2G8/h6VlySaIkjrHrERQEhSRyR2rsqexruyV7eRthI4ezjiJqUr7/APDnsq6hdKLqXf55DZRVfaNvr9K2tJv/ALdbI7JscjJAORWZe+GobibzkkMcu7JxyO/atTSbEafa+Vv3knJOMV4VR03DTc+Vjz82uxdrkfiYsi6ClzEu5oJQxwOcd666orqFLi3khkUMjqQQRWdKfs5qXY6FueL+IPCVn4ssYdZtEddSAUtsbHAHf34rp1mSDQ7aLUbdry3t8cyEhhgDNY3iHxJb+CILlryNVnbIgiHRqyfAPxDg19n0vUrdQ02QrouAfwPevYanKO14rbudE6VGEnCW7PXtQuZLrwvcT6OA8slqzQA9zt4/GvDfgtYeLx4vaSdrmHT4XK3KTZAI54APfNeseHNL1GwmjFheq+nDkxSA9PbiusMkMcoQvGsjn7uQCa4faRoRlTSUr/gcMoybteyR5V8dNYTRLKCWyvUiv3YM1vtz5ijPJql8PPFieJdDdBeLFfQcvCeNwx1Wux8c/DvSPFTPc3BeC9Ix5q8jj1FeOweCr3wr4tksIlV2lTekhbCsPau3CqlVpKCl7y7myr1YzSWx6lLpMOoozyRtb3AGVcDhvwqiui3lsSBKLhSeAT0/E1Hpt/eaLCJPEd2sVgq7AZjuw2eNp69e1dnpkNvc6ak1pcw3HmKJFEbA9fTv+dTOo6Wjeh69LHyhFKX4nG6rb2UcStdae4lA5McuDXOM0M0oFjYMyHGVBMr/AMhivV5fDllqUfmSs4JyDtwMHofbrV7StHg0gSfYlBDjkMADn6gVH12EV3ZuszhTjpdy9dDzvS/DGoXBEkVmVjYDP2nhsfjXSaf4Na2kLtJBEW4PlJzXSy6kqL8sLu/dVIOPxzXParcarerGdLB80Od7LnEZx096z9tWqPokYTxuIqK+iRtrpzwxrHC8aR/8tHI+Zh25qje+KLCy1mz0dZFF5cD5PMOFHpn3ODgVVt7XW7TT7i61G6M5iRpFgBzvIHAzXnFtZWni3WdOVJ5XvnbzLnggoq88n9BTpUI1LucrpdjzKtV8t27s3PHfhDV9e8VWtz/awj0+NQd6PhlI5ICivRNFs4rXoTLOUUPKw54HTNLPpyT2qQ25SJF+XeFyxAGKv/u7aHLMEjQcsxxge5rnq4hzgodhNRV2m22eTfGXV9cnvYdC8PNKpmjO/wAocue4J7DArnPBX2/QIIVuWmHlbvPiKHgDPX15rtvij4g03w5aDU7WCO51CQjywDlW56nH9KtfDHxHL420a4m1fT4onRwm4LgScc16FOp7PD3UPd6siUlTmnfV9Bfh/qr61azpdsY5ZQTCxb5tvPar2i6QIbtYppIVCEqMt88gye1RvqXhrwvq/k3UcNnckHY4yTt96oXWjXV14uXU4pPtNncgPbyxHhQMGsW+aUmvdi1pf9C51Zxhae7OH+Ofi/VNP8QW2g6PcTWsUUSMfKOC7HkZI9scVR1Dxv4p07xLpEF/lGEMMc0BG4TBgM7h6n+te5X/AIf0rUtRgvb/AE23mu4APLnkHze3+TTNX/sOG8S41CG0a8hXcjyINwA9DRSxVGMYw9nd9fU5JU6sm1F7nAXPi/wv4P1XULfw/oyvdq2J2jwmT/dH09q7KeS38ceEidOupLfzgDkfeRh/CwrxP4jfD3XdM8SnVNE827trmYzIyAtsYnPIr1XwfpGt6D4Oh8mGE6ncTedcR8AKp4wB0yABV1qVNQjVhK8tNW/zIjL3nBLQ1vBnhdfDsVx584uJrlhn5MKBjpXQKJrczMx82LJdefmHtTLOKVmEt6U888hFJwvHvXjaeJ/G2k+K7mweB7u3+0M2x484Qnsw7YrljTqYqUndNr+tDWE40kovZnoureKINE1K2sfLZ42I354YA5OR61PLf2uualLpizW89g8RSaF0OXz6Gs74m6la6N4bGrS2ts94hVYxMuTg9QPwrQ8L2ekahpen6jYICpAlVlYnDHrRamqaqWae1/MU+Zvl/qxzFv8ACfQ9CuL7UtKa4SUwSIkTvlBlcfU1R+F/gWfwrqst6YYTb3EGDIGJZcnpj6Cu+13WLOC7g0y5dEe6wmZG2g57D1NbMcSRR7Y1Cr6Cm8XWVO09eb8io04Jq3RlbUbRNR0u5tFk2LMjIWXtmvP9e8PWMHg6DS7e7FzNZF8ENlt2N39K6yz1eI2eyGaJ7zOVjU9RnvXN21vJeXl/EUWKQq/vhvY/Qmqw8ZQbu7JO56mGounV9q+h0vgrWIdV0W38tsyRRqr/AJVzHjvw21tey6vp9qbiKcYuoAM4PTeo/mK5jw5qQ8GeJjZOXktWbbvPUqeenqK9pinjmt1mhPmRuNyleciirzYWrzw+FmuKhLB1lVp/DL+mj5SnijgvZmjz5iyblbkYxXsXh34oWLWsVteKxlRAvmluG+vvTviP8Ojq8r6johSK6xl4fuh/ce9eKzW9xZXMkFzbtDOOqMpxn+leheljIJv/AIY9WnLDZhBKS1XTseqQTXl54K8QixYm0+1GRVTn5OC4HtXKyyzWIm1bSbqRJ4VVVVRyR1JrM8G67d2eoSQO8gtShMi9jXZ/C+WM6/cKYBJDIdyKeQq5PrWjXslKVrrcMRRboVOTvf8A4czdT1a/1+Cw1S7SZgh/1RU8epHpmvQJJLTXfDsV/pMTBrQeW8TAbsYrb8bSWlj4fmdoIfNOFiXaB83/AOrNcZ8Krz/iZXVvIV23I+aPPHA4I9e4rj9oqtL2kFblOaEnVwiqpWcPx7nJeKfiTrWi6hFY6ZlIYF/eSP8AMWJ56HsK6Lwf8RLnX2t49UhAnVg8ckIwrY6gj1xW/wCNfBunzSNeTW8LWyr8wL+Ww9ge9Z+g6n4e0krHpOgF7nAXzFYMD2+8enStE6E6XNCF2eWqNaVRVaSTj91vI5T4oeD9d8S+PoZ7NpLnTZwiqy8CJR1/rXp9v8OPC8VvFG+lxSOqhS7E5YgdTXLax401fRZmhayWxVwZER/nzz2Nc63xE1cknz259hScMROEYwfKl2e/3G0MiqVXzpqz2PdxIrxh0IZSMjB60lvIZIwSPm78HFY1nerpGmKupTASr/ATz7AfpUlh4htru6SDa0bv9zd/FXkOlJXsro8lSTszaooorIs8a+O/hSXWmt7izTMyDGMcNVX4P/DU2cEGr6vFLFeq5MULjjpwxr2u4jEkZyoYjkA+tePw694ouPFz28VtcRQq20xKvyj3r1sPXq1aLpwsrdfIVV021OWjX4nqVxeTwwS5tyJgMKE+YE9q462nTxH4gg+2Wc1rd2zZ8yLIwR61u3L3lnsmlaZ5CQdg5Het6ymW4i81Y9jHqCOa5VJUo3S36m1amuVNapjbS7imkkg81GuITiRQeR749KbfWkN1E5kgVpFBCMVyR9D1rwrxLc6tovxwWWB5dlxNHgDkNG2BjHp1r1u88SNaa2tlPbyCPfjzAvHtzTnhZwcZQ1urmNOScml0M+60jSNf0+S08QxLlXO0hipI+v51jeCvB50XxQ1yupxTWMaFYI1c5C+hHtXo8lvBcoPNiR1PPTOar3FhZRW7EqIIxySnFEcU+Vwu7M2mqVWXNK6YydngnL2rrtflkbkZ9fasi/N7qOxftEYty4J8tsZA5Iq9Jo8U9hKtleTh5FIWXfnbXDL4V17TA6w3X2uUMXjJJGfx9RV0Ywf2kmu5rGrFNcqv52Ou8S+RomiS3tu4gClctjOf8Sa5nTPGGsNbwXdppcLaUcmR5JCH465PQH2rW04S6/4SntfFMMsTK4GQMNxyG/Q1DpOg6DDtt31Rpo1O/wAqUhFY57561pBQhFxqq7T/AK2OSpUrVIpRTsdAy3GqTWVzDK6WjqJNoOOO4NPt9P0+21MfYoLeJ8ESeWACc+uK0YninhX7K42JwpU8DjHTvXm/xa8WQ+BLC2XT0VtQupCxYnLBe59smuam5VJezjp5f5mvMor390elzXMFuyrLIqFugNeX/G/W5Doa2mlyuzq/mTCPPKj19smjwh400/VtBhvdVvRNdliTCEycDoD2rs9BsrRoZLq7ht1nvQf3RA4jPRcHr6/jWsKawsueavYhRk4c6PNfg94qj8UGLQta0iC4+yxsYpzECFA7EH+dezIlvZw4jjjhjH8KKFH5Cq9hpmnaTG5sbS3tUPLeWgXNV7+GSWcTqxC7dqr659Pesq041p3jdR/UmhScnee55z8a9AfxB4V/t2wgdLyyfcOPmeEdcj9fpXJ6F4j1zSvg8LqyvHSYaiY0LLkqm3JA9s16/rJXTdAmvtSecRwLtEUY7ZwAR361hzeFtO8S+EvsdlO0RY+coVNqI/oRjGa7aVaCpKFRXinv09B14QU/dlr2J/hL42bxjpDfbUUX1uf3hVcBh2Psau/EDwmmvRJcRXJtrhBt3Z4Zc/zxXmtsZfg2nmXMSXc16pRURjgBT948denFeu6FfQeJ9Cs70gos6rK0YPTgjFY1oewq+2o/B3Mottcsty9oNpJp+j21tPKZnjXG/PUduteH3HxP8T2XxIns3jEunfajD9lEXIQHqDjOcc17vqdubnTbmCMDc8ZVRnHOOK5zwnpTmaW81K0t1utgi3Bfm4681nQnTtOpVVxTUklGJ4P8Q9W1LVviHJe+Hby6jbcscS7ipUjjjHbIr6C8JSapD4XtrjxJ5b6gsZMxVRnA6Z98VxXjXwXF4d0fVNc0CKa41IAlFb5jGGPzMPUgZxWF+z5L4huL3U5b2WWXTmwXE7EkuT1Hrx1rrrRp1qHNS2j16+n9bmcG1U977jN+IHxG07xaYtHXTpPsZuV8u5Y89SD8vpXr3gLQ28LeG/skpyquZAqHdtBA4FYTfCLw6Naj1BDcoqS+atvv+QHOePauMvfidqUHxSudOjG/SfMNn5GM4xxu9jn9KmXLWpqhhtt3cqN1PnqF/wCLenXS31vr9tPI1ojblSQE7WwDx6A16J4T1K58ReC47qb5LmeJkyhxzggGvJfFPjnxXpvi2fTGtUktWIRLOSEOHQj1r1rwHY6jYaU0epLEiMQ8MaDGxSOhHrSxMZLDx50rrb0BNKtaJ80aZ/buj+N4RatcST/aFBjxktk8gjuOK+p9FhjQSu0Kx3pJ3g9cHkfhVhdJ09b/AO3LZwC7xjzQg3fnUt5ZxXJR5Mq8ZyrqcEfjWWKxkcRZJW/r8jppSceaMnozz34jeFReCW4gizJncGA5Xufwqn8NfGEdvaR6ffybuRsYfw9ufavQWF1asBdOtxbH5d+MMueOfz615H4x8PpZ+IbhIHjthLh4igwobrt/HqK2oSVeHsamvZn0GFqQxNP6vW1XRnuXvXlnxj8Ky3cEesaZCWlhBE8ca5LL/ewO9dD8Otea/wBOWxvZP9OgG3DHlh2rsq4YynhKvp+J5X73A1/NfifOGhaJbX1vHKt0VRm2yoowy+ua9n8JeHNK0bTVntMM8iDfKzbvyzVPxH4CtL+d7zSpDp1+wOWj+459xXBP4Q8SKzpPE8aIcvIkx2P7gA9a9GVSOKjZT5fI9SWIhjoqLqcnkQfEzxDNdax9iDKUj43L6f41583iC/0nxXpsocxJFtKN2bnNddHoytqhhSU+Zu2M0vb1bmur8ffD+2vfBTCzMT3dqDJA69TjqPxFdanToqMH1OjHyVDDxpU3r+fkeiXATVtNs75NoR41kIYZGCM1ZNtaXWnZSCIADpgKM+hrl/hrPNdfD+3t7pGE9qvlspGDxyK5HxX4l1Cwku4oLxo4GJ3D29a8yOHlKbpxfws8zC4aeI92Dty/kU/GOqwXDjTWRJEhbMRkOSmf4Q3pXLHTrFjltuTyetQafcrezztHMWIblW5JNdetnYhQDcLkDB4r1lFU1Y+ogoQglDVHWeMPK8RGOXQ7tXnh4ZAffuDUnh3Q9TudStZtRXyPsz7lKnO7j07dq5fTJIm1azl0s+ZevMok2oRhcdPTFdF47v7+78RjSLWWS3to41bKjCsTycn2Arz5QlC1KO1nq90fm3OpXbPSn3BDsALdgaI33joQQcEH1rg/hfqt5cvqWnXkrzfY3wJGOTz2z6V3vT8a8yrTdKTgzphLnVxa53xzdXdj4X1G60pD9sSPIZR8wHcj8K6KvMfiZeXlrq1sbe6eCAgBwp4P1rTCU/aVUjRR5rnnPgvx7q//AAkUen6rdTXNvM4jJb74z0I/OvoZtQgis5JVyViGCvevk/xTdzDxYbi3TyirBlbpx6173Hf6rbTabb28PmQ3EUfmyj5g+R616eOwsW4uKtciM7e5N3sWrfxHo+t6xBMbcf6O20TFQTuJ4H0rrtTvbPTrKW61CaKG2QfO8hwKrWen6bY+YYoYQ3Bdto6gYH41wXxq0nVvEmn2Fno9s81sGZpZF7dgMfga89QhWqRhG6XmOV0nKxVi+L1teeIk07TLYfZi4RZG6v8AQdqX4heKNYjvI7e0tHEPDKycq4Pc1neDvh3Z2flSMGk1KBcgE4Gfau2tJraCyuUurdkVRl95ywHsfTvXc40KU1yRvY3pUJzV5aM5Tw94v1+KwaxsdKe5uIhud5BtCA969I8M3F/d6ZHPqaKlwwzwMAD6VxMfiG0iKRiSRrVzsDAgFRnjnvXS68Z7HQxe6Vct5YxI7HLDb6gVjiYxk7KKi31G6caSalI1tRgijtmBLZbkkgtmuUvrG3vblGis2BiYZmfIGPYd6peDfFt5quqw2t+XCyMQjEYEgH6V6Q6K4wwBArGTnhXyy3HTxEVGydzwv4jeJp/C3iK2t7GWWLMayMitxz61wOs6dq3jLU47m4E8shO1Qctkexr074v+F5L/AFt9S+zSSBY0CsQdmQehI+tdj4T1PTbTSLafU7e00mRgsaB2xuPTgnrXpKvCjRjUjG7Zy1qkq03HocL4f8O6d4K0iGXVtkl7OpKQOQBH+Pc1zHjDxRqJ1l47WWYOZ1KbWznkYGPbpXpXxO8M/wBqpaX1g6PCPlKryCD3FY8PwtmivdN1SGWMuHSSVHOCMHOeev0p0a9KSVWrLV/1Yuq7UuWCPSLe7OoadZRTxs0sqK0oAICsACR+daUG2GItcBY/L+XJPGPWotIjP2bzHQpvcsoPXHbNZPxBdhoDJGjs7yKfk44Bz1rx7Kc1TWiuaTaiuRdDb1S0XUNNntm2lZUxyMj2rM8Jx3FtpqWt2w86J2G3bj5R3/Wuc8OfE7R9a8R2+iWEU29lIEjYAyo6AfhXTalqUenlLyePbCquZML82QM9+2KfJUjF05LfUxhFTlzLdGX8QfA9p4xsIYZ5ngngJMcqjPXsfatvw1pX9iaHaaf5vnGBAhkxjdjvXB+HPiNH4r8U29pYWtykUYLlTj5xn7x+leoDpRW9tThGlU23sHJG6qJ3uFcJ4p0PX5PEkV/pWprDaOUVo3k27SPQd8+ld3Xz9+0Pfa4PEVhbwCaLS40DoynCu+eT+HFVgYynV5Y2+eplXty6s97eaOFEFzLGrEY+ZgNxoVIoQGjRFDYHyr1/Kvmrx3c6r4iuLLU7KRr20FokOISW8qTHzBgOhz3r2/4a2uqW3g3S49XdvtCqSUk5YL/CCfUcVVfBujSU3LfoKFWM5cqM+88ZX1v4jGnjTnkVpfLI2ngdjn+tbZ8IaF/bzawtjGmot1lHckYzjpmt1okLiTy0Mg6MRz+deG/HvVr/APtSwj0u7lNrGhEi27fdl3d8H0p0b15qFH3dNfMHHlTlPU9jvdPgN/FqD20Uk0KkbyvzAe1YWveLRZ6ittCkm1CrO+PvLnBxkUnw+1e9l+HdtqOtrL9oihdnZ1wzqucE/gK4Tw18U7LVNW1Aarp4AVC8QyCeO3406VCTlJSjzcug3JON46NnoXj3xGNF8Jy31sW8+Vf3Ixzz3/KuF8AeN74Gzg8SLMbe+ZvKmlbeGB6D867TStU0zx3pd3Zz2uwxgBo5BkrkcEV5TqXw/wBS8M31pd+YlxZpNwUbO056YPTiujCUqTjKjUVpef6Gc5ydmtj0Hxf8T9J8O+IRot1azToFXz5EIwgYdh34INSXjwRwxSXUSX+k3MTSJcMR8wIyo9c4rLfwT4b8cSJd3RmTUEiVZGjON4HQkEde1d7aaFZWmnWumIha0gi8tFfnpjn61k3RoJRV79f80b05VLtbLoeOWgeSCfV9IE6XVrJ823OHTsT6GvTvB/jG11iBIbl1hvVADK3G41t6dolhp0ciWduqeYSXJ5LZ9c1wvijwQ1s8d7pU2JQ2CGO3nsaqVajinyS07M9yniKWNgqeI0l0Z6UHUsVBG4c4pWAIIIyK8vsPFOpaReRwa0juqD5XPv23V6HpeqWupwrJaShwRnA6iuKthp0tehxYjBVMPq9V3Rx3jvQBAzarZW7SL/y3jjOG/wB4VzGl6ldzP5NtGw3Do2cdD1r2UgEYNVo9Os4mLRW0KEnJ2qBW9LG8sOWaudOHzN06fJUXN2MvwhZyWmlGOdMMxJbgcmvOfixolrFaSvDl23gnBwU6c8depr0HxFqk2mHylASNkJVlHOSen1rhfEeg63r91atbwmSAlVYl+E7ljnqelbYXm9p7WTsmPD1vZyliKj919O/kcP4W8HXTu0kCu0KgFpsY4/pXVnQbMEg3rZHoteqeH9ITSNGWyDF+CXb1J615O99CrspkYEHB6V008TKvKVtkejgsdKteNNcqXQ6O18Siee6k0i1s0eNjww2M/vn1q9Fp0PjJI57vfZXsIBJjIYsp7Htj+VY934Z1OwkntrGxS4jkciOfI4U9AwPerOoX0vgzS47VfLGrXeWLj7iKPT+Vc8oxdvYvV7f8E+MV07SWh2Fjp1j4Y0u5lhQkKPMlkY/M+PU1T8N+KbTxK0q2wkQwEFgSDuB+lZGla8mqWUum6gxaa5iZCjjlsjqMdq8j8Exa1oHjtLQLLCBJtljPQqD39Rgms4YV1Yzcn7yKdSMErbH03XCfEzRJNUtYJrFUaZX2OCcZHb8a7K+vILKzkubp1SFBkkmuQn8V6dqemrJYyJIqygE52/N2yPTpXLhueM1OKO2m7O5i674Y0GPw3b3uuwSxyW6AStFyfXHTn0rk7/4xW7SWunaDpJ8qHEcbSv2xjkD/ABrq5vEVrqv2xLyMGzljKsCc7GHXFcto3gHRtNsJNe1WZo7dXL26Dkn0r04Ri1/tDemy9TKvCUJqVNaszfFOvaza+KoG1DVYo4l2uYYXIXp39c16b4N8dWd3pm2dWDR5KlRwy5//AF1826yZtX1+drRJZ/NkAAPJx6V7L8PtNm07wy9hdwxLdTvuViPm2j1/OtsThoezXMvu0LgpVarjHbqei3N5F9vjubMF2lXgYA/GuI+JmppY2VytzO0U0i4UOu3I9FFV/iQde0fw7Bc6UZkO4B5I1zsXGQM/X09KyfBumX3jzQvN8VmWTypsLORgsMdAawo0lC1Vv3V951fWI05ezhq7HNeGNVhv1+zyxyLENoVz0H1r6H8K/Z20SK3ifzI0XbjdniuW0Xwlp1vb3EFnp1vJagfK4O9t2MHOe9WNIuX0S1Itdmxn5iYHPpgHPWpxc411aHQwVCf2mrlbxxp+n+Gxa6pYoY7s3GI1LHYpbqQPyrZ0HxX9oLxakIopI8ZcNwc9Ki1C+8OeJ9llqTYljbIVm2lT7EVwPjW88L6Zok1lpV2WvBLvLuxJ/wB36c1lTiq0FCabl3Mp05QeiPaba4hvbYSQsskTcev4V5T8XvAOteJdTgvNMmjkt4ItqWxO3afb68VX+FXjK3tbaS0vHHzEuNuTjjpXZv4kl1m8Wx05DDFJw0zDJx+HSphSq4Ws3FbdyoUZV4dkZnw58P6hpegR6Jrdw7SsTPtRs+UvACg/XnFdq2lxbEVJJRtcPkuT+H0rEghnjvo4meaO6JIEjDKsvpXUpu2DfjdjnHSscRUlzcye/Y2kvYxjGErigAAAdBVbUIpZoCsJXkEFG6MPSsDxHr0uk3Q86VIYVG4/LncvtW9pd7Df2Uc9vJ5isBz0P41i6coJT6HPdPQ8N0HwUvg7xH/wkWtXH2eKKZjbQFvnkJz8vpjmvQrHV4fEuINXUWoZHj8rnEgYdQfYVm/GvwjqfiaysH0lEle3cl4icE571w1l4c8U6ToktncQA3KoZIF35ZV6HpXrRtiYKpKS5tvQig1Tk4+Tu/kdj4E0DR/DWl63qOl3n2u8gieISkcKBnaAPyqp4B8caxe+IhZ6m5ltfLLSSOgAXjPFdZ8NPDTaR4XEWooGuLobpkPoR0rC1rwvPpOuQ3FlHBFooz5zO2BGp6kk1nz06k5xqO76P07HPHmjFNaI7jSfE2k6tdSW1leI9wnWM8N+ANVfG2hP4h0xbe2lgWaKTeBKu5TwRg+nWvna31s6D43a40y8inhhl3JIg4kUnp+I4r6a0eazuLEalbqiC5USO471hXw7wjjUg/Q1UvaXizxbwsF+E+o6kdeuPtc94ijyLYEqoLcMx7cZr2zQdRXVtItb5F2iZA230rhdcs/BfivxKq3F2x1BFG/ypCodV6BqbonxL8Mw+IbfwxpcMoiDeSkyj5N38+veqxC9vFSUXz9dNLCpy5Lrp3PQLrUrO1uIoLm5iimlzsV2wWx6Vwek+DLnT/F329pVltS2cscgqexB6muQ+OviK3OuLpM1gxa0iEoulkww3c4A7iqWv39+vwU36Te3F1HJdLmSPIMK91bnPXFaUMPUhSUov49NRVGpS5Xsj3+aGOa3eCRQYnUoy9iCMEV4LrHwvk8NeJrPUrOQ3WnS3IjZdp3Rq3GD7e9eifBrUtS1HwBZTawWknQtGshOWdR0J9+34U74snW4vCt7PoUjCaILL8oG4KD82P5/nWOHnUw1Z0k1roy3GNWN72Mbw/4Pk8N+Lbqe21CaOK6hICMcqD68+ldRot1o+pPdaXDfx3wjXDxMOR2zmuE+D+r6l420DULXXneUQsqJKAFdMjnn3rq/A/w+tvC2sXd9FdyTmUbY1YYKg9cnua0xDs5KrK0klst/ma+0Sgo0lo9zZ0fwrZaO9w1hJcJ5qlcF87T6ivM/DHi2SX4hzaNqNw5TcYopEYg7x39+hr2pQMswYkH34FcHbfDi0tfE7axbzgOZPNCleVOckA+hrPD14Pn9s91oZS5oWcEP1f4l6JoXiD+xtTuGNzuCs6L8qZ6A12V8kU9k4kUOhXI479q838UfCOw1rxe2uvfPDHIwkmh2g8jqQe2cV3F34i0XTZ7W0udRt4pZgBEpb7w6CsakaajB0m3LqaRnJybaskcdq9rLcwrBqIHlbjsl3YZc8c8cisi3sdW8H3yTywvdWgbcrpyMVr/EvWbrT9WtoZbLzLFgCrgdT35rlNS+I11o+rafKJBe6NcwiOS2YD92RwefX+delSVScFypWfQ9qOZKNKySts0evaF4gsdZjBtZR5mMmM9cVr143Pa3krReINCjW2YjzVVRhZB3x/nmun8J+OzqKmPUIo4pU5Ylwhx9DXDWwbXvU9vyMa+B09pQ1XbsdF4s02XUdNAt1DTRtuCnqR3ANc/p3iS70yKRLzSbpgn3hEu4g/5FdfYanY6gD9iuoZiOoVskfUVYkRCQ5XLAgZHX/wDVWMK3LH2c43Rz06/LB05xujhj4u1PXP8AR/DulTIWGGuLgbVQetNT4cQsima+YykZciMYz3rvI0Ea4UAfQYppiYknzpBnsMf4VSxLhpSXL+IvrDjpT91HFWXjJ5dQVbvTprWJmVcuwIGehIxxVjx74Vl11obmyuI4buNfL/eH5WBOfzooq61sNNTp6Hm026qakVfB/gVdK1AalqM6z3SJsjRT8qD3Peu0ezt2uBOYY/PHSTb8350UVz1K86r5pM1jTjFWKHinSBrelNaGQISc5IyPxr5+8QXVp4Tk1DSUmFxeSnzHeMfLFgdBRRXflsnKXs29Nype6ufqZPw/1JJtYW2vgXtrhwXzyM9q9x8daK/iPwxDpumfutjKRxkYA6ZoorpzBulUjOPQ1oxU4XkUfBXw9g0VdwX9/nBlK88enpXQ6P4NtbK5Fzd3E15cAnBkPAHpiiivLqYqrNu73Jl/KtjqGjR0KOqshGCpGRTUhiSPy0jRY/7oUAflRRXNdk2Q0W0AB2wxrn+6oFZknh+1e6eYBRvGCNv9aKKuNSUdmaRqSjszzrVPhBv8Qx3+mX5hhMm9o2JyPXBq74h+FtldKbiMeZP/ABqBjd759aKK6ljq11qKn7r7p9GVbPwy+nQtax2sccZ+ViF5I9zjNdF4RitobsQMWjuVO4gkYYdRiiiumdSVSDcj2WlKi1a1lfQ7SSGN5Y5ZFBaPlG7jPBrwr4k/E7WNC+JIsLCTFjalFkiKDD5AJyeveiisMupxq1eWaurHz9aTUdD0rxBdeGdRtYTq1zDDLPGMZb5gGHGfzrW8NWVtpdgIYJ0kVzvR88svQUUVnWvCmop6XNFBW5upp3t1HZ20k85IiQbmIHQVheF7+z1i7utRtruKYyjYsYYFkQHuO1FFTCC9lKfXY1T5Yu3U6SuO+LWlXOseCby3s5lidWWRtxwGUdQT+v4UUVlRk41ItdzKSurHi/wp8CrqOqNNqtzbvaQAhk35LHFe4xX+i2Xgy4ZLiMadaRMkpibOz2+tFFejjZyqVeRvRWMaUFFc3U8w+GOoeHdW8XXtpbRSPK8TCG4ce3+FM0bwRovg3x6l3c6gLtISJFB2oIyc/e5OccHFFFbYic6dTlUtGv8AM0wtKFTm5lsd94y8A6N46aDUPtTxy7AomgIYOvYEfnSeJPBLr4Hh0Pw64iEUgdt5/wBZ65NFFed9aqwtG+kXoS6UZXfVi/Db7JoOmDRJ9Uhm1AM0pUNkLnsO1dVZaeY3Z7iYzg527iSMGiiniJNPm6y1ZUIqMeVdDlNR0eDwPo3inW9IBWaePzFhAyiEcAgfU5rz34deL/E2oeFPFErTS3LQwb7eaZvuSHjAP45x7UUV24aKrUZVKmrul+RhP3ZqMTT+Cw8Z2zTz6stxcafOBsE7k4PqD6V7Cb6KSCZ7OSO4eNSdkbg844FFFcWNa9tZJKxWHblC7PEPGPxbne4isbfTi0YkPmYYgNg4x9P8KwfiZodzqnjCzu9HR5FvLWORrNWzJbnH3So6DvmiivZjSjh3B01vf8rkzrTmuRvRHtl1p3neC7C11m0N1cCFInXPzBiMZz61w+qfCQ2sEo06Y3KSnBjfAZB6j1ooryIYupS1g92zodKKima3jy9l8C/Dm0GmW0lzMI1t9xXIUEZJYdua8+tkvfF3hoa6sTwzWrCCfaDjp94e3rRRXfh1ai632m/1NcDialHExhB6PT8Cr4Vsr/SfF9jO8z27iUPv3ZSRO/PfvX0ujK6hlYMD3FFFc+ZPm5WztzDDwpS5odR1FFFeWeef/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucoid intimal thickening and luminal narrowing in a small muscular renal artery (arrow) in the early stages of healing in malignant nephrosclerosis. Similar changes can be seen in other thrombotic microangiopaties, such as scleroderma and the hemolytic-uremic syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light microscopy showing thrombotic microangiopathy with onion-skin thickening of a muscular renal artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Concentric onion-skin thickening of a muscular renal artery, leading to complete obliteration of the vascular lumen, during the later healing phase of previous fibrinoid injury in any of the forms of the hemolytic-uremic syndrome, including scleroderma and malignant hypertension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunofluorescence microscopy showing fibrin deposition in thrombotic microangiopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy in the hemolytic-uremic syndrome shows fibrin deposition (bright yellow areas) in branches of a muscular renal artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34362=[""].join("\n");
var outline_f33_35_34362=null;
var title_f33_35_34363="Dx neuropsychiatric lupus";
var content_f33_35_34363=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic approach to manifestations of neuropsychiatric lupus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Sequential evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirm diagnosis of lupus according to ARA criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Careful history and physical examination - exclude systemic illness and medications as confounding variables",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        For specific symptoms or signs:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Stroke - CT scan, blood tests for coagulopathy (including lupus anticoagulant), MRI, echocardiogram, carotids ultrasonography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Seizures - EEG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neuropathy - EMG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Psychosis - MRI, EEG, lumbar puncture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cognitive abnormalities - Psychometric testing (to differentiate organic from",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        psychosocial disease), MRI, EEG, blood tests for coagulopathy, antibrain antibody",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Anxiety or depression - Psychometric testing (to differentiate organic from",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        psychosocial disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Meningitis/fever - lumbar puncture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Monitoring",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If patient improves: monitor history and physical examination&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If patient gets no better or worse: MRI, LP",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34363=[""].join("\n");
var outline_f33_35_34363=null;
var title_f33_35_34364="Physical urticaria testing";
var content_f33_35_34364=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F50072&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F50072&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Inciting factors and diagnostic tests for physical and other inducible urticarias",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Disorder",
"      </td>",
"      <td class=\"subtitle1\">",
"       Inciting trigger(s)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Diagnostic test",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Symptomatic dermographism (urticaria factitia)",
"      </td>",
"      <td>",
"       Firm stroking, scratching, pressure",
"      </td>",
"      <td>",
"       Moderate stroking of the skin with a blunt, smooth object (eg, closed ball point pen tip, wooden tongue depressor) or dermographometer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Delayed pressure urticaria/angioedema",
"      </td>",
"      <td>",
"       Application of pressure &frac12; to 12 hrs before onset of symptoms",
"      </td>",
"      <td>",
"       <p>",
"        Sling with weights placed over arm or shoulder for 15 minutes (7 kg weight on 3 cm wide shoulder strap). Patient reports symptoms over next 24 hours.",
"       </p>",
"       <p>",
"        Dermatographometers are used in research (100 grams/mm2 for 70 seconds).",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cholinergic urticaria",
"      </td>",
"      <td>",
"       Elevation of body temperature (exercise, hot water, strong emotion, hot or spicy food)",
"      </td>",
"      <td>",
"       <p>",
"        Exercise using a machine (stationary bicycle or treadmill) to the point of sweating, then continue for 15 minutes. If this test is positive, then passive heating of one/both arms in 42&deg;C warm water bath to cause increase in body temp of &ge;1&deg;C.",
"       </p>",
"       <p>",
"        Some patients may react to skin testing with own sweat.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cold contact urticaria",
"      </td>",
"      <td>",
"       Exposure of skin to cold air, cold liquids, or cold objects",
"      </td>",
"      <td>",
"       <p>",
"        Ice cube test: melting ice cube in thin plastic bag for 5 minutes.",
"       </p>",
"       <p>",
"        TempTest&reg; where available to determine patient's threshold.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heat contact urticaria",
"      </td>",
"      <td>",
"       Warm object in direct contact with affected skin",
"      </td>",
"      <td>",
"       Application of test tube containing 45&deg;C water or metal cylinder heated to 45&deg;C to skin for 5 min.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Exercise-induced urticaria/anaphylaxis",
"      </td>",
"      <td>",
"       Physical exertion",
"      </td>",
"      <td>",
"       Treadmill testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aquagenic urticaria",
"      </td>",
"      <td>",
"       <p>",
"        Skin contact with water of any temperature",
"       </p>",
"       <p>",
"        Salinity of water important in some cases",
"       </p>",
"      </td>",
"      <td>",
"       Application of 35&deg;C water in compress to upper body for 30 min.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Solar urticaria",
"      </td>",
"      <td>",
"       Exposure of skin to sunlight (triggering wavelengths vary)",
"      </td>",
"      <td>",
"       Exposure of normally-covered skin to UVA (6 J/cm2), UVB (60 mJ/cm2) and visible light (projector).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vibratory urticaria/angioedema",
"      </td>",
"      <td>",
"       Lawn mowing, riding a motorcycle, horseback riding, mountain biking, exposure to vibrating machinery, holding some steering wheels",
"      </td>",
"      <td>",
"       Vortex mixer is held against skin for 10 minutes.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Consistent with the recommendations in Magerl, M, Borzova, E, Gim&eacute;nez-Arnau, A, et al. The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009; 64:1715.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34364=[""].join("\n");
var outline_f33_35_34364=null;
var title_f33_35_34365="PVSG survival after 7 years";
var content_f33_35_34365=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F79644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F79644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Lower cumulative survival with chemotherapy in polycythemia vera",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 273px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative survival after year seven for patients in each of the treatment arms of the PVSG 01 protocol who were alive at seven years after randomization. There is a progressive survival disadvantage of patients treated with either of the two myelosuppressive regimens (chlorambucil or P-32).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Wasserman, LR, Berk, PD, Berlin, NI (Eds), Polycythemia Vera and the Myeloproliferative Disorders, WB Saunders, Philadelphia, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34365=[""].join("\n");
var outline_f33_35_34365=null;
var title_f33_35_34366="Phe and tyr metabolism";
var content_f33_35_34366=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Phenylalanine and tyrosine metabolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 611px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34366=[""].join("\n");
var outline_f33_35_34366=null;
var title_f33_35_34367="Expiratory Arteriogram Celiac Artery Compression Syndrome";
var content_f33_35_34367=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Expiratory Arteriogram Celiac Artery Compression Syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 360px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFoAR8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDoWlA3BM47VHNMxRQOO31qHeT95cVIjqMBlOfWgBkyq/zOuAfyqu8MRbcY844wBVpipUgA4603JCnJC0ARSRKVyF2gDGKktmXeucA4wBQEZs7jkd6UxhmXZjj9aAFKDzCSBgcc05nCMECbifTpSSh920AZH60fMenyUAOleMYXJIHNVlIxgdD2qRsqVLAEDg56GgIkjE7RgdCvegBojAYOBzjpT3BVlUALxk4pQVT72QccZpMZdtzcnoaAEkbjB79CKiYb1xySOvFSxRgSYPOO9PdTGQR1PBoAgBPCou0Dp71Pbxyy5EjFcc57YpGLBCRj8BRvmfZEB9TQBKAoyOWb36UjSFSpCjmpVGEKLjPqOaQgYIXHvQA1GOWyOGIpkioQFRuO1EsgwNq8Y61CyysE2gD3NACIA0mcjGcEmplMm8pEFXPBppi2xdRu9KkEmU9COCQOaAIWhWN2XBLn+LHAqJlESkrzn19aknn246+oqO6mPlZYDGOMUAYk3BZZOCeT9Ks6HEJbnjOE5ArKupT5o+beB3rovDKf6NJKiEyE9/SgCr4tv8kW4+6o5Hqa45oUL7hx6Y9a1Nanae/lbBxnkVmyttXLcf0oA5S+08zav5kgPUVor4i/s3UIILJVecNjJOcVg63qTQynY7bmOFGa6D4V+HF1PVhfXaGSNDkAjgnPrQBoePbrVb63icGYDqAqkD9a4dLDVrpdsrS4PHzHivavGN6hlWFFTbH2/pXNROJUy8Yj56YoAxfCfh9LJ1mmAeXsO1egaY5luFjkxgdhWHGNrL5ePzrb0eMtu45HIPrQB0MTqo2omQO5qYurE4XA7HOKqEtHgMpVT2prFnJ3Zx2GOaAETkgqpzS4Ds4K7KU7l+VSee9RyDfwrduc96AFxsAAbrx9aaM7SoyCTSxg/dX7g7mn7lkbapyRzxQBNEirEdzAnpio2VMnZwxpycAA8019ikZPTqQaAI49rcbjx2AqUAF84Kgc4NKzLH93nI6gVA7leWzjtzQAjkZCkYHXIqdcbgyghccCmZjMYLNlj2HakZjtyqnp65oAdO+FCkAk8kA9KEUsFO0lfemwRgAlj3555qcH0JC9eaAGtsVwSDup4lDEcbm75pp+dOCBjpmnwrGpyCMnqMUANhA818rk+3SkjJXcQw3NQ7KJTsbA/u+tABYiTbigAwvCrxzzxSSEg7cZX06U5vn5U896Rx5itgcDuaAHRRIQpDAc80jFk45I7VXVmjGNuT1wBVkTh4gpjw/rmgCEO464YjvjpVi1CMjeYOT0NULkvG/y8jrSwzAyKQCMdQaALeBvXy1LD6Vi64+yLYB83XI7V0IlAXETKUPPvXF6uzTXDMXYJnFAFGIZJ3Ywx6mt6K5a2stik4I4IrAbBkCgkqetWrq6YW2MEIflHNAGbcPHuLR5Izye5qpJGZSyrj5hgDrUsSh5HXJx6V0Om2VtY2hurraGAyNwxigDhV8F3V9fxzyDy4fTvXoFveWfhvSlt7YjzAMHHWufn8RyOJFgO1AcKR3rFnuXlcs53MT1POaANWa8N1OZnOd2etNjuFCqEIODyayzMXjxkA/TtS2zL1CkBTQBv286s20dPQDiuo0p1S3DbTuFcfpwJkjzn5j1xxXZQpsBxzx60AWGnlH+sGR2yakEhk6ZDH36VWUhlwCHPpnJpsO5HIYMp/PFAFxhvUDJ55yaUDAVUwB3Jp+4ElVHK9RQcHYCDxyKAIpOcbm6dKmwCF2nIx06Unllm6DafXtT5U+U8gjtg4oADIXZiv3RwM0xcLubAA7052yuI1AA9qi5JILZOemOtADonyGK5Le4oCsxy2MGkZm/hAOeKeDgLtxx29TQA1VVF5z1pPML5Ea98U+d/kBPXvjimK64wgIBPGetADnVl5zgdMe9SfMFwGHv7012PQqSuPqaTqoOw4NAD1UEZfOewFNwRn0zyKRfMU4BC06NSPvHJ6g0AL5bE7wcY+6DSEuEZJDx6Co3kYZA556VKpJbLjJI6UARxrkfKuD6U9WIJyKm42gtxx0BxUAYBiFyTQAyeNtylcE0RQ4cktjjgGlSTknB+X9KcxDNuyfoBQBFJEXRgz8+tU3QRYYfl61oSKF+bGMg571UlbClWA+tAEj3G20ZvuqOnqa5O9LvI2Su2tXU7j/R2iBPqf8ACsOR2MR8tffJFAESyNECfl57Cq11csx2lht68DpUrSrsfjax44FVioI5KHjGcUASWQJvYQpGC2T9Kf44v3FstvuwGOMCqthOkV2JNy/Jkdaz/F0/mtEYXVh15OaAKFm7eWd5xjip0cbM7sc8ZHJqvbjdkudoB5PSppGVogseCwP38c0APySAFJOfSrlmAp2IDzySe9UwDGQnzD1bpVu0AeQDe2QeaAOq0VA8qgkEDoT0roXbLbFY9ulZ+ixRSRDEeAO54rXJjU8KeeC1ABAhjIY9ccCpJCkknzgU1QAMZYfUVLEEkfDoMjvQA3YGHHyk9qczDhXYnHel2YX5QM55JNKEyegJ9KAHxjbEMMcH1pm/GUwBnoc05HLDy2GAPbrTE2PI3CqV6DHNAATIqrnHvio3yiDIyx6Z9KklCiQqrZPXrTpM7QGwuOntQBBHzlguCKdAFwDgsc5NEYONqfM3r2qbDLHwAWFADSNx+YDIPelxhtoQE9RUbFznf8o6Zp7ltiDjPrjHFACDBO6TJPtT88KFIGeTmkYksApxinfIFDthm7ZPFAC7ScbmwwqNiWBBY+wAoDPuy2PmORSSOzLtyc46igBUV3f92QcVKMxsTt5PUmo4hHGmC3zdSc0rIgUguWNADZ23LgHr0x2qxpmn3OoXq29lE007DIUdh6k9hUOFSM5+UntXf/DbXtJtIjZywrZ3Mhybh2+WX0BJ6fTpQByXiPQbrQr8Ws7pIJEDrIBgH1H4HNZUm4EHIHHSvZPiHo51TQ2lhXdc2mZUwOWX+Jfy5/AV4tIrEAk5PX1xQArMQSWHOKhuXMMRccZ7mpfOijA80An2rO1e53P8i/uscA0AYd+RMWbcxXPANU5wdgO7oOhNXLj++AcH+90rHvWUbWBO49utAD8oQY8A7uc1QuJAJAN2AODT3nXaSxAKj+HpWRdSHOExnqeaAGzzlZNqABTn8ay3XfIGIOFPY5FFx5j7pHb5R2HBNVre4UDkBFU/nQBtRsrJx9TmgAsTIFxgcVXt7gFCW4A6GnZkcmT5VXoDmgCzHyRyTzzk1qWNsGkDRk/McEVk2wG1cjk+ldDoMZe5jXIHPpQB3el2vl2Cn72athcD5gAO3tUcTMibFY9OhFSQPHsJkyG6n/69ADwC3GQDjrTRG4JAbc1DMqKFONxNSBVILbsc4wB0oAeQ4O08huhp/lsqghgCOtMiQlkDEg/Wl25crhiVPXPWgBGJ3gYGeoIprEL86gE55NEjjzSOrdMdxQ25227QB0BFAAhLhRwcnk1G5d5zggL0BNTMVRSu3Bx16VDCyrGFIxjoTQBMRtIP3cenem8g71b5R1FKuWbaMgY5Jpnl7pNqdB1b+lAEqMVBZQBnuaAS5HbHXNPREYkc49QM0vy7QDj8uaACMA5z27mqssyqp3c5PbtTbyRmiwpO0d6o27gkAlie5zwaALkdyZEKrwR3pYJWGVbAHemLGN5K5UH2qYQgEknOecHtQBFuJlDoRx/DU4bZHvJ+o9KpQeYbk/JwDVsoZHycjPUUAFvIkxbcTt7VICu7ameOhPemeSTGwjIx34xTflXjeSB7UAdj4a8b3WjlLa9Rrqx6Yz86c9j3HXg/nWL4ntbWDUnm0+RZLC4JkgdT0GeVPoQcjn2rFbbE+5W+U9eOtSTShkUDOM59qAKd2QkbMvIFYt2/PytkN+lal9IFifnHasIkYL5LE8YxQAwxiUEL9wH1rM1ciAqpUnHT2rodLtdwXdnkVz/ioBbohXwAMUAYN7ceXCOQc1k3Vxt4TnPfvUk3lqCrE+uc1lMV81hH1bqx6UATXD4jJDAHGDUGn5kDK3ADfKaqyI7iTZxzwCOMVLYkoOW4J7cUAaYcqMZBHTAp0EgaIrnA7EdM1VUD5lUhT6ng1YjBaMA52j86ANOyjIAduuetdv4Vt4XYEngDPSuS0qNSAzNkDjGMZr0LwxCfLbCHbgYFAG2gVlQqTjPIFKEaVvlGFHHNOgYRjlBx2XmpFkVotw6scZxQBEkIUMWIYjoPSnQtiTBAORmnOQEKc5PQ0sQBj5A9KAFKkJvYc9h60IDgMflbOaUnaOc+hak3Bj94gnjpQBA5XcNpJYd6cjSBTkN9eKVlKkMMMc+nSnGQAlZSSAc4xQBEUcj1xzUmGKDC/WlVAyDb371Zj2xKC5HHbvQBWZi/JDKB0p9uu4HrjPWi5u4hGVTkn3qvFKxgUfdIPYdaAL73CpHshGWHqOtUpGYg7/lJ9qkgIOS4wVqC4uGeXCg4A9aAKd7AcrJC+2UDHzdGHoahs5kkc7V2yL95SeQasyEsMTDg9sVXk00uVlibZIOh29fY+1Q007o6YTjUiqdTTs+3r5fiunZ34pS5HQ+uKUyskYyCCfzrEbXI47uKHygoB2ytnIB6ceorQnuTg9g3p2ohUjO/K9isVga+E5XWjbm1Q43G1xg8d6U3bEA5IHp6is4kEnBJz6HFIH/v/eFWchpG7CActg8UNdpGdqqGasxmcRkBSRjNM6nccjtxQBq/asxs/AA6AioY7nJ4OGz+AqhufPIwPY8VCJ85CYVu/FAFrULgGMqoBI6+/vWeISQCBy1ShpGYcHA44q1DEzOGKkjr6UASZEFszElMLzXDatIsryySMQvY12PiC5SG18tDlmHTrivOr5mcMCxXnkGgDJupFbcnfqKzpwVcbQRnqR0qxegJuVQGY/55qodyKDuJGM/Q0AISzzsf4c4zVuGLcpA49D2qqeuTknOcGtO1gikQHccjrQAsIRSUPzAjg1YCqcbcnBwKjiUcqAQe3qKntlKvjBJHQevvQBraMjtIMDJz0Nep6MohskU/fIyxFcDoMHmOm0MCT8wrvLcsihQdq0ATPkp1wCeTRtZgADkLzgd8Up3NBgHJZuuelSxxiJQ2QGX8c0ANiVhlmH0p8chyQCAe/FKWEm5QvHUnNRbjHLhhkdqAJztPyr2PNSiIKAHBye9NUImDgDPJp/2nH3AGB/OgCdbV3h2j5TjNU5Ehj65MlQnUJ3Pl7yFPr0qIMoJJIB9aAFaY5CKdoB6io3Lnndk9Kc+1clj1/lWbqF6kQwhBIGc9qANBgFZWYLjv6VNvXyw2cH0HasaO987ac4TGeKlWYsePyNAGq0gYBVbPfND4ALBME9TmslbjDY4z2IHSnmZuOuT1oAuebH0cg/0pjT4U/Nx2qqdxwCMjuRULzEOF6DFAGfeaTGytJCfK5+71FSWwmSONJmIb88ipLqUuR12VG23B2gcDHNZRowhLmjoehiMzxGKoqjXlzJapvdfP/O5I5jL5YEH2NNJCsxGTnmopDlAMc9DVlY2UAEfNj1rU88RZWwgXJ7kelLdDcm4NtJ6j0pUjAYZJB/lTGUvL8pYgcUAVgcHAViR05qRIuCUBJzk1ajtmcAMCFHrV6C3VQVZQcDIOM0AV7S3yu5iD3wO1T3VwttCWk7joAKe8kUKfvBjjtXNaxdea2wk7exoAxdYupLh3OcgHrXPXjMUYgBj61qXrKVKbBx1rCu5dqEMWAJwoHagDKcMSxCkbuSDzTIl3Ha3GDk59KlLtGyhVyT1NEpyhPqeaAEhAeUMwO4H7o7VoylYgCjjLdRjmsa3Jjmdugz9cj61ct5jJKS2MD0NAGhaqJJcLnAHWta0tyVXcOvVhWVapulQqWXJ5ArqLAuyBMA5OOlAG/wCGIGjJk2nGep710hcSOGTjHaqOmxGCFVxzjNWY2IlbcCF6igDRBK7QCB7ml5yf5Gq8beYgctwO3TNPMqqBkHI7mgBYpyAwKgED8aRSWBBI/HtSRuDvkAHPAA707cCcAYJ64oAuTRtgBdoBHUnmkRFQckZqq8p3kjr05p0UjdTigB5iTrt6n8aSWJHIVVAA7mozcSFioBOOuKkV3d+Rx70AZGryyGUBACF67eOKwbpTLggHkc+1dBq0R4zlawJFYO4cnaOBQBHbtJCV/unuK04jvDEnAH3apNjy1GRuA6VYiO1Qduc96AJg7BsYH1qXzThiSGI6VDEjbiTwD0qUQbmOeePzoAXzm8tctyfSomGAW5OKlFsQSASFPbtSSWpRCNvB5AFAFF5XCBmXn6Um8lsgAD1qeWNiArjg1NZ2iSEHbj3oAjg+crhKv+SQu4pyOMZ61LEFiJwOnGDUyksxJwo68UAVUiJVjIAXPAHpUpjUYCxgD9afGyknc+FzxTWmVX8vLfj/AI0AKCDkEYz0qVW2RF3YAeneqtxdLGgUZLY6YrIuriQIwGeufwoAZq94zSbUOCTxXPXE5wS4JI4GDVmU+cQzA46Amqtwpxt4ODnNAGNJ5hduDk54NZ140iooKgdwetbEy/NuwVIzg1j3zASdMkd/WgCgEdsuwUenNRyZRNjDIPJoYv5gO0qo5z60XDbmXIB3dBigBmzfCpXAHQL61PaQYYZX5s9antYlbbvQ9MjmrlnFiUB8HmgCa0Q+ZuJCbePrXV6IA1wgxjBH4Vg20Sq+5ed3TFdZoNsIoTI2OvQUAdLE2V3MR0wBTtyuoG5Rz1qmQVIHPPbtUjFhgKoHrQBehQBs7iVA9KDtkbbydpyarLKVTaxbjp71JEpyTnDEZIBoAs4XYQvy47UjbggPGTUe4NjOOBTDK/lsBhQDz6mgDcNiWOXUDnNONoVB/dgdwfWugisJWwcY9RV1dPkkjK4UYHU0AcYISpYlOT1wOtOhjbeu4YbPU11E2mqqhcgn6UkWnoS+GBFAHLXmnrPkbwpx+dc/e6LOi5YHafQV2l7YSwZZOeeOabIHa2UuPnTmgDh4dIy3zBs9ye1SCxMQGF3D0Nbk0DO+8j6VEykOQ4xx0B6UAZkUa/MWXBq0ibVG1VB78U502uCVHHrUkLlgcjC+1AFSVSG5ABHXHpTZiAB3B7Zq0ZU2tuXNV5GRoioUKeoOaAKZRS3KnI5GTVu2wqbOmfbpTfLBKgEDsTVxY0XG4jcO9AFd+DtPIPXFRuAQQuffmrbASZUfgMVCsQWQDnnvmgCBdnOcnt0pbl1AGFDcdR2qacRxRFnOcenUmsh5i7/MSAR3oALiVdodvoe1UJ870xkluuRVnyxICF+bnODVqG2ZwCCffNAGULTzB93OOlR3mnCC3Msq8njI6V1EEKwhh8rEj8qw/Et0gtTEoJx780AcffmMyjY2F+vSsO4UszFhxn5a1JyC4ZiQFHX1rPunXcHzlAKAM6YszEONvGMDmomDrIgKg46GpkKyytjIxzinQKzSliQQMj3oAswhVOASWzx7VoWqxrksCWzxmqEICsisquG6nuK17PA+VIgeetAGhYWwkRNgIOeAK6+zj8q1UMo44GKxdJQOQoQZ710aREqqn7o6L60AOjJfknJ/SpGjVcgnLYyOakEBO0ZHHI4qdAI4yWUZI7etAEFsnmn5wQe3pVhIAZMyEKD04pUURDKAbx14oZvmB5J/lQAIoTzDhWB6VBtTbkE89s1NK+QoAy2ecUjKOoPQ4xjpQB63NIkec4PGeDWbPdByu1jt7gVnanrMEO6MsM4x3rPTVkKZ3qPQCgDpXk84Ku3Bx9aqPKIDuxgCs+HV90fIGcfeHWoLi6MyDHzMaAJri8EsuWGAT0zTEOQwAODxntVWGFo/nfPzHvWlA5Bwv45oAxLrEIYSOAT0FZjMCMDkfrVjxQzLOo7/AKCs6GYqMH0596AGl9znqCD3oLCLq5AyeMc0yNhl0JPJzimXLsYtpBIPGaAJoZ4Nrcls+vY1M0MLjIUhhzwayrSOVGAOQvatVNrKCzc9AKAG+WFG4hRnpk0nJOMHA9qsuokADZ3DoRUC8MApJA4NACxggAkMKLkpGucD0FSbgGbdu6VkXsw2kAN17UARXkjSucnAHpVYjbw3I9acGUyHfk+1SqhaTYwAGeDQAltbtx5fTPrya0wuxAq42k8k9ackW0DBPTqOKdju44AoAr3DJCGdumOua4fVpjLcMQCVzzz1rqNXuiFeP+HHJNcdqDL5g8snaT19KAMu6PmEsq4VR0rFnByA2Tz2rVv3O4+WfkYkfWsufe33XxjoKAKisUYtls9cVJb7/NDKN27rUcjNJgHgk4q1EPKjGRvNAF1FKkFVUnuccitrSYjvXOTn+GqNg3ygMCS/Wur8PWbGRR/AefpQBsaPaeTGz4HzHp3rU2KjDccH1xVnYqpsDFsDk0i84DrhcdO9ADolyRITgA/KD3pXbdKQoGetKpXf1IUUqvvYup46c0AMR9uQSCx547U1s7jjJyuee1NkJZ8c8cAinsNseSTn+dADQNp3cg9Oad0Cq27BGSTSxEAZJ560rZkym8gnnOKAE8R7lldkcHHQGuZm1MRsPmIZeua7PxxAtvOXC9OTivOdQuYHDbsZbPJoA63T9QaW1DB+eoxW7o9wZCPmY4OK800dpo5QEJK5rutFvxC480YI55FAHfwWkcgQucc5xVy8s4UiLLhSBnPXNUtKvYpYTI7jGMgVNJdb2AJ/dnt2oA4XxY8nmKcAqOKw4JiVCnCnGea6nxLbeYS2fl9K5SSB0RnXkdj/AEoAsLKpGQw3DqaUh2IIGU71msHVT3Y9fapILqXYI92VBySaAL7sFiGWHB4zTWldlQRAcEUxiCmWHXoKnWPBQDGB29aALvmeUiMG3eoHWk3JtwAATzUSqofBOFPf3ponCuytkgdMjpQAk0uEIAJI7ntWVuZtwUkbvarzys7lVHLdPcVT8pjkrx7UAQqjOcFTgdCa07RF2qWB3A8ZptnC4yzgZAGKlIbl8dDQBJIBuDfMR0H1pHmXJB4XpjOafExI5AB659Kilk8uJiTnA54oA5TxHI0srKjEfWuUlBWTZlm+proNamDOwyQw6EisOZg4XIzt70AUtTb93GMKCBkd6ypJFMRVsM/8q171BK44xjpWLdowOQowOMigCr5wA9T0NXbcknADcjp3rEDlblQRgnv6Vt6b80yjJK9/egDpNHjDtjaDg9D2rutIgRYt7ZyOgHauY0q1LyqVXAz612OzyoVVSckCgC2pVgSM5z609twXJJ3dhVePGCQ5wDmrYYkZ6+lAC7RjCnGeuKYI2QHByOvFSs+5RnjHYDrSOxCkqc5HftQBEMtHtDY5zmnNwMnn0xSrtKnaOvX0pxASM8nceAfSgBFkG35QD7etSI6o/wC8KgenWo0JGFGMAdfWiYlV9PQ0AO8WawZfMZ04Ixx61542nPeO7qAcEkD0rUu7mS8uODuFaNlEkQ3Bccc80AN0O1kWFMxgnPSuke0/0bDxfOfen6JGLhwFRRtrrfs8JiKOoG0Yye9AHPaSsqIducDoM1qLM+3kjjt1q5p1vFudB1zWiui7ipl4B6YoA5TVLhDEwkAHHXNc+0nmIkcYHvz1ruvEWhJFYMck98/jXDmII4yCR2oAzZ8DcHA2/wAqoecY7lXCqUHatW9+cEooAFc0Js3ZDBlXOM9jQB1COJIlwhweeO1WfJBAbHAHriqWmoXX5Oa2jaEorMdqHtQBXJjKqwYccAGql4CEBjbjPPNRXzfZSxIJUHIFQG6EmAOh9aALVmMEsCeep9KfIjNKpjHH6UWyjG5iSp7CtKGIyR/d7dKAK6ZVNpC/UVC8eSxDYX161Phkm5wdtMkY8sOnYUAVhkt8rEkDr0qpqMjCBlB61oMDu54zzWNrUu4nDDCjoKAOZv5dxO5+nHNZe3L4CgL1yK0byItuzytUkdunylR940AUpvvSf3j3qqcKhUpu7lulXpcFmwvyevrVWSTyyTt7UAc+bMtcMxUD0rSs0kjIwqqe9XFtzIhkUfUetWra2djsIAB7HrQB1vhXy3CBwMnBZs11NzAHUNAQPUVzWjQmCNQQMH07VvJME4c5FADgoDAspbI6D1q9CrCEkHbnt6VXjm8zKoh4PXFTgr5ZXO8jqB2oAd82Oq8c5HFNUMHJlA+b+HOaC5BUAD6U+EFi5IJ7H2oAjYlWYNjGOABSuoMILfKPSnEEEkjHqTSNJ8m7AwPWgBNwAC7Pm7YGKFJc/dAx3qPEjuNrcE1Z8vLgGQBRQBw1oxYgRlc56GtEtLglsZHvXI+HLqR7pmJJ5/ir0Wy0hbq13EkMeTQBb8MX/lsiKoyTgnNel2sNvNbeZId2B0zXkxs5dMAblwOhFdR4c1gzKI3YjjmgDp53jhkPk/w8jjpVGfxFNAFD8FffOR9arX90hf7xx7Vzmr3R8py5GB0NAGxrfiNpYtjSjBHQGub81pW+QZU9q5PVtTMm1Y3yfWrOkajNGo3fMRk5oA6G4CvEyKSjHsRXK3lsYrlUyd2eT3rcj1P7SxIYBzxjHSp1s1uphvIz60AWtAKCJQANw9a6lI/NjXPbtmsDR7cRbiQNqH8TXRAqEwncZz6UAcvr6KCxVgOxBrEgizL8pJyemeldDrcDTO2QCO+KyrW1fduAwB3oA1rG3BYDBbA59q2I4kWMrjDHk9qoWbeXjZzxzWu7jG7HUflQBjX9uqqZF3E9OKowYHYjHrW9K29SvB44rGztc7+poAgumVo8gnGPzrl9TO4twcD3rpZ5QIXwcYHHFcvPKnmMHbLd/egDJnfCkEEAdM96pzIFiY4wO5Aq3eHG5uMZ79qqXQbySAfyoAokNsIY4BPHtUcuVxjlicE1aUEgsxGOnNQy4l+UNgr+lAFy3RkiCL7dB0rRsIQ8y7gC3QZrJtgecEhexz1re0ZszJuHfqaAOn/s0RxLhvlxzULI4OVUlQeSRWqXUQjPU00wCQBRkZ647UAUI5pQx3EKMVNE7AcBgT1OOtTvZ7Pu4Y1Eq7WPmn8aAJTcRySKeSepJqdJ90jbRgD04rOfIA8sEbu57UkbtGCzHJ6Z9aANUyNLgYAxwAaZKQ6EYU4OMmqUM/BLP161dR1ZTxx29aAK8rABU3bSe+KmQdvMBB6A1HLGh5b72M05fu4OAR3NAHI6RZxOmQuGrrNJu2t9i4A7cVymiyiWMSREYHB5rpY9zGNyAB3oA7dPs1zbnzSDuHSub1SxbTU+0WgUrnkd6ntM+WDuyPWn3cmbZ4x8xPrQBz0WviRWDMMr2zWB4h1WSUHbkr61T13SZIbiSaAupJzjNZlgz3BZJcnHb1NAFe3MzylpOo6AV0Vkg8j5yAcU63tQgHAC9Tx0qO/yXDQn5Rxj1oAt6INtw4IGAO5rodKObnJGMdDXO6Ur7mkYfJjHNbOnCQF2GQR39KAOqWMxoJUxjuBSw3Uccit5nJ6g1DpM5mHlSDj1pt/ZFWOOg70AXLu2S7weM9c5qtJYpGv7zk9uag0+Vw+1WJGe/etEzbjhkGO1AFW1txuzuO30q4S3KnlSPumrKW4MIkjGOxHrUDuGPAORQBUOYw5A2lemazJsb/u4Pc+ta8ilnJ+961QlgIILjb6Y70AY+pqFiwTyegHSuVnkAmlUnAx1x3rpdXcIeWG0VxV/NulZApUZ/OgCN3B3Lwc8kntUN4QY0BYcDPPeosqsioDlj970ouVKzKM/nQBDGgJD9AfbBqKKQNdtuGSPerUmV3LjcAOKrWaL5jMQQx49qANNEUjGMDuc9a29BwlwMjPue1ZVvGCu8nIPGPWul8PQ7pSzqAu3gUAbwUCLeG+8eOc4NJG5iU5OCf4vWmKPmZWcYHQVPGA2ARvAHOaAHA5GR+WKaRlSXQkg9O1SdUA24z3prEYABbHSgCIIkhb5SAB1J6VWuoDGgKhueeeeKuNG28Dt1pWbzG74HGKAMpCEUFlGSOhq3BJl1zgEcgKcU29X5gpAU98elQRhlJ4O0cUAaUjKV3McnOM9ahl3AfJlxRF0ChMKeTntTwoUsVLZPT0oA8d0jX0tEEciNuHUiux0nxHBcqAsw3+lcXrOhMmfLPIrJ0x3sLotIp475oA93sLzdHgZJ9Qc1cLuSoOSp7VxXhnV0lVVVuO9d5p5S6kQoMj9KAKV3ZrL8rRswrOl0JIsTRpjnv3ruWtQvzdeKrXFk5tiwUkdeaAOFlhIcjaF7YqG+tSLXccAfrXQahYlJRLt5I6ViXzyygxFSNvbFAGI1y6RFVc5HQ1LpOqPBdBp8FD1q0NKzGd4YknORWPr22yU7T14oA9A0XWLd2Z4zk/XFbF3dxTxAgEZ4rxKw1xllCoSMdhXd6RqEsq73ztPQHvQB0toFW6HB2n1rRyrMCTkdhXNW92yuRKGHOa0rW883jODn0oA1prkRKoUNx3qNJGYLxjPJqJpBwjgn2qOack4A2jPQUAXNyr1G7njtUF1tK7lBHoM9KdHcJJhcD5RyKr3DEHA6mgDk/ELgEhyfXFcNeOFmcg5x0rqfFFw3nsgznmuOuGzuBHPqBQAkEqvcFXU46DJqzIhcMc5I4z61QhIdQXAz9auJLtKgfTA5oAVyfJJzyRzUluwMQCxnnvUd2CSgVht9q0LaEKi8Hae9AD7B2yoYcDsK63RSBHnbx7Vg2NoWdWwVX2711NtAERQBgDnFAFh0Utux8p4xQhCttxtA6kCoNz7mBIzVqHlN2AVAoAerknkEAdOKUNtJ46++cU0hmXjPNCIREVbdnsTQA9mbbvZfk7c1GSVGRnB5xSiUshG325pQCRy4wKAK8+1pOmOOcdqakexQckL1xjrUs67WLAgL3pzAeXuB5XtmgCoWfP3QAenNTFmVQM5bHQ1HgkZAOR+VEy/u8MSPWgDN1nSXjdwyE+ma4HVNHYtJleua+m9R0eGbJKrnHcV5/r/AIcgBc8jGT7UAeFWZm02R2RiB2Br0XwHr0t0ywM5znisPxDYxq5QKOOmBR4SibT9QifgZ7Z5oA9pjvGUBWYgmt/T4vtNuSp+XHJrire4Mu3zTjvmup0u4aG2VQfvfyoAdrGhnbFKuCOh5+tcPq8Mcd4VUE5Nel63ehdE3bSce1eV3U0t3esFG3uOOlAFuaPNgcfeArz/AMXsqwyeY3btXWyXEgZhk4HB965jxLZi8yM9RjigDz/TpVSYlB8ue/WvQ/DmqFEWCQZHGO1cINKkgnIDZCmt20CxBDubPfNAHqNtbLdxb9+0mnW0JimCmT7vvmud0TVGEYXdlQMYz0rahuN+WC9B2NAGmsyqS25SM9+1I0gL8Hk96yAfmLSAgE59Kmt3dpsjqOvFAGyvEZVMhh61Xu7gRx7mJwARToZic7uvQ8VS1fb5JVSBnqfSgDmtTCTyFmb8q5q7ssMSucdvet2cKZxjJ/lUV0PlwAMHue1AHOJAUciQE8cAVCygSDaSoHU9625bVsOU+cgZyelZwjzlmGGzxmgCukrm6QEnDc81v2wEgXa2R+VYEbN55OMbemRWxZMysHwSe4AoA6nT4U2hQScnqK3Aq7QRnK8fWszQ03AkkAYzjHStnBkjxjHuO9AFS4KoMqOtOjOxQTjb3U1I0YTjbn0pJ4xweCfSgCUHAymQCeBSkEna3THWq0dwBLtYgn0FSzy5Xjt2oAERN3K5JPPFOJ+Yr1x6Hio+SgPKmmltqjnOe2KAJJAGjOfvA8d6hkIUkA9O4p2cnIwOOahkBWT19RQA8TBBnGPSkDY+duQ3P0qFEEkZwpwp496mQKF5yfY0Aeuq24bT1NYevQRuhBGSepqaLUW8wkk05Lae/ZmK4j+maAPHfEWjkTkoSQDzXPmDyr1e2D0r2vXNAYQPIIwcA54ryfW7KZXdwpBHtQB2GmmN4kG8dOtd1odsksA/iAHWvHtBnmKxqWyPr0r1vwzdm2sD5wDZ4yDQBoa1ZmbTnRQMCvMdRiFpPsVuT1r0i61uEWcxVsADHJ6V5drF0lw26PlucnNAGdf3GJACc44wKoPJIXJGOfWmXocOGP3v1qBfOCGR+egFAB9h3tIz4BPP41SubXj52wo7Cr0UzPKA2Rt5NVr5WfdtzjtQBU08yrcFUXCE9c13OkxZiUEHd69hXGabFIkn7zv2r0nSLdF05HLYYjqaAKs8eFDEgkdqntrcum8ZJolRS5Izz3qaCfbhFXaB1PrQAxcxkA9Kqa2U8lVjYFsZOe1Pu1kd22MQAfpmsW9uCrneCxHpQBRlQ9VPUcfWqsiZHzY3DrirDSB2BHHt6VWfKkkZ255PTNACSKFtcnkZqlLEXTbsAFXyf3PCg57E1XDtvIwpOPXgUAUI7cktiMECrtqGTl1x6cg4qxZRZiYE/e55FWRYndjrQBe0lzGwDvkmuiikJh/dGubiRVfBOSDg9sVoafLuYLnAzySaANJGLHLnNN8xS4+U+xpylcqSQV+lK5BcEFQoFAEIUCQOQDxzU2QCAi4PWmvGdoKg5PrzTow6NhgSCM0AOcJtGDjPX3o8wPtXoo45pSdrKCgIP6UpUecAVG0c0AMcYiBUj5qryKS+0D73epmQyOMMBHn8qkKxlCOWboNtAFb/AFZUZy3bHNSxRuqc7HB756VHgRODyT0wB0p0TZYlYyifSgD1Pw14emuj5r5WPOST3rvLewS3iCIBjH51ZtYVt4RGg4FS0Ac/qMDPHIJIgQRXlnirw6AWlRRsIORXtEsivI8b8qBzXMeIrNVtGCqCrdOKAPBbDT2iUttxtbjFdOt4YLZVLEAjNKtkxlmRVxtam3tlJDApZC2OhNAFLUQZ7UhpNoIzgVzD3EdtCDK2cdCK3r92jsdrjkCvPtXkk8zBPy9j2oA0BeJcz7QvWrUojiQBTnGDg965m2uCmTtYMOMirKXEkrOMtnsM80AbUbpKrEkDHp0qrcQhlLkZNQwljEvTd35xU4iJUgP0PQUATaUqeaMqMDrXoGkKt3bBCMKK4GxtHDN94k16Dobpb25Lj5scCgBLizWIsN4z1FZaBFl+csTnnFa0z795fHr7Csq4QrsIY8mgC5IsexzkA9jXN3wBkY8BfU1szMRC2COepJzisC6fLsCMp9etAFBsDIyNxqu7MFJzu56djUt0RkkKAOnvRGocDICDscUAMlKsi9cjkiqfGGJ4yeBV6eMhiy/KP51UljBkjXseaAL9pGQieV+Na9jD5zESdB+lZtkhBwhGBwTW7aLtjHGc9hQBQnhCzkKMKO9NV/KABJrVngHls20EHqDxiskq3mEhBx0HWgDSjlCx4HXpU9uVlJU4V+uDWXG8z5UIMjn/ACat2gZirSD646n8aANNVYg7j2wM96YMA7mI4pRjCnaQM9CaSVcIOPlJ/GgAJEkhZjgAcZFRopkmyTlAOCKfGCXXccgc4pxYqGwoVfQUARyDJwRtIHXNNhmAbCYx3pbhPu788c4rNeRt58vj8KANORxI5Vcc/pTUikQnBIAPJotYwEDsAWPQVK4IGCeDzxQB9Kx/dB5wadWXZX7GNBKufcVpI6uMg8UAVZIcuzoMknkGszXsTW4jBG70rUu5vLHygfWudvZPMuBu6ZoA4i0sG/tyaNmAJ5APermvWy/ZgqqSOhApupzrD4otQBjfxn8DVvW7oQGTGDkcUAcH4gskjsCq439z3rznU7VsbQcqeme1eiXk7XBnBHToCOtYU2mvIu4ocHk8cUAcPa2OWOXOAelPuFZGyFGc9PWtmezaGZtqnZ3zTJbFTIrs4BPXFAFKwgdgWfhT2FaLQiDad2SewroNK0kPCWIwMdxUVzo4aZTG3yjk0AGmw/KrKOO9dKoVYB5YG7HNVNPs1jTBPyqM8jGakkZVOQzA+9AEFw8rR7Ohz3qnNBKyAuxJB49quFwxJJ4x+dMdsYCtle9AGfLuiiwTk9jWdePmEHC7zV3Vpdp2qQAehNZMk/yEOAPTFAFOdTtyzZYcgetMUfN8xO0/pUjoZWDPgY6UsAR8gA8Hk0AJdJhgUfnvzUMOTcqc5HTBqV1UyNyp+nNNgP7wswzjigDRtlVZFAyATyK3YlVI1WPOOtZOkxlmAPI68mtqMYXYAd2entQATlfshPRjxmsidWIwOSBnIrYuRHGpXA596xpWCvyMAcADjNADLRD54y2AT61fDeSWA78iqcK73/dg89c9KmmUrEx5yBg+1AF+G4RxgOC3Wpzhlxx1+8KxbGACMuWGW6HNXk3xlSmWz1HSgCyM7gzcKelOlZVjyMgUjzrtBY4I4wO1RwksxDEnPTPSgAeQyL6Y6E05IY3I7EDtTyiSbVbKgHkHvUjW2zMiE8dBQA7aFh2+vPHegBQ3AAz60KP43GAe2KfIGkUYwD7igD1I6qQUWMgLW7Z3uUUqeK8xtJ3EqlmNdvp7FoVI5yKAOnuozLaF++M1zyRtLLjt6muhtf31i0Y5ast4mtzIzEYAoA8v+IU/2TXbSWNioUj+tU9Uv5bx8554/GtHxppst/OkrZwjZz261nzLEiIoOSQCcUAUWR4sEp155p/2gNA4ABI/SpdQ+aMAjGBxkVjG4CvgsVJ4xQBK1ss+GIwgqOS0iQMygbc55py3QJ25ITvU8UayrwTyO/FAFmJ3lthHbKM4wTTvsk8bDcAE9a0NOgaOABE46k4p90XeTBOF96AKVvbvKzLtYL61HdWbLCxJPHT3rdsbhYY8MNx9abfRrOu8YAPp60AceqOW5OR0+lJKuRgD5vatKSFY9wJO4mqjAxqxJ4xQBg6mRkAZ3dx2FZdwdvHBPoa0r8hi2DknqTWNPIyrtDZ460AOYqIx5jDeemM9adbJuzjk9s1kyyMGwDyeme1aVkdyhWYZx1FAA77XYfKx9R2p9lmQ42gZOM0y4A2kLjB/CremquFQEBs9vSgDesYUVQxOD7VeiyGJBAz3NQKAkaAAEfSnAlVG3nPc0AF/u2Db8zHqay2RVyXB9vrWhMxD8njuD6VRuJEPAPX86AFsht3Echh19KfMcJtLE57etSWgG35Rjg47VRncm4wG59qAL1pCVj2AcZ59q0fJkhUKMAdc1StC6AMmSRwc1txSZRVkwc44FAGTJCzSjPPpUj22XDZ+YD+HtWk0kWDwM/SoRJtGQuAOlAEEcZQkE5z3NWF2ozeac5/hFQlmzu7E0xmK7mbhj70AWCUL5wcL0FVZi4G5TyTx9Kljj2p5gfcT0BoSPcc53EfwgUAdMIclWBArt9DRvIjxzwK4fTEZiu8nGec9q77TiIoI1AzxQB0tjgKV4z3xVXUrZWV/TqRVqxK9uuOap6tN5TZRd2evNAHKazEn9lXRwcqOBXnRdnt0ZgB2A716B4jvBDZSeYmNwPAOa82gvxJH8uCVJ4z0oAi1C8ZUwWwfWuWuLhpLk4PQ4FaGsysFk24yeeDWFDKTLksR+tAHQ2oG1QSeTzmur0nTvNOecdq5TRIFlmUv8xJ6dhXeWM32YgYXJ/SgC3EhVPLChe1UruF2GM4x0rUidH3H5ST071lX5cP8zjA/OgCsZliUISSfUU+O/JXKjAA71lTyjc2DnB5NReYJAhBJz096AH3NwZ5GUEc+lZ97/qdpY47mrFxGqv5qjA71j312XfYF4oAoyyDJHvWHekbxhsd+O1aEzlcluecZrLnKyMQTgjpQBSfh+T+PrV3TWxJzkEjpVZcjJJGO2atWRblm6+tAFmfYoCgEknrWlpkTB1IB+nc1nYDuCuQa6DS4mLBmbGO+eaANPy5cAKMKe5pz7tm0EYB6VcjGQpJIIFVpo9zEbF+bqe5oApXG4kbeuMkVlMGM+WGM9c1snEKHK545qJ7UXG08AfyoAhhBWIYYYqNI8yZBHPPvVqWMB9vAXtzTWjKyL0wffk0AXLBByAeKuPJl85wo6e9R20QWEMFyTz9KVPnYjGee9ADkJkB7Z6A0yRDuwrcelSMSDtAFJIypGGUfMD2oAZ53Ueg5HpTEaM8An5uuaa2S27nkdhS5VWX+HCjJBoAl8z5TzgjtiiObnb0P0pIwDG/zd+1NkDOoHGfbigD0O0swZgAMH0rolDRIhPGBVGyh8y7jxlectWzqcYVVKHoOtAF2wncbWI61HfOGJDjPpVO1mKYbdxVe/uMlmWQmgDkvHV3sjxH6YryTS9Q864u0TqrnkfU12Hja9kkeVS2cDk5rzvwqC11d4OFLf1NAG7qEkRTbjmsKNP8ATGK4GT3rTaEyzvjOOnSo5rV1OSDx0oA39LCQ+U24Ada6BZd8eFBPv3rzuS/aCVd3yhK29I10XA8ssAT36ZoA7OG68rCqecVSvnebkk1XhlTOT97FE1wuTlqAI2hBUkDp79ahbaoCjhh0qJpiZGHCg+nYU0ttBJ60AR6lLIExkDjmuanvI42Y5y49a0r5zLKQjcdOtctdKVumUgkZ6mgC/JIJDuGMntWe6lNzYHXjPeozL5bbWbv6UxXMpLH5VHbNADDIu8/3vertoAsbc5JrLYI0uULZq3bvk5DEnoBQBpwsrSKpJBBrrNMiJQMD19q5DTVWS4wQQRXbacoECuzYOe9AF1sqAqj6nvVaeMqxck8Cp2+9kMR3pJQGj/edh9aAKBbcgwmSec0RZTJOeR0PSo5Jgm0KvsoNTQyHaSRj8KAKss379RwfrU0HzuGfAI7VUhUNNlsMSenpWxHCoQY+92AFAFmOYC3A2lSfWoSACAGG4nqKa7OMIwGFHSnxELGS24g0AOUAMeCSB196ZMoZlUHBbqaVpBjBOPYVENx+bIwaAHRkKrZ3cCm7S0ZCgEGpsAQcoB68daiUEx9KACNQYzk8DsPWkklKEDIBx0A5pfLIODIFDenWkKtGx2gsf7xoA9rsrfaisxAbHNTX+Wh4IAoooAzomYqAP0qlqRIgbg5HX3oooA8f8cXiQ+YQck1y/hst50rKoUNgmiigDqo0hjALuNx5z61W1C9twhROSepFFFAHB67cv5pEbbvUUuhXrRTKMHPqaKKAO+tL4G3+U7nI5xViAO6gr949c0UUAWUt2YM74B9hT7mEyWrNEMuB0oooA5zhG/egh89qztTAcjaoz60UUAY13GRzziqbA4yrHB4NFFAEaqyuo3dD2HQVqQoRbk9Pw60UUAXdKV/OXJ44zXc2ihrVFKfSiigB0ZYNhlP0p7DEXIxk0UUAZso2Sr8vT1p5wbaRh1oooArWAAmAHU85Pet21IUk5yRRRQBDM4LMvQnue9VyZEUruG0c80UUAMQuDnI5p6yMJDyCB7fpRRQBaMoZeTx7U3zDtJOAo6DHNFFAEb/MNwwDiq8jvIx8pi2PQ0UUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A lateral arteriogram in the same patient upon end-expiration. There is a notable region of stenosis not seen on the previous film (arrowhead). Beyond this region of stenosis, there is post-stenotic dilatation (red arrow) signifying a region of significant and persistent proximal narrowing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sherry Scovell, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_35_34367=[""].join("\n");
var outline_f33_35_34367=null;
